Special Supplement - Pharmac South Expo Chennai

(GMP & ISO 9001:2015 CERTIFIED COMPANY)

Plot No.7407, G.I.D.C. Estate,Ankleshwar 393 002. Gujarat, India. Ph No.: 0091 2646 222825 | Fax No.: 0091 2646 222824. Cell No.: 0091 9825205460 / 0091 9624042444

Email: sales@prudencepharma.com; inquiry@prudencepharma.com Web: www.prudencepharma.com

MANUFACTURING PRODUCTS API & INTERMEDIATES

Manufacturing Products API RIVAROXABAN

l GLIMEPIRIDE l TORSEMIDE l CELECOXIB

l SILODOSIN l FEBUXOSTAT

l MEMANTINE HYDROCHLORIDE

l PIRFENIDONE l PHENYLEPHRINE HYDROCHLORIDE

l ETORICOXIB l GLIBENCLAMIDE [GLYBURIDE]

l AMLODIPINE BESILATE l AMLODIPINE MALEATE

l AMLODIPINE CAMSYLATE

l S- AMLODIPINE BESYLATE [LEVA AMLODIPINE BESILATE]

Manufacturing Products Intermediates

l 5-CHLOROTHIOPHENE-2-CARBOXYLIC ACID FOR RIVAROXABAN

l (S)-2-(OXIRAN-2-YLMETHYL ISOINDOLINE-1, 3-DIONE (OR) (S)-GLYCIDYLPHTHALIMIDE FOR RIVAROXABAN

l 4-(4-AMINOPHENYL) MORPHOLIN-3-ONE FORRIVAROXABAN

l 4 HYDROXY PYRIDINE 3 SULFONIC ACID FOR TORSEMIDE

l 4-(3-METHYL PHENYL) AMINO-3-PYRIDINE SULFONAMIDE FORTORSEMIDE

l AMLODIPINE BASE

l S-AMLODIPINE BASE [LEVA AMLODIPINE BASE]

l SULPHONAMIDE OF GLIMIPRIDE

l SULPHONAMIDE OF GLIBENCLAMIDE

l 1-(4-METHYLPHENYL)-4,4, 4-TRIFLUORO-BUTANE-1,3-DIONE OF CELECOXIB

l 4-SULFONAMIDO PHENYL HYDRAZINE HYDROCHLORIDE OFCELECOXIB

l 4-HYDRAZINOBENZOIC ACID-HCL (4-HBA) FOR DEFERASIROX

l 2-(2-HYDROXYPHENYL)-4H-BENZO[E] [1,3] OXAZIN-4-ONE FOR DEFERASIROX

l KETOSULFONE OF ETORICOXIB

l KETOSULFONE OF ETORICOXIB

l CDT-SALT OR HF SALT OF ETORICOXIB

www.mazadapharmaguide.com

SOUTH INDIA EXHIBITION SPECIAL SUPPLIMENT

14-15-16

SEPTEMBER 2023

HYDERABAD

14-15-16

SEPTEMBER 2023

Chennai to host 8th edition of PHARMAC SOUTH

Our bureau, Mumbai

Theeighth edition of PHARMAC SOUTH will be held at Hall 3A & 3B Chennai Trade Centre, CTC Complex, Nandambakkam, Chennai –600089, Tamil Nadu on 14th and 15th July 2023. PHARMAC SOUTH is the premier, high ­ powered Contract Manufacturing, Pharmaceutical & Nutraceutical Exhibition & Conference. Participants include manufacturers and trade professionals from industries as diverse as Pharma Machinery, Analytical Instruments, Lab Equipment, Herbal, and Cosmetics. It is one of the must­attend events for the pharma & allied sectors. The twoday exhibition ­ cum ­ seminars are organized jointly by Orbit Exhibitions and Indian Drug Manufacturers' Association.

PHARMAC SOUTH provides a unique forum to understand industry trends and markets, dialogue with key technical and regulator personnel and associated stakeholders and compare notes with major suppliers of products and services in the pharmaceuticals industry. The exhibition is expected to witness great visitor footfall displays of the latest pharmaceutical machinery, packaging equipment, software technology for the pharma industry and management, and more! The entire pharmaceutical production process is demonstrated and celebrated at Pharmac South. It brings together the leading pharmaceutical equipment manufacturers and suppliers and key industry buyers for

four days of business and networking. Pharmac South Exhibition will help build a better understanding of what a target audience wants and develop strategies that resonate with them. It is a channel for obtaining information on the latest developments and trends in the pharmaceutical industry.

Pharmac South plays a vital role in the growth and advancement of the industry, with a solid representation of brands and products who exhibit at our shows, giving professionals an opportunity to try and test out a vast array of products that best suit their requirements.

Pharmac South is geared to further create business opportunities and tap the lucrative market in the analytical, lab equipment, pharma machinery, and

EXHIBITORS PROFILE

l PHARMACEUTICAL PRODUCTS l PHARMACEUTICAL BULK DRUGS l VETERINARY DRUGS l ADDITIVES

l INTERMEDIATES l PHARMACEUTICAL FORMULATION

l API l PHARMACEUTICAL MACHINERY / PRINTING & PACKAGING l PHARMA ANCILLARY & UTILITY ERVICES & MAINTENANCE. (WATER & HVAC SYSTEMS)

l NUTRACEUTICAL PRODUCT/ DIETARY SUPPLEMENTS

l CONTRACT MANUFACTURERS l CONTRACT RESEARCH ORGANIZATIONS (CROS). l AYURVEDIC / HERBAL PRODUCTS. l SOFTWARE FOR PHARMACEUTICAL INDUSTRY & MANAGEMENT. l BIOPHARMACEUTICALS/ BIO LAB INSTRUMENTS & EQUIPMENT. l PHARMACEUTICAL ENGINEERING / REFRIGERATION / CLEAN ROOM TECHNOLOGY.

l ANALYTICAL LABORATORY SUPPLIES (INSTRUMENTS, GLASSWARE, LAB REAGENTS -CHEMICALS). l BANKS / FINANCIAL SECTORS FOCUSING ON PHARMA INDUSTRY.

l TRADE PROMOTION BODIES-TECHNICAL PUBLICATIONS / TRADE ASSOCIATION / MEDIA / PUBLICATIONS. l PATENT / TRADE MARK LAWYERS

packaging market in India. The event aims to deepen understanding of the changing landscape in the sector to enable responses to marketplace trends and towards establishing a unique drug safety ecosystem in India.

Pharmac Expo empowers the manufacturing industries by facilitating ideal grounds for networking and the opportunity to get acquainted with the latest technologies by bringing the best of the industry to one stage. With a lineup of engaging supporting programs that include a conference on current topics and the Hosted Buyer

Program, the trade fair not just offers insights into the industry but also gives a chance to the exhibitors to connect with the buyers directly.

Visitor's profiles include decisionmakers and seniors from pharmaceutical; top management and CEOs; regulators, research, and policymakers; promoters of start­ups and small ­ scale pharma companies; industry associations and key members; pharma distributors, wholesalers, traders; financial institutions' R&D managers; quality control managers.

CHENNAI TRADE CENTRE, CTC COMPLEX, NANDAMBAKKAM, CHENNAI – 600089, TAMIL NADU

FUTURE PROSPECTS OF INDIAN PHARMA DRUG MARKET

Sateesh Kulkarni

A Review of Pre and Post Pandemic period

Despitethe economic fallout of the Covid ­19 pandemic, the global pharmaceutical industry is recording a compound annual growth rate (CAGR) of 5.6% and is projected to reach US$1.6 trillion in 2025. India is estimated to touch US$ 130 billion in value terms by the end of 2030. During 2022, in spite of a number of geopolitical issues, India continued to supply medicines globally, living up to its reputation as the 'pharmacy of the world'. The pharma market in India has grown by 12.5 per cent in 2022. India’s domestic pharmaceutical companies are expected to report steady revenue growth of 6­8 per cent in FY2023 and in FY2024.

The industry is typically involved in four types of businesses: marketing of generic medicines, marketing of branded generic medicines, marketing of innovator medicines and manufacture and supply of active pharmaceutical ingredients, which are used as ingredients in medicines as well as finished formulations. The government of India extended support to pharma companies using the Production Linked Incentive (PLI) scheme to ensure self ­ reliance through enhanced domestic manufacturing capacity for high­value products.The PLI schemes are for bulk drugs and pharmaceutical manufacturing, together accounting for an outlay of around USD 2.7 billion.

Despite the strong foundation of the global pharmaceutical industry, the Covid­19 pandemic period has brought changes to many aspects of the pharma business and these are creating both short term as well as long term effects.Immediately following the pandemic, the industry witnessed huge supply chain disruptions. Covid­19 had raised the demand for many drugs including antibiotics, antiviral, antiseptic, antihistamine, certain biologics, respiratory medicines, vitamin and mineral supplements, vaccines etc. As the demand rose sharply, facilities upgradation became the priority. Also, sourcing of raw materials was another challenge. Availability of Active Pharmaceutical Ingredients (APIs) and intermediates particularly from China was severely impacted. Along with this, the situation was further aggravated as some countries imposed restrictions on export of antibiotics and other APIs considering their future demand. This supply chain disruption created the necessity for producing their own APIs or shifting the production sites to different locations.

Prior to the pandemic, global pharmaceutical units invested a significant amount on research and development of biologics and personalised medication, while other top companies were busy with biosimilars. Covid­19 shifted the focus to vaccine development, given the urgency to manufacture the

appropriate number of vaccines at the right time.

The long­term effects of Covid­19 on pharmaceutical industrieshas resulted a shift of focus towards selfsufficiency and self ­ reliance. As a result, both developing and developed countries are now in a stage of planning for self ­ sufficiency in all types of medicines for crisis management.This will lead to capacity enhancement also.

Challenges

While there has been a push for more research and development (R&D) in India, the industry is primarily focused on manufacturing of generic medicines and export of bulk drugs. Indian companies, which mainly sell generic drugs in the US, have been facing pressure due to price erosion in

this year. Merck had over USD59 billion in total sales in 2022.

Opportunities

Except for the regulated pharmaceutical market, clinical study for individual products is very rare. However, for getting approval of a new product, it is mandatory to conduct a clinical study. Under these circumstances, many pharmaceutical companies will strengthen their capacity for quick arrangement of clinical study.

In addition, the Contract Research Organisations (CROs) will get a boost in their business as they play an enormous role in the launch of new products.

New opportunities are emerging in automation in operations. Automation system is the need of the hour in every operational procedure, even in

These two regions are the front runners in the pharmaceutical business due to strong emphasis on research and innovation.Twenty­five percent of the revenues earned by the top companies of these two regions are reinvested in research and development (R&D). In fact, they are the leaders in introducing new medications to the world, having nine of the top ten pharmaceutical companies of the world.

China is leading the emerging pharma countries and their overall spending on medicines is expected to grow at a CAGR of 4.5%­7.5% through 2025 to reach between USD170 billion and USD200 billion. China produces and exports around 40% of Active Pharmaceutical Ingredients (APIs) sent out to the world. The key drivers of Chinese pharmaceutical industries are low cost of utilities and a pro­active government support.Japan is one of the largest pharmaceutical markets in the world with a yearly turnover of around USD110 billion. The generics market of Japan had been rising as the government started to promote the use of generics in 2007.

The Indian context

The pharma sector in India too is gearing up to move from 'volume' to 'value' leadership in the coming years. The key to success, going forward, will depend on regulatory simplification, increased industry ­ academia collaboration, and strengthening innovation mind­set.

the world's largest pharmaceuticals market.

Revenues of the drug sector are expected to increase in 2023 and further supported by healthy growth in the domestic and emerging markets. At the same time, pricing pressures in the US and European markets will moderate the growth to a certain extent.The period 2023 and beyond presents immense opportunities for the Indian pharma sector to reinvent and innovate. Innovation needs to be made part of the larger ecosystem of developing novel drugs for unmet medical needs and making them accessible to patients.

Globally, the post­Covid scenario has changed a number of rules of the game. The industry has realised the need to make self ­ reliance, automation, clinical studies and ethical practices as the key drivers for the future.Pharmaceutical companies which had a windfall from the pandemic over the past two years selling vaccines and treatments are now facing newer challenges. Pfizer has been the biggest corporate beneficiary of the pandemic financially, with more than USD56 billion in 2022 revenue from the vaccine it developed with German partner BioNTech and from its COVID19 antiviral treatment Paxlovid. The company expects its revenue to drop to around USD21.5 billion in 2023. Merck reported sales of USD5.7 billion from the treatment last year. Analysts expect that to drop below USD1 billion

medium size companies.

The ‘new normal’ has had an impact on the pharma industry as well. New models of marketing have emerged. With the pandemic bringing in social distancing, seminars, clinical meetings and other scientific communications moved to virtual spaces. These changes involved reduced promotional cost.At the same time, telemedicine is emerging as an alternative choice for doctor consultation. Various apps for patient connection and medicine selection are becoming popular and this is where pharmaceutical companies are paying their utmost attention.

Going forward

The global prospects

The pharmaceutical industry is mostly dominated by original brands with a market share of 56%, followed by generics/branded generics with a market share of 36%. The rest of the market share is accounted for by OTC and/or other products.The revenue generation from biologics has increased by 70% in the last five years and currently this segment is occupying more than 25% of the total market. Over the past decade, generics/branded generics and biosimilars are growing faster than brands and original biologics. The US alone comprises more than 30% of the global medicine market and their current growth rate is around 3% per annum. The European pharmaceutical industry generates a yearly revenue of USD295 billion with a growth of 5.4%.

The Indian pharmaceutical industry, the world's largest provider of generic medications, generated domestic revenue worth USD42 billion in 2021 which is estimated to reach USD65 billion by 2024. This industry has shown a growth of around 15% led by the production of Covid­19 products in the last one year, compared to the single digit growth of 3% shown last year. India has the highest number of USFDA approved plants other than the US, and it is projected to supply 40% of the generic formulations for America and 20% for the world. With the current valuation of USD 50 billion, the government policies and the robust R­D expansion in the pharma sector are expected to lead to the path of resilient growth not just in volume but in value as well. Domesticmanufacturers are looking to tap into international generic market which provide high margins. The number of Abbreviated New Drug Applications (ANDA) to the US FDA is also increasing every year. The Industry is witnessing a paradigm shift as the focus is shifting from the manufacturing of generic drugs to drug discovery and development. Leading players like Glenmark, Sun Pharma, Cadila Healthcare and Piramal Life Sciences, have applied for conducting clinical trials for new drugs. With the passage of the New Drugs and Clinical Trial Rules, 2019 (“CT Rules”) the clinical trial sector is also growing steadily with many choosing India as one of the trial sites when conducting global clinical trials. Reportedly, India’s clinical trials market is expected to each USD3.15 billion by 2025.

(The author is pharma consultant)

INNOVATIONS IN INDIAN PHARMA MACHINERY

Parina Kumari and VanditaKakkar

In the early years, pharmaceutical manufacturing in India relied on basic and manually operated machinery. The focus was primarily on simple formulations and basic manufacturing processes. Machinery such as manual tablet compression machines, manual capsule filling machines, and simple mixing and blending equipment were used.With the industrialization of the pharmaceutical sector in India, there was a shift towards more advanced machinery. In the 1960s and 1970s, Indian pharmaceutical manufacturers started adopting semi­automatic and automatic machines for tablet compression, capsule filling, coating, and packaging. Local machinery manufacturers emerged to cater to the growing demand for pharmaceutical equipment. In the 1980s and 1990s, Indian pharmaceutical machinery manufacturers started collaborating with international players to bring in advanced technologies and expertise. Joint ventures and technology transfer agreements with foreign companies allowed Indian manufacturers to access cutting­edge machinery and manufacturing processes. This collaboration led to the adoption of more sophisticated and efficient machinery in the Indian pharmaceutical industry. In the 2000s, the Indian pharmaceutical machinery industry underwent significant modernization and technology upgrades. This period witnessed the introduction of computerized control systems, process automation, and advanced inspection technologies. Indian machinery manufacturers began developing innovative solutions to cater to the evolving needs of the pharmaceutical industry. In recent years, India has seen the rise of domestic manufacturing capabilities in pharma machinery. Several Indian companies have emerged as key players in the manufacturing and supply of pharmaceutical machinery. These companies have focused on research and development, product innovation, and customization to meet the specific requirements of the Indian pharmaceutical industry. The Indian pharma machinery industry has been increasingly embracing advanced

technologies in recent times. Automation, robotics, artificial intelligence, and data analytics are being integrated into pharma machinery to enhance efficiency, quality control, and process optimization. Continuous manufacturing, green technologies, and sustainability measures have also gained importance. Indian pharma machinery manufacturers have expanded their footprint in the global market. They have established partnerships and export channels, supplying machinery to pharmaceutical companies worldwide. The reputation of Indian machinery manufacturers has grown, with many companies gaining recognition for their quality products and competitive pricing.

The Indian pharmaceutical machinery industry has undergone significant evolution and innovation over the years, driven by technological advancements, regulatory requirements, and the growing demand for efficient and high­quality pharmaceutical manufacturing. These innovations have played a crucial role in enhancing the efficiency, productivity, and quality of pharmaceutical manufacturing processes in India.

Following are someremarkable innovations in Indian pharma machinery:

Automation and Digitization

There has been a notable shift towards automation and digitization in Indian pharma machinery. Manufacturers are incorporating advanced control systems, robotics, and computerized processes to streamline operations, improve accuracy, and reduce human errors. This trend has led to increased productivity and efficiency in pharmaceutical manufacturing.

Muti­functional machines

The trend of all­in­one capabilities in pharmaceutical machinery aligns with the industry's focus on maximizing space efficiency and optimizing production processes. It enables

manufacturers to achieve more with less, contributing to cost savings, increased productivity, and a more streamlined manufacturing environment. For instance, an in­line drying system has been introduced, eliminating the need for tumble dryers and drying tunnels. This single machine effectively performs the same task as two separate machines. By integrating drying functionality into a single unit, pharmaceutical manufacturers can save valuable floor space while maintaining the required drying capabilities for their products.

Advanced packaging line integration systems

Every year, a wide range of inventive packaging methods, such as pouches and bubble packaging, are introduced to cater to the needs of the pharmaceutical sector. This ongoing evolution in packaging techniques reflects the industry's commitment to ensuring the safe and efficient delivery of pharmaceuticals to consumers. These systems integrate multiple packaging machines into a cohesive and automated production line. They incorporate advanced control systems, conveyors, robotics, and data management capabilities to streamline the packaging process, reduce errors, and increase overall efficiency.

Artificial intelligence (AI) integrated pharmaceutical machinery

Adoption and implementation of AI in pharmaceutical machinery may vary among different manufacturers in India. However, the industry is increasingly recognizing the potential of AI in improving pharmaceutical manufacturing processes and is actively incorporating AI technology into their machines to stay competitive and meet the evolving needs of the market.These systems use advanced imaging technologies, such as machine vision and to inspect pharmaceutical products for defects, contaminants, and quality attributes. They can detect flaws in packaging, tablets, capsules, and other dosage forms with high accuracy and efficiency. Similarly, advanced automated packaging systems that streamline the packaging process, minimize errors, and improve product safety. These systems include blister packaging machines, strip packaging machines, and cartoning

machines, which offer high­speed operation and meet stringent regulatory requirements.

3D printing integrated pharmaceutical machinery

3D printing, also known as additive manufacturing, has gained significant traction in the pharmaceutical industry as a disruptive technology with diverse applications. It is primarily used for manufacturing personalized medical devices and drug delivery systems.The integration of 3D printing in pharmaceutical machinery offers numerous advantages, including rapid prototyping, customization, reduced costs, improved efficiency, and increased design flexibility.3D printing enables the creation of complex and intricate components that may be difficult or costly to produce using conventional methods.

Quality control equipment

Ensuring the quality and purity of pharmaceutical products is of utmost importance. Indian pharma machinery innovations include advanced quality control equipment such as highperformance liquid chromatography (HPLC) systems, spectrophotometers, dissolution testers, and particle size analyzers. These instruments help in accurately analyzing the chemical composition, purity, dissolution rates, and particle size distribution of drugs, ensuring compliance with regulatory standards.

Data management software’s integrated with pharmaceutical machinery

Indian pharmaceutical manufacturers have increasingly embraced process automation and data management systems to improve efficiency, reduce human errors, and enhance overall productivity. Data management software enables efficient tracking and traceability of raw materials, intermediates, and finished products throughout the supply chain.

Quick­disconnect features

These features have been developed to simplify and expedite the cleaning process, minimizing disruptions to production. This features have revolutionized the cleaning procedures for pharmaceutical equipment, allowing (Continued on page no 06)

manufacturers to maintain high cleanliness standards while minimizing downtime. This innovation has positively impacted the efficiency and productivity of pharmaceutical manufacturing processes.

Efficiency boost

To maximize productivity and generate higher revenue, pharmaceutical machinery manufacturers have prioritized efficiency by focusing on three key factors: speed, machine production capacity, and hours of operation. Manufacturers have made significant advancements in designing machinery that operates at faster speeds than ever before. By increasing the rate at which the machines perform various tasks, the overall production output is significantly enhanced. This allows pharmaceutical manufacturers to produce a larger quantity of products within a given timeframe.Moreover, machinery manufacturers have also focused on increasing the production capacity of their equipment. By developing machines with higher production capacities, pharmaceutical manufacturers can produce a greater volume of products in a single batch or production cycle. This not only saves

time but also reduces the need for additional resources or equipment, leading to cost savings.

Focus on quality and compliance

Indian pharma machine manufacturers prioritize quality and compliance with international standards. They ensure that their machines meet the stringent regulatory requirements of the pharmaceutical industry, including Good Manufacturing Practices (GMP) and certifications such as ISO.

Advanced process control

The implementation of advanced process control technologies ensures tighter control over manufacturing processes. This includes real­time monitoring, data analytics, and predictive modeling to optimize process parameters, reduce variations, and ensure consistent quality.

Continuous manufacturing

Continuous manufacturing is an emerging trend in the pharmaceutical industry, and Indian machinery manufacturers have been incorporating this concept into their equipment. Continuous manufacturing allows for uninterrupted production, reduces

waste, and offers better process control, resulting in increased efficiency and cost savings.

Flexible manufacturing systems

Pharmaceutical machinery manufacturers in India are focusing on developing flexible manufacturing systems that can accommodate a wide range of product sizes and variations. These systems allow quick changeovers between different products and formulations, improving operational efficiency and reducing downtime.

Green and sustainable solutions

The innovation in Indian pharma machinery emphasizes sustainable and environmentally friendly practices. Machinery manufacturers are developing energy­efficient equipment, implementing waste reduction measures, and adopting green manufacturing processes. This focus on sustainability aligns with global trends and regulations while reducing the industry's ecological footprint.

Track and trace Systems

With the increasing focus on product safety and compliance, Indian pharma machinery has incorporated track and trace systems. These systems use

technologies such as barcode scanning, RFID (Radio Frequency Identification), and serialization to monitor and trace pharmaceutical products throughout the supply chain. This ensures product authenticity, reduces counterfeiting, and enhances patient safety.

Modular equipment

The innovation in Indian pharma machinery has brought about the development of modular and flexible equipment. Modular systems allow for easy customization and scalability, enabling manufacturers to adapt to changing production requirements and accommodate different product variations. This flexibility enhances productivity and reduces time to market. Innovation plays a crucial role in helping Indian pharma machinery in several ways. Here are some key ways in which innovation benefits Indian pharma inery: 1.Enhanced efficiency , 2. Improved product quality, 3. Cost reduction, 4.Scalability and flexibility, 5.Compliance with regulatory, tandards, 6. Global competitiveness, 7. Sustainability and environmental responsibility.

Authours are from University Institute of Pharmaceutical Sciences, Panjab University

OVERVIEW OF INDIAN PHARMA MACHINERY

Rajesh Nath

The Indian pharmaceutical machinery industry plays a crucial role in the manufacturing and packaging processes of pharmaceutical products, encompassing a wide range of machinery and equipment used in areas such as formulation, filling, packaging, labelling, and quality control of pharmaceuticals. The industry has experienced significant growth over the years, driven by the country's robust pharmaceutical sector. The industry is characterized by the presence of both domestic and multinational players, offering a diverse range of machinery solutions to meet the industry's needs. Indian manufacturers cater not only to the domestic market but also export pharmaceutical machinery to various countries worldwide. The industry has established manufacturing facilities across various regions of India, equipped with modern technology and a skilled workforce to meet the growing demand for pharmaceutical machinery.

In recent years, the industry has gained recognition for its ability to provide cost­effective machinery solutions without compromisingon quality. Indian pharmaceutical machinery manufacturers have made significant strides in complying with international quality standards, such as Good Manufacturing Practices (GMP) and various certifications, to ensure that the machinery meets global regulatory requirements. Furthermore, the industry has actively expanded its export market, capitalizing on the growing demand for pharmaceutical machinery worldwide. Indian machinery has gained a reputation for its competitiveness in terms of pricing, adherence to quality standards, and the ability to cater to diverse customer requirements. As the pharmaceutical industry continues to evolve, the Indian pharmaceutical machinery sector is keeping pace with the changing needs of pharmaceutical manufacturers. The industry is investing in research and development, embracing

automation and digitization, and exploring advanced technologies such as robotics, artificial intelligence, and data analytics to enhance productivity, efficiency, and quality control. With a positive growth trajectory, increasing domestic demand, a focus on quality compliance, and a proactive approach to innovation, the Indian pharmaceutical machinery industry is poised for further expansion and is wellpositioned to contribute to the growth and success of the pharmaceutical sector in India and abroad.

Statistics and Industry Highlights: The industry's adherence to quality standards, government support, and focus on research and development contribute to its competitiveness in the global market.

• Growth Rate: The Indian pharmaceutical machinery market has experienced a robust growth rate of approximately 8% CAGR over the past few years. This growth is fuelled by the increasing demand for pharmaceutical products and the need for advanced machinery to support production.

• Market Size: The market size of the Indian pharmaceutical machinery industry was valued at approximately USD 2.0 billion in 2021. The industry has shown consistent growth, driven by the expanding pharmaceutical sector and the government's focus on promoting healthcare and pharmaceutical manufacturing.

• Domestic Consumption: India's pharmaceutical market is one of the largest globally in terms of volume, with a high demand for pharmaceutical machinery to

support production. The domestic consumption of pharmaceutical machinery is driven by the need to cater to the growing population's healthcare needs and the rising demand for quality pharmaceutical products.

• Manufacturing Facilities: India has established a strong manufacturing infrastructure for pharmaceutical machinery. Several manufacturing facilities are located in key regions such as Maharashtra, Gujarat, and Tamil Nadu. These facilities are equipped with advanced technology and employ a skilled workforce to meet the industry's demands.

• Export Market: The Indian pharmaceutical machinery industry has witnessed significant growth in its export market. In recent years, India has become a prominent exporter of pharmaceutical machinery to various countries worldwide. The industry's export revenue reached approximately USD 650 million in 2020, highlighting the industry's competitiveness in the global market.

• Employment Generation: The pharmaceutical machinery industry plays a vital role in job creation. It provides employment opportunities to a large workforce engaged in manufacturing, research and development, quality control, and maintenance of pharmaceutical machinery. The industry's growth contributes to the overall employment landscape in India.

• Government Initiatives: The Indian government has undertaken several initiatives to support the pharmaceutical machinery industry. Programs such as "Make in India" and "Pharma Vision 2020"

aim to promote domestic manufacturing, research and development, and technological advancements in the pharmaceutical sector. These initiatives have facilitated the growth of the pharmaceutical machinery industry.

• International Recognition: Indian pharmaceutical machinery manufacturers have gained international recognition for their quality products and competitive pricing. The industry has witnessed increased demand for its machinery in global markets due to its adherence to international quality standards and compliance with regulatory requirements.

• Collaboration and Partnerships: Indian pharmaceutical machinery manufacturers actively collaborate with domestic and international pharmaceutical companies to develop customized machinery solutions. Such collaborations enhance technology transfer, promote knowledge exchange, and foster innovation in the industry.

• Research and Development: The industry invests significantly in research and development activities to stay at the forefront of technological advancements. Manufacturers focus on developing innovative machinery and equipment that meet the evolving needs of the pharmaceutical industry, such as high ­speed automated systems, advanced packaging solutions, and precision control systems.

Latest Figures and Trends:

• Automation and Digitization: The industry is witnessing a shift towards automation and digitization in line with global trends. Manufacturers are increasingly incorporating advanced technologies such as robotics, artificial intelligence, machine learning, and data analytics into pharmaceutical machinery to improve efficiency, productivity, and quality control.

• Quality Compliance: With a focus on meeting stringent regulatory requirements, Indian

(Continued on page no 08)

pharmaceutical machinery manufacturers are adopting international quality standards such as Good Manufacturing Practices (GMP) and ISO certifications. Compliance with these standards ensures the safety, efficacy, and reliability of pharmaceutical products.

• Pharmaceutical Packaging: As the demand for pharmaceutical products grows, there is an increased focus on advanced packaging solutions. Indian machinery manufacturers are developing innovative packaging machinery that offers features such as tamper­evident packaging, blister packaging, track­and­trace systems, and serialization to meet the industry's evolving needs.

• Contract Manufacturing: The trend of outsourcing pharmaceutical manufacturing to contract manufacturers is gaining momentum. This presents an opportunity for the pharmaceutical machinery industry as contract manufacturers require machinery and equipment to meet the production demands of their clients.

Future Outlook:

The future of the Indian pharmaceutical machinery industry looks promising, driven by several factors:

• Rising Domestic Demand: The domestic demand for pharmaceutical machinery in India is driven by the country's growing pharmaceutical sector. The Indian pharmaceutical market is estimated to reach a value of USD 65 billion by 2024, further fuelling the demand for machinery and equipment.

• Increasing Exports: The Indian pharmaceutical machinery industry has been actively expanding its export market. In 2020, exports of pharmaceutical machinery from India amounted to approximately USD 650 million. This export revenue is projected to grow at a CAGR of over 12% from 2021 to 2026.

• Growing Market Size: The Indian pharmaceutical machinery market is expected to witness substantial growth in the coming years. By 2025, the market size is projected to reach USD 3 billion, reflecting a compound annual growth rate (CAGR) of around 10%.

• Favourable Government Policies: The Indian government has been implementing various policies and initiatives to promote the pharmaceutical sector, including the pharmaceutical machinery industry. The "Pharma Vision 2020" initiative and schemes like "Make in India" encourage domestic manufacturing and innovation in the pharmaceutical machinery sector.

• Technological Advancements: The industry is witnessing rapid technological advancements, with a focus on automation, digitization, and advanced manufacturing techniques. The adoption of technologies like robotics, artificial intelligence (AI), and Internet of Things (IoT) in pharmaceutical machinery is expected to enhance productivity, efficiency, and quality control.

• Investment in Research and Development: Indian pharmaceutical machinery manufacturers are investing significantly in research and development (R&D) activities to develop innovative machinery solutions. These investments are aimed at improvingprocess efficiency, product quality, and meeting the evolving needs of the pharmaceutical industry. In recent years, R&D investments in the pharmaceutical sector have reached around 8­9% of sales.

• Contract Manufacturing Opportunities: The trend of outsourcing pharmaceutical manufacturing to contract manufacturers is gaining momentum. This presents opportunities for the pharmaceutical machinery industry, as contract manufacturers require advanced machinery and equipment to meet the production demands of their clients.

• International Collaborations : Indian pharmaceutical machinery manufacturers are actively engaging in collaborations and partnerships with international players to expand their global presence. These collaborations facilitate technology transfer, knowledge exchange, and market access, leading to enhanced growth prospects for the industry.

• Focus on Quality Compliance: Indian pharmaceutical machinery

manufacturers are increasingly focusing on adhering to international quality standards such as Good Manufacturing Practices (GMP) and obtaining certifications like ISO 9001 and ISO 13485. This emphasis on quality compliance ensures the safety, efficacy, and reliability of pharmaceutical products and enhances the industry's reputation.

• Export Market Diversification: Indian pharmaceutical machinery manufacturers are actively exploring new export markets and diversifying their customer base. Apart from traditional markets like the United States and Europe, manufacturers are targeting emerging markets in Asia, Latin America, and Africa, where there is a growing demand for pharmaceutical products.

Over the past years, the industry has significantly built­up production capacities. This is in response to the continuing good economic situation and the good structural conditions in the pharmaceutical industry.Many factors have a stimulating effect on the demand for production and packaging machinery for pharmaceuticals: There is the increasing superannuation of the population in the industrialized countries, the trend towards small and very small batch sizes, e.g. for personalised medication, the development of production capacities for the rapid supply of vaccines in the event of a pandemic, the increase in lifestyle diseases in the emerging countries, an increasing population with improved drug supply in emerging and developing countries as well as the increasing cost pressure on drug manufacturers by health care providers. In conclusion, the Indian pharmaceutical machinery industry has witnessed significant growth, driven by domestic demand and exports. The industry is evolving by adopting advanced technologies, focusing on quality compliance, and catering to the changing needs of pharmaceutical manufacturers. With a positive outlook and favourable market conditions, the industry is poised for further expansion in the coming years.

The author is managing director, VDMA India Services Private Limited

FUTURE PROSPECTS OF INDIANPHARMA DRUG MARKET

Dhruv Joshi, Mukesh Nayak

Introduction

One of the largest in the world and well­known for its massive production and export of generic medications is the pharmaceutical industry in India. India has a strong network of pharmaceuticals manufacturing facilities and research organizations, making up a welldeveloped pharmaceutical infrastructure. A variety of public and private sector businesses, from huge multinational firms to small and medium ­sized businesses, make up the industry. Indian pharmaceutical firms are now well known for their proficiency in creating generic versions of branded medications and reverse engineering. As a result, more people now have access to affordable medications, especially in the area of vital medicines and increasing healthcare accessibility. The business has also seen large investments in R&D, which has resulted in the development of novel therapeutic approaches and the discovery of new pharmaceuticals. Many Indian pharmaceutical firms have intensified their research efforts and are currently involved in numerous clinical studies and drug development initiatives. India plays a vital role in providing affordable medicines to the global community as well as the Indian populace.

INDIA PHARMA DRUG MARKET

India is renowned for its affordable vaccinations and generic medicines and is the world's largest supplier of generic medications. As per the report by Insights10, the Indian

pharmaceutical sector has developed over time into a robust industry, rising at a CAGR of 13.4%, valued to reach $130 Bn in 2030 from $48 Bn in 2022, and is currently ranked third in pharmaceutical output by volume. Some of the key sectors of the Indian pharmaceutical business include generic drugs, over­thecounter medicines, bulk meds, vaccines, contract research & manufacturing, biosimilars, and biologics. India is home to the most US Food and Drug Administration (USFDA)­compliant pharmaceutical production facilities, with 500 API (Active Pharmaceutical Ingredient) companies accounting for around 8% of the global API market.

Over 50% of the world's demand for various vaccines is met by the Indian pharmaceutical industry, as is 40% of the US market for generic drugs and 25% of the UK market for all medicines.

A total of 10,000 manufacturing facilities and 3,000 medicinal businesses makes up the domestic pharmaceutical industry.1 India holds a significant place in the world's pharmaceutical industry. The nation also possesses a sizable pool of scientists and engineers that might propel the sector forward to new heights. Currently, Indian pharmaceutical companies provide more than 80% of the antiretroviral medications needed to treat AIDS (Acquired Immune Deficiency Syndrome) around the world. India has earned the title of "pharmacy of the world" thanks to the affordable prices and superior quality of its pharmaceutical products.

Support from Government

The Central Government has launched a number of initiatives to

strengthen the ecosystem for startups. For instance, the Department of Biotechnology, Department of Science & Technology, Council of Science & Industrial Research, and Biotechnology Industry Research Assistance Council have generously provided funding, mentoring, and high ­quality infrastructure to biotechnology start­ups.

Strengthening of Pharmaceutical Industry (SPI): With a total financial investment of $6.04Mn, the Ministry's "Strengthening of Pharmaceutical Industry (SPI)" scheme provides the support needed to MSMEs and existing pharma clusters across the nation in order to increase their productivity, quality, and

2 new projects of MSME Pharma clusters have been approved under API­CF from Telengana, out of which one project has been accorded final approval and one project has been accorded 'in­ principle' approval.

There is no plan to increase the financial assistance limit of $0.2 Mnunder the sub­scheme API­CF of Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers.

However, Ministry of MSME is implementing Micro and Small Enterprises Cluster Development Programme (MSE­CDP) under which, the upper limit of project cost for considering Government of India (GoI) grant for setting up of CFCs has been enhanced from $0.2 Mn to $0.3 Mn in the New Guidelines of the scheme. The upper limit of project cost of $0.3

sustainability for tenure from FY 2021­22 to FY 2025­26.The scheme has three sub­schemes­ (i) Assistance to Pharmaceutical Industry for Common Facilities (APICF) to provide infrastructure support for pharma MSMEs clusters for strengthening the infrastructure facilities; (ii) Promotion of Technology Upgradation Assistance Scheme (PTUAS) to address the issues of technology upgradation of individual pharma MSMEs and (iii) Pharmaceutical and Medical Device Promotion and Development Scheme (PMPDS) to create awareness, to conduct survey, studies, organize seminars, events.

Under the sub­scheme API­CF, as on date, govt. has approved / shortlisted support for a total of 8 MSME projects. Out of eight selected MSME projects, the total amount invested in three projects to strengthen the existing pharmaceutical MSME clusters for their sustained growth by creating common facilities is approx. $6.5 Mn. The detail is as un

Mn is applicable for pharma clusters also. The scheme is a demand driven Central Sector Scheme and State Governments can send proposals as per the new scheme guidelines. The detail of the approved CFCs on pharma industry under MSE­CDP is appended below:

Pradhan Bhartiya Mantri PMBJKs (Jan Aushadhi Kendras): By the end of March 2025, the Government hopes to have 10,500 PMBJKs in its disposal. The PMBJP's product line includes 240 surgical equipment and 1,451 medicines. 2

Growing Investments

FDI (Foreign Direct Investment) up to 100% has been allowed for Greenfield pharmaceutical projects through automatic route. Brownfield projects has been allowed FDI up to 74% through automatic route and beyond that through Indian government approval.Between April 2000 and September 2022, FDI equity inflow

Continued on page no 10

totaled $20.96 Bn in the drugs and pharmaceuticals sector. This accounts for around 3.35% of all FDI received across all industries. In both the US and the EU, prescription drug sales are dominated by Indian pharmaceutical corporations. India has the most FDA­approved plants outside of the US.3

India's pharmaceutical exports from April 2021 to March 2022 were $24.62 Bn, an increase of approximately 1%. 5.92% of merchandise exports came from India's pharmaceutical exports. India exported goods to more than 200 countries during FY ­22. Markets with strict regulations, such as North America and Europe, get about 55% of India's exports. By country, India is principal export partner of the United States, accounts for 45.5% of Africa's $8000 Mn generic market, and supplies 65­70% of the vaccines (essential immunization schedule) needed by the WHO (World Health Organization).4

KEY TRENDS TO FOCUS ON Promising Growth in Respiratory Therapeutics: The demand for medications that treat respiratory illnesses has skyrocketed as a result of the rise in respiratory problems and rising pollution. Bronchodilators, corticosteroids, mast cell stabilisers, anti ­IgE antibodies, leukotriene receptor antagonists, antivirals, pulmonary surfactants, and respiratory stimulants are among the key components of respiratory medications. Diseases of the lungs and respiratory system are referred to as respiratory diseases. Asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, pneumonia, and lung cancer are among common respiratory illnesses. Patients with asthma, COPD, and bronchitis make up the majority of reported cases. Respiratory illnesses present enormous growth prospects due to their heavy burden.

Generic Drugs Growth: A generic

drug is a prescription medication that has been created to have the same dosage form, safety, potency, mode of administration, quality, and performance characteristics as an already approved brand­name drug. The extra work that goes into clinical research and drug discovery is not necessary for these medications. Generic medications are more affordable and give a

more quickly, adding innovation to their products, and increasing compliance and manufacturing efficiencies.

Change from Prevention to Treatment:Prevention must be prioritised before treatment. Innovation is anticipated to put a greater emphasis on prevention and explore the prospect of developing vaccinations for non­communicable diseases, such as some types of cancer, rather than concentrating on treating patients who are already ill and just creating vaccines for infectious diseases.

the necessary standards of quality.

According to Dr. Viranchi Shah, National President of the Indian Drug Manufacturers Association (IDMA), cluster manufacturing and the creation of Production Linked Incentive Schemes (PLIs) are driving the expansion of the pharmaceutical industry. According to him, India anticipates topping the world in the following 25 years. The government's support and the favourable growth conditions are enabling the Indian pharmaceutical industry to expand rapidly.

Conclusion

nation the chance to reduce its overall drug spending. The segment is expected to experience enormous expansion due to the numerous benefits of generic medications as well as affordable domestic manufacture. According to the ICRA report, the government is preparing a number of initiatives through Pradhan Mantri Bhartiya Janaushadhi Kendras to provide free generic pharmaceuticals to half of the Indian population at an anticipated cost of $5.4 Bn. All efforts support the tremendous expansion of generic medications.

Digital Transformation: For improved patient care, increased transparency, cost­effectiveness, improved production, and drug research, digital transformation is essential. Modern technologies like artificial intelligence (AI), augmented reality (AR/VR), machine learning (ML), and additive manufacturing are assisting pharmaceutical companies in improving their R&D processes, completing clinical trials

Growth Prospects

The key to India's success as a pharmaceutical supplier is its capacity to deliver high­quality medications supported by strong innovation skills and a structural cost advantage.

Despite low productivity levels, the cost of producing formulations in India continues to be 30–40% lower than other comparable manufacturing hubs like China and Eastern Europe. This is a result of lower labour expenses compared to other regions. India's labour cost advantage will continue in the medium to long term despite inflationary tendencies, especially if Indian businesses can boost productivity through operational excellence and digital initiatives.

Compared to nations like China, the local pharmaceutical sector has a stronger supply of talent (e.g., B.Pharm, M.Pharm, and B.Sc.). Indian pharmaceutical firms are expanding towards the production of complicated goods (such as microspheres, liposomes, and emulsions), while maintaining

There has never been a better time for India to assume the lead as a worldwide producer of highquality pharmaceutical products, as the country's economy has grown to become the fifth largest in the world. India must put more effort into developing improved pharmaceuticals, medical equipment, biologics, diagnostics, and vaccinations. Through innovation and tight surveillance from regulators, this will give medical products the muchneeded push towards quality, affordability, and accessibility. India's rural areas still hold tremendous potential. A PLI programme worth $238.28 Mn has been introduced in the manufacturing industry in 13 crucial areas, including active pharmaceutical ingredients, pharmacological intermediaries, and important starting materials. The Indian Pharmaceutical Industry has been extremely responsible with its authority. India has established a reputation for itself and is now referred to as "The Pharmacy of the World" in some areas. India's reputation is mostly a result of its supremacy in the vaccination and generic pharmaceutical industries. The absence of dominance in the highvalue medications is the sole flaw. In order for India to truly become the "Pharmacy of the World," it must concentrate on producing high­quality pharmaceutical items. It should be emphasised that China only earned the moniker "The Factory of the World" after producing high­end goods.

Joshi is business analyst and Nayak is Head of Marketing, Insights10

IMPACT OF COVID-19 ON INDIAN PHARMA INDUSTRY

Dr. Vikas Pandey

Pandemics are enormous threats to the world that impact all aspects of our lives, especially the global economy. The emergence of the COVID­19 pandemic in December 2019 has had significant repercussions on the global economy. With increasing interconnectivity, the economic effects of the pandemic have become more pronounced. As countries and industries grapple with the unprecedented challenges posed by COVID­19, it has shown its great impact on the global and Indian supply chains in the pharmaceutical industry. The crisis has underscored the importance of establishing a risk management system to assess future risks stemming from supply chain disruptions across countries. Moreover, the COVID19 outbreak has presented Indian pharmaceutical companies with an opportunity to become a reliable hub for the production of drugs and intermediates. India's robust pharmaceutical industry has long served as a cornerstone of accessible healthcare, and this trend is expected to further intensify. The healthcare sector in India encompasses both private and public sectors. India holds a significant role in the global pharmaceutical industry and boasts a talented pool of scientists and engineers, providing ample potential to propel the industry to greater heights.

The COVID­19 pandemic, truly an unforeseen and disruptive event, has served as a wake­up call for pharmaceutical manufacturers across the globe. Prices of numerous active pharmaceutical ingredients (APIs) experienced a sharp increase, ranging from 50 to 100 percent. The pandemic also brought about a sense of medicine nationalism, with many importing countries recognizing the importance of repatriating the pharmaceutical industry to their own shores and promoting domestic production. Although, the Indian API industry possessed the necessary

capability, it faced limitations in terms of capacity. Recognizing this issue, the Government of India intervened by implementing the PLI scheme as part of the AATMANIRBHARTA (self­reliance) initiative, aiming to incentivize the industry to enhance its manufacturing capacity within India.

According to the survey, India's pharmaceutical industry has managed to sustain its growth momentum even in the aftermath of the pandemic. In contrast, many other sectors experienced adverse effects and reported negative growth due to disruptions caused by COVID­19 and its impact on consumer behavior. India's pharmaceutical market, with an estimated value of $41 billion in 2021, is projected to reach $65 billion by 2024 and is expected to double to $130 billion by 2030. Additionally, on the global stage, India holds a significant position as the largest supplier of generic medicines, accounting for a 20% share in global supply by volume. It is also a prominent global vaccine manufacturer, commanding a substantial 60% market share.

India holds the third position globally in terms of pharmaceutical production volume and ranks 14th in terms of value. Despite global trade disruptions and a decrease in demand for COVID ­19 related treatments, the country's pharmaceutical exports have remained robust during FY22,

sustaining

growth. The survey reveals that drug and pharmaceutical exports during April­October 2022 were 22% higher compared to the corresponding pre­pandemic period of FY20, showcasing continued growth momentum. Despite supply chain disruptions caused by COVID­19, India's pharma exports have witnessed significant growth, increasing from $15.4 billion in FY15 to $24.6 billion in FY22, and reaching $18.8 billion during April ­December 2022, marking a 3.6% growth compared to the same period the previous year. The surge in exports can be attributed to the stocking of medicine inventories by countries worldwide and the increased demand for vaccines and COVID ­19­related medications, which India was able to meet. Domestic pharma exports experienced a healthy growth rate of 24% in FY21, driven by the heightened demand for critical drugs and supplies related to COVID­19, which were shipped to over 150 countries. Moreover, cumulative foreign direct investment (FDI) in the pharma sector surpassed the $20 billion mark in September 2022. FDI inflows have quadrupled over the past five years until September 2022, reaching $699 million, supported by investorfriendly policies and a positive industry outlook, as stated in the survey.

Market Outline

During the Covid­19 pandemic,

the Indian healthcare sector underwent significant transformations, with one notable change being the increased prevalence of online consultations. The surge in teleconsultations can be attributed to the convenience and safety factors that have gained prominence. The government's publication of telemedicine practice guidelines in 2020 further facilitated the growth of telehealth as a legitimate healthcare delivery channel. According to Invest India, the national investment promotion and facilitation agency, the telemedicine market is projected to reach $5.4 billion by 2025, with a compound annual growth rate (CAGR) of 31 percent. Over the next decade, Invest India data suggests that the National Digital Health Blueprint has the potential to unlock an additional economic value of over $200 billion for the healthcare industry. India's digital health market is anticipated to experience significant growth, reaching $18.34 billion by 2030 from $3.83 billion in 2022, at a compounded annual growth rate (CAGR) of 21.6% during the forecast period of 2022­2030. As per the World Health Organization (WHO) Global Health Expenditure database, India's health expenditure (% of GDP) has increased from 2.95% in 2018 to 3.01% in 2019. The majority of healthcare costs in India are shouldered by individuals rather than the government or insurance companies. However, there have been improvements over time, with the figure declining to 48.21% in 2018­2019 from 69.4% in 2004­2005, although it still surpasses the global average of 18.1%. Efforts have been made to enhance government expenditure on healthcare and expand health insurance coverage.

New opportunities for India in global API market

The Covid­19 pandemic has presented new opportunities for various stakeholders in India's healthcare industry, including

(Continued on page no 12)

pharmaceutical companies, private hospitals, and medical device manufacturers. As a result, the healthcare sector in India is poised for significant growth in the coming years. Projections indicate that the Indian pharmaceutical sector is expected to reach $75 billion by 2024 and expand further to $130­138 billion by 2030. India has played a crucial role in global healthcare outcomes, notably meeting 60 percent of the global demand for Anti­retroviral (ARV) drugs. Furthermore, Indian manufacturing sites have filed approximately 38 percent of the Abbreviated New Drug Applications (ANDAs) in the last five years. Notably, India boasts the highest number of US FDAapproved plants outside of the US and has established a reputation for adhering to top ­notch standards set by the FDA and European Directorate for the Quality of Medicines (EDQM).

Amidst the tumultuous effects of the COVID­19 pandemic on India, the healthcare sector demonstrated resilience and adaptability. India received global recognition as a prominent provider of pharmaceuticals, earning the title of the world's pharmacy. The government responded by revising its policies to prioritize self­sufficiency in the production of vaccines, drugs, medical devices, and equipment. Overcoming the challenges presented by the pandemic has laid a solid groundwork for the healthcare sector to accelerate its progress in the times ahead.

As per the International Trade Administration, it is projected that India's nutraceutical industry will capture a minimum of 3.5 percent of the global market share by 2023. Furthermore, the nutraceuticals market in India is expected to reach a value of $18 billion by the conclusion of 2025. Within the nutraceutical market, the dietary supplements segment accounts for over 65 percent and is experiencing a growth rate of 17 percent. This segment is projected to grow at a rate of 22 percent annually, particularly due to the increased focus on preventive health amidst the ongoing pandemic. Currently, India imports nutraceuticals

worth $2.7 billion, but there has been a significant opening for foreign investments in this sector.

The rapid adoption of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy) products and services by the public during the pandemic is evident in the financial performance of Indian Medicines Pharmaceutical Corporation Ltd, the public sector manufacturing unit of the Ministry of AYUSH. In the fiscal year 2020­21, it achieved a turnover of Rs. 164.33 crore, marking the highest in its history.

Following the COVID ­19 pandemic, the Indian pharmaceutical industry is experiencing a crucial turning point. It is anticipated that the pharmaceutical sector's

The Future Prospects

Considering the ongoing COVID

19 pandemic, it is crucial for the Government of India (GoI) to undertake significant measures to eliminate technical and financial obstacles. These measures would encourage the pharmaceutical industry to enhance the production of active pharmaceutical ingredients (APIs), consequently reducing its reliance on China. India has formulated a plan to establish a fund of Rs. one lakh crore to boost the pharmaceutical sector and promote the domestic manufacturing of pharmaceutical ingredients by 2023. Additionally, the government has approved the extension/renewal of the existing pharmaceutical purchase policy, with the inclusion of an additional

development and promotion of pharmaceutical industry hubs. The COVID­19 pandemic necessitated urgent action to enhance the medical supply chain, particularly for essential items such as sanitizers, face masks, disinfectants, surgical gloves, protective gear for healthcare personnel, scanners, infrared thermometers, test kits, inhalers, and ventilators.

Conclusions:

The impact of COVID ­19 has highlighted the necessity to reshape the perception of Indian pharmaceutical associations and, more importantly, decrease the reliance of private pharmaceutical companies on single suppliers like China. India is projected to experience a growth in medicine spending ranging from 9­12 percent over the next five years, positioning the country among the top 10 nations in terms of medical expenditure. The expansion of domestic sales will largely depend on the capability of companies to align their product portfolio with chronic therapies for conditions such as cardiovascular diseases, diabetes, depression, and cancer, which are witnessing an increasing prevalence.

contribution to the country's GDP will increase from the current 1.8 percent to a range of 4.5­5 percent. Drawing from India's successful contributions in the production of drugs for tuberculosis and retroviruses, it is reasonable to expect that active pharmaceutical ingredients (APIs) will play a significant role in driving this growth trajectory. The prevailing negative sentiment towards China, largely stemming from the pandemic and its trade practices, including debt diplomacy, has led to a substantial shift in interest towards India. This shift in interest will particularly benefit the API industry. As a result, there is a notable surge in private equity interest in the Indian API industry.

product, alcoholic hand disinfectant, to the current list of 103 medicines.

The GoI has taken significant measures by proposing an incentive package amounting to Rs. 13.76 billion. The aim of this package is to promote domestic manufacturing of critical key starting materials, drug intermediates, APIs, and medical devices. Key stakeholders from the pharmaceutical industry, as well as NITI Aayog, have suggested various strategies to support the market, including expediting approvals for pharmaceutical infrastructure projects, obtaining clearance from the environment ministry, and offering tax exemptions and subsidies to foster the

Numerous government initiatives have been implemented to lower healthcare expenses and promote cost reduction. The prompt introduction of generic drugs in the market has been a key focus, which is anticipated to be advantageous for Indian pharmaceutical companies. The emphasis on rural health programs, essential life­saving medications, and preventive vaccines will create opportunities for the growth of pharmaceutical companies. Although the pandemic had devastating effects on various sectors, it has also acted as a catalyst for the rapid progress of the Indian healthcare sector, establishing a strong foundation for future advancements.

The author is associate professor, Amity Institute of Pharmacy, Amity University Madhya Pradesh

(Continued from page no 11)

INDIAN API EXPECTED TO GROW AT CAGR OF 12.24%

How do you see the Indian active pharma ingredients (API) market going ahead?

The Indian Active Pharmaceutical Ingredients (API) market stood at USD11806.93 million in FY2021 and is expected to grow at a CAGR of 12.24%. This growth can be attributed to the high growth of the biopharmaceutical sector in the country. Additionally, the increasing geriatric population in India is further expected to boost the demand through FY2027. Furthermore, the growing prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer, and respiratory disorders, among others is going to boost the market.

The Indian active pharmaceutical ingredients market is relatively fragmented. The API market has several manufacturers focusing on expanding their footprints by adopting various business strategies such as collaborations, facility expansion, and drug approvals.

According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million lives each year. The major drivers boosting the growth of the Indian Active Pharmaceutical Ingredients Market are the rising drug research and increase in the development and manufacturing of drugs and the increasing uptake of biopharmaceuticals.

Besides, the sudden outbreak and spread of the COVID­19 pandemic across the globe, with India being severely hit by the pandemic crisis, also opened opportunities for the growth of India's active pharmaceutical ingredients market. Due to the pandemic spread major countries boycotted China for trade as it was where the virus originated, similarly, India also banned all kinds of imports and exports with China.

This led to the development of manufacturing facilities in the country and improved the status of domestic players. Also, India being a major pharmaceutical hub witnessed demand from various countries across the globe for getting medical supplies and drugs.

Other factors boosting the market growth include the

increasing prevalence of infectious, genetic, cardiovascular, and other chronic disorders, the growing geriatric population, expanding adoption of biologics and biosimilars, and the rising production of generic drugs in the country. India operates over 250 facilities approved by the USFDA and UKMHRA and provides generic pharmaceuticals at affordable prices to millions of people worldwide.

The Indian API market has achieved tremendous growth over the past few decades. It is ranked as the third largest in the world, and the country contributes approximately 57 percent of APIs to prequalified list of the WHO. The increasing incidence of chronic diseases, along with the growing importance of generics are some of the major factors driving the growth of the Indian APIs market. Advancements in active pharmaceutical ingredient (API) manufacturing, and the growth of the pharmaceutical sector are also driving the market growth.

What are the challenges and growth factors for the market?

The increasing cost of crucial manufacturing input factors such as energy, raw materials, and labor, has been a severe challenge to producers. The increasingly volatile business environment has also led pharma companies to seek strong and sustainable partners. API market is now well established so one has to remain innovative and competitive focusing on the portfolio of APIs in terms of size, quality, and cost.

What are your expectations from the government for the market?

• Supportive policies, simplified

regulations of environment and simple GST norms.

• Provide incentives to startups.

• Reducing import dependence and promoting growth of domestic industry.

Tell us about your company.

Prudence pharmachem was established in 2003. The company is involved in the manufacturing and development of a wide range of high­quality pharmaceutical bulk drugs (API) and its advanced intermediates in its ultra­modern state of art facilities conveniently located in the Ankleshwar industrial area which is 350 km away from Mumbai­India.

The company is a family enterprise and managed by dynamic and highly technically qualified partners and professionals who have sound and vast experience in manufacturing of Pharmaceutical bulk drugs (API) and Intermediates. We have equipped with modern manufacturing facilities and state­ofthe­art technology for achieving Quality products manufactured by us. We are fast growing integrated and GMP & ISO 9001­2015 certified Pharmaceutical bulk drugs [API] and intermediates manufacturing company. We have an excellent multipurpose facility meeting WHO GMP standards, since its inception, we have been the sole and reliable manufacturer and exporter of Pharmaceutical bulk drugs [API] and intermediates.

We have equipped with modern manufacturing facilities and state­ofthe­art technology for achieving Quality products manufactured by us. We specialize in the development of new processes and technology with the latest technical know­how which can be designed to ensure the non­infringement of patents, through the application of alternative synthetic procedures and to develop and manufacture various Pharmaceutical bulk drugs [API] and Intermediates with the highest quality, functionality, and costeffectiveness.

Our services range from the manufacture of patent­free products to the manufacture of novel products through bilateral agreements between ourselves and our clients. Within a short span of

time, we have earned a good reputation in manufacturing Pharmaceutical bulk drugs [API] and Intermediates for consistency in quality and supplies at the right time and at the right cost. In the market today we are a strong, reliable, consistent manufacturer of key APIs & intermediates for global markets. We have established ourselves as strong and consistence manufacturer of Rivaroxaban, Silodosin, Torsemide, Memantine, Glimepiride, Glibenclamide, Amlodipine, Celecoxib, etoricoxib and Febuxostat.

Brief us about your product portfolio.

We are manufacturing high­valueadded active pharmaceutical ingredients which are mainly used in Anti­Diabetic, Anti­Hypertensive, Loop Diuretic, Benign Prostatic Hyperplasia, NSAID, Anti­Gout, AntiAlzheimer’s, Decongestant, IPF, Anticoagulants/ DVT therapies, etc. Our product range is Rivaroxaban, Silodosin, Torsemide, Memantine, Glimepiride, Glibenclamide, Amlodipine, Celecoxib, etoricoxib and Febuxostat.

What makes you different from other players?

In the emerging market, we always ensure to maintain regulatory compliance and balance cost with quality and reliability. We emphasize on continuously listening to our customers and make sure to meet their expectations with our speedy response and ability to anticipate problems before they occur.

Please tell us about your expansion plans.

We are in the progress to initiate a manufacturing unit of active pharmaceutical ingredients to accommodate higher potency and a wider range of molecules with increased production volume.

How much will you be investing in expansions?

We are planning to invest Rs 200 cr for expansion in upcoming years.

Any plans to launch new products?

Yes, our research team is currently focusing on efficient process development of new products.

RAMESH CHODVADIA, MANAGING PARTNER AND CEO SPOKE ABOUT THEIR EXPANSION PLANS

STRATEGIES FOR SUCCESS: IMPORT AND EXPORT STRATEGIES IN INDIAN PHARMA INDUSTRY

Dr. Sanjay Agrawal

The Indian pharmaceutical industry has experienced remarkable growth over the years and has emerged as a global player in the healthcare sector. With a vast pool of skilled professionals, state­of­the­art infrastructure, and a robust regulatory framework, India has become a preferred destination for producing high ­quality generic drugs and pharmaceutical formulations. The import and export scenario of the Indian pharma industry plays a crucial role in shaping its growth trajectory and global influence.

IMPORT SCENARIO

While India is known for its prowess in pharmaceutical manufacturing, it also relies on imports to meet certain requirements. The country imports various raw materials, intermediates, and active pharmaceutical ingredients (APIs) from different countries. China has been a significant source of imports for India, particularly for APIs. However, there has been a growing concern about over­dependence on China and the need to enhance self­sufficiency in API production in recent years. To address this concern, the Indian government has initiated several measures to promote domestic API manufacturing and reduce reliance on imports. These measures include providing financial incentives, establishing dedicated API parks, and encouraging collaborations between industry and academia. The aim is to boost the domestic production of critical APIs and reduce the vulnerability associated with excessive import dependence.

The import scenario of the Indian pharmaceutical industry involves procuring various raw materials, intermediates, and active pharmaceutical ingredients (APIs) from different countries. Here are a few examples of the import scenario in the industry:

Active Pharmaceutical Ingredients (APIs): India imports a significant

portion of APIs, which are the key components used in producing pharmaceutical formulations. China has been a major source of API imports for India, supplying APIs for various drugs, including antibiotics, cardiovascular medications, and painkillers.

Excipients and Additives: Excipients are substances added to pharmaceutical formulations to enhance their stability, solubility, and bioavailability. India imports a variety of excipients and additives from countries like the United

equipment, laboratory instruments, quality control devices, and packaging machinery from countries like Germany, Italy, and Japan.

Laboratory Reagents and Consumables: The pharmaceutical industry requires a wide range of laboratory reagents and consumables for quality control, research, and testing. India imports laboratory chemicals, solvents, glassware, and other consumables from countries like the United States, the United Kingdom, and

Indian companies have built a reputation for supplying highquality generic drugs to the US market, which has helped drive export growth. Additionally, India's adherence to international regulatory standards, such as the US Food and Drug Administration (FDA) regulations, has further boosted its export capabilities.

States, Germany, and Singapore to meet the diverse formulation requirements.

Packaging Materials: Pharmceutical products require specialized packaging materials to ensure their safety, integrity, and shelf life. India imports packaging materials such as blister packs, bottles, labels, and caps from countries like China, Germany, and the United Arab Emirates.

Research Chemicals: The pharmaceutical industry heavily relies on research chemicals for drug discovery, development, and clinical trials. These chemicals, including reagents, intermediates, and specialized compounds, are often imported from countries like the United States, the United Kingdom, and Switzerland.

Machinery and Equipment: To maintain high manufacturing standards and enhance production efficiency, Indian pharmaceutical companies import various machinery and equipment. This includes manufacturing

France. These are just a few examples of the import scenario in the Indian pharmaceutical industry. The industry's import requirements may vary depending on the specific drugs being manufactured, the regulatory standards to be met, and the availability of domestic alternatives. Importing these materials and components helps Indian pharmaceutical companies maintain their production capabilities and meet the growing demand for affordable, quality healthcare products.

Export Scenario

The Indian pharmaceutical industry is a major contributor to export earnings. Indian pharmaceutical companies are known for their cost­effective generic drugs, which are in high demand worldwide. The industry has established a strong presence in various markets, including the United States, Europe, Africa, and Asia.

The United States is the largest market for Indian pharmaceutical exports, accounting for a significant share of the total export revenue.

Apart from the US, Indian pharmaceutical companies have also expanded their presence in European markets. Many Indian firms have received approvals from regulatory authorities like the European Medicines Agency (EMA) and have established partnerships with global pharmaceutical companies to market their products in Europe. The African market is another key destination for Indian pharmaceutical exports. Indian companies have been actively supplying affordable drugs to African countries, catering to their healthcare needs. This has helped improve access to essential medicines in the region and strengthened India's position as a reliable supplier.

The export scenario of the Indian pharma industry is expected to grow in the coming years. The industry's ability to produce costeffective generic drugs, compliance with international quality standards, and strong research and development capabilities will drive its export competitiveness.

The export scenario of the Indian pharmaceutical industry showcases its global reach and contribution to the healthcare sector. Here are some examples of the export scenario:

Generic Drugs: India is known as the "pharmacy of the world" for its significant contribution to the global supply of generic drugs. Indian pharmaceutical companies export a wide range of generic medications, including antibiotics, cardiovascular drugs, anti­cancer drugs, antivirals, and more. These generic drugs offer affordable alternatives to brand­name medications and are exported to various countries across the globe.

(Continued on page no. 17

FUTURE OF PHARMA AND LAB EQUIPMENT IN INDIA

Where does India stand compared to developed countries with respect to pharma equipment?

In recent few years, India has seen a rapid progress in the field of pharma equipment. The manufacturing capabilities of India has strengthen itself and is growing multifold. The growth driver for equipment industry is the research and production capabilities of drug manufacturers.

One of India's strengths in the pharma equipment sector is its cost­effectiveness. The country offers competitive pricing for pharmaceutical machinery, making it an attractive destination for companies seeking affordable solutions.

India has made progress in adopting new technologies and gap can be filled by collaborating with countries like China/Taiwan so that we can achieve technological advancement while maintaining our core strength of costeffectiveness.

India has made significant progress in the field of pharmaceutical equipment manufacturing and is considered one of the major players globally. However, when it comes to comparing India with developed countries in terms of pharma equipment, there are certain factors to consider : • Manufacturing capabilities • Costeffectiveness, Quality standards • Technological advancements • Collaboration and partnerships :

Overall, India has emerged as a significant player in the global pharmaceutical equipment market, offering cost­effective solutions and a strong manufacturing base. While there may be variations in terms of technological advancements and adherence to quality standards, India continues to strengthen its position and contribute to the global pharma equipment industry.

The budget has extended customs duty exemption for imports of certain medical equipment, what impact it will have on the equipment market and treatment in India?

I have always believed that

opening the borders and collaborating with companies across the border will help our companies in achieving new feat. While the exemption benefits the import of medical equipment, it can also incentivize technology transfer and domestic manufacturing. International manufacturers will be encouraged to establish local production units or enter into partnerships with Indian companies to produce equipment within the country. This can lead to job creation, skill development, and the growth of the domestic medical equipment manufacturing industry.

The extension of customs duty exemption for imports of certain medical equipment in India can have several impacts on the equipment market and healthcare treatment in the country:• Affordability and accessibility • Upgrading healthcare infrastructure

• Expanded treatment options

• Technology transfer and domestic manufacturing

• Economic impact • Potential challenges: It's important to note that the impact of customs duty exemption will depend on the specific equipment covered, the implementation process, and other related factors. Nevertheless, in general, the exemption can help improve access to medical equipment, upgrade healthcare infrastructure, expand treatment

options, and stimulate economic growth in the healthcare sector in India.

How do you see the future of the Indian pharma equipment market?

The future of the Indian pharma equipment market appears promising, with several factors contributing to its growth and development:

• Growing pharmaceutical industry

• Increasing healthcare infrastructure

Infozen offers world’s Most Advanced and Cost Effective High Pressure 45000 psi Microfluidization Homogenizer for Nano Emulsion­ Nano Suspension, Nano Particle Preparation, Micro Encapsulation to achieve the desired Particle Size @1 pass.

The company offers widest range of Liposome Extruders of Lab, Pilot and Commercial Scales with capacity ranging from 10 ml upto 400L/hr.

Ultrafine powder Micronization and Mixing Technologies Ultrafine Powder API AIR JET MILL can achieve the desired Particle Size (D90< 2­5 Micron @1pass).

The company is backed by Noozle Technology with Preparation Engineering Center, to carry out sample trials from the lab type to pilot scale production. ISO9001: 2015 approved TUV, CE certificated TUV.

• Export potential

• Technological advancements

• Regulatory compliance

• Focus on innovation and research

• While the future of the Indian pharma equipment market appears promising, it is essential to address certain challenges, including maintaining quality standards, bridging the technology gap with developed countries, and ensuring a conducive business environment. With appropriate measures and support, the Indian pharma equipment market has the potential to grow further, contribute to the healthcare sector, and establish itself as a global player in the industry.

Brief us about your product offerings.

Infozen India Enterprise is focused on Providing Most Advanced and Cost Effective Nano­Micron Technology Solutions and allied Pharma Technologies.

We offer various technology solutions like High Pressure 45000 psi (3013 bar) Microfluidizaion Homogenizer, Liposome Extruders,Air Jet Mill, Isolator, DPI Dry Powder Mixer,Infozen also offers various wet Milling solutions like Bead Mills (Dyno­ Nano Mills), In Line Himigenizer, Basket Mill, Dispersers, Mixers. Infozen also provide cost effective solutions for Lyophilizer, SprayDryer, Thin Film Evaporators,P articles Size Analyzers etc.

What makes you different from other players?

We offer the most advanced and highly cost effective solutions in a market space which is dominated by 2­3 Players and are very xpensive .Long Machine Life with least Maintannace cost with shortest lead time customers can have the advantage of first in market Our onsite training to the customer’s operators and Engineers is rated amongst the best leading to

Tell us about your expansion plans.

We are planning to expand product range by introducing New generation Microflow Reactor and API production Lines, Microsphere Technologies and other advanced technologies.

KARMENDRA DESAI, Founder, Infozen India Enterprise, spoke about Indian pharma equipment market

OPPORTUNITIES AND CHALLENGES FOR PHARMA INDUSTRY IN INDIA

Parina Kumari and Vandita Kakkar

The pharmaceutical market in India is one of the largest and fastest­growing markets globally.Ithas experienced consistent growth over the years. According to reports, the market was valued at around $41 billion in 2020 and is projected to reach $65 billion by 2024. Factors such as increasing healthcare spending, rising middle ­class population, and the prevalence of chronic diseases contribute to market growth.The Indian pharmaceutical market is primarily driven by generic medicines. Generic drugs hold a significant market share due to their affordability and accessibility. The country's robust generic drug manufacturing capabilities have positioned it as a major global supplier of generic medicines.The domestic consumption of pharmaceutical products in India is substantial. The country's large population, estimated at over 1.3 billion people, creates a significant demand for healthcare products and services. Increasing awareness, improved healthcare infrastructure, and expanding health insurance coverage contribute to the rising demand for pharmaceuticals.India is a major player in the global pharmaceutical exports market. The country supplies generic medicines and active pharmaceutical ingredients (APIs) to various countries worldwide. Indian pharmaceutical companies have a strong presence in both regulated and non ­regulated markets, catering to the demand for affordable medicines.

The pharmaceutical industry in India has experienced significant growth over the years and is poised to continue expanding. However, it also faces certain opportunities and challenges.

OPPORTUNITIES:

Large domestic market: India has a vast population, which creates a substantial domestic market for pharmaceutical companies. The rising middle class, increased healthcare spending, and the prevalence of chronic diseases present significant opportunities for pharmaceutical companies to cater to the growing demand.

Generic drug manufacturing: India is known as the "pharmacy of the world" due to its robust generic drug manufacturing capabilities. The global demand for affordable generic medicines provides a huge export opportunity for Indian pharmaceutical companies.

Research and development: India has a strong pool of scientific talent, and several pharmaceutical companies are investing in research and

development (R&D) activities. The country's cost­effective R&D capabilities can help in developing new drugs and therapies, leading to innovation and growth.

Favorable government policies: The Indian government has implemented various initiatives to promote the pharmaceutical industry, such as the "Make in India" campaign and initiatives to improve intellectual property rights protection. These policies aim to attract investments, encourage domestic manufacturing, and foster innovation.

CHALLENGES: Regulatory compliance: The Indian pharmaceutical industry faces challenges related to regulatory compliance, including complex approval processes, varying state regulations, and issues of quality control. Adhering to international regulatory standards and ensuring compliance can be a significant challenge for companies.

Pricing pressure: The Indian pharmaceutical market is highly price­sensitive, with a focus on affordability and accessibility. Government regulations, price control mechanisms, and competition from generic manufacturers put pressure on pricing and profit margins for pharmaceutical companies.

Intellectual property rights (IPR) issues: Intellectual property rights protection and enforcement have been a concern in India. Patent

infringements, generic drug approvals, compulsory licensing, and data exclusivity are areas where the industry faces challenges, impacting innovation and investment.

Healthcare infrastructure: India's healthcare infrastructure, especially in rural areas, faces limitations in terms of accessibility, affordability, and quality. Improving healthcare infrastructure and addressing healthcare disparities are essential for the growth of the pharmaceutical industry.

Counterfeit drugs: The Indian pharmaceutical industry grapples with the issue of counterfeit drugs, which can harm patient safety, erode consumer trust, and affect the industry's reputation. Strengthening supply chain management and implementing robust anti ­counterfeiting measures are critical challenges to overcome.

In summary, while the Indian pharmaceutical industry offers substantial opportunities due to its large domestic market, generic drug manufacturing capabilities, and R&D potential, it also faces challenges related to regulatory compliance, pricing pressure, IPR issues, healthcare infrastructure, and counterfeit drugs. Addressing these challenges and leveraging the opportunities can drive the growth and success of the industry in India.The Indian pharmaceutical market presents immense opportunities due to its large and growing population, generic manufacturing capabilities, pharmaceutical exports, and increasing healthcare awareness. However, challenges such as pricing pressure, regulatory compliance, intellectual property rights, and healthcare infrastructure need to be addressed to sustain growth and drive further development in the industry.

Kumari and Kakkar are from University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India

Active Pharmaceutical Ingredients (APIs) : Besides meeting domestic demand, Indian pharmaceutical companies also export APIs to several countries. International pharmaceutical manufacturers use these APIs to produce finished formulations. India has emerged as a major supplier of APIs to countries in Europe, the United States, Southeast Asia, and Africa.

Contract Manufacturing and Outsourcing: Indian pharmaceutical companies have developed contract manufacturing and outsourcing services expertise. They offer cost­effective manufacturing solutions to international pharmaceutical companies by producing drugs on their behalf. This includes manufacturing tablets, capsules, injections, and other dosage forms. Contract manufacturing and outsourcing services have led to a significant increase in India's pharmaceutical exports.

Vaccines and Biologicals: India has a strong presence in producing and exporting vaccines and biologicals. Indian vaccine manufacturers export a range of vaccines, including those for polio, hepatitis, influenza, and more. These vaccines are crucial in global immunization programs and are supplied to various countries through partnerships and collaborations.

Over­the­Counter (OTC) Products: Indian pharmaceutical companies also export a variety of over­thecounter (OTC) products, including vitamins, dietary supplements, analgesics, antacids, and skincare products. These products cater to consumer healthcare needs and are exported to global markets.

Herbal and Ayurvedic Products: India has a rich tradition of herbal and Ayurvedic medicines. The country exports a wide range of herbal formulations, extracts, and Ayurvedic products. These products have gained popularity globally due to their natural and holistic approach to healthcare.

Regulatory Compliance and Contract Research: Indian

pharmaceutical companies provide regulatory compliance services and contract research to international clients. This includes assisting with regulatory filings, quality assurance, clinical research, and drug development services. These services contribute to India's pharmaceutical exports by leveraging the country's expertise and cost advantages.

These examples highlight the diverse range of pharmaceutical products and services that India exports to global markets. The country's strong manufacturing capabilities, cost advantages, and adherence to international quality standards have positioned it as a key player in the global pharmaceutical industry.

CHALLENGES AND PPORTUNITIES

While the Indian pharma industry has experienced significant growth in exports, it also faces various challenges that need to be addressed. Some of the key challenges include:

Regulatory Compliance: Ensuring compliance with various international regulatory standards, such as those set by the FDA and EMA, is essential for sustained export growth.

Intellectual Property Rights: Protecting intellectual property rights and adhering to patent regulations is crucial to fostering innovation and maintaining competitiveness in the global market.

Quality Assurance:

Maintaining consistent product quality and adhering to Good Manufacturing Practices (GMP) is essential to build trust and credibility with international buyers. Despite these challenges, the Indian pharma industry has several opportunities for further growth and expansion in the export market.

SOME OF THE OPPORTUNITIES INCLUDE: Research and Development (R&D): Investing in research and development is crucial for the future growth of the Indian pharmaceutical industry. By focusing on innovation, new drug discovery, and the development of novel therapies, Indian companies

can strengthen their position in the global market. Collaborations with academic institutions and research organizations can foster R&D capabilities and help bring new and innovative drugs to the market.

Biopharmaceuticals and Biosimilars: The global demand for biopharmaceuticals and biosimilars is increasing rapidly. Indian pharmaceutical companies can leverage their expertise in biotechnology to develop and manufacture biopharmaceutical products and biosimilars. This sector offers significant growth potential and can help Indian companies expand their presence in the global market.

Contract Manufacturing and Outsourcing: Contract manufacturing and outsourcing services have been key driver of growth for the Indian pharmaceutical industry. Expanding and diversifying these services can attract international clients and increase export opportunities. By offering specialized manufacturing capabilities, customized solutions, and adhering to international quality standards, Indian companies can establish themselves as preferred partners for pharmaceutical outsourcing.

Digital Health and Telemedicine: The digital health and telemedicine sectors have witnessed rapid growth, especially after the COVID19 pandemic. Indian pharmaceutical companies can explore opportunities in telemedicine platforms, remote patient monitoring, digital therapeutics, and healthcare technology solutions.

International Expansion and Market Penetration: While the Indian pharmaceutical industry has a strong presence in various global markets, there is still room for further expansion. Companies can focus on entering new geographies, building strategic partnerships, and acquiring local companies to establish a stronger international presence. Emerging markets in Africa, Latin America, and Southeast Asia offer significant growth opportunities due to

increasing healthcare expenditure and growing demand for affordable medicines.

Regulatory Compliance and Quality Assurance: Maintaining high regulatory compliance and quality standards is crucial for the growth of the Indian pharmaceutical industry. Companies can invest in state­ofthe­art manufacturing facilities, adopt international quality management systems, and ensure adherence to stringent regulatory requirements. By demonstrating a commitment to quality, safety, and efficacy, Indian companies can enhance their reputation and competitiveness in the global market.

Healthcare Infrastructure Development: Investing in healthcare infrastructure development within India can create opportunities for the pharmaceutical industry. As the healthcare system expands, there will be greater demand for pharmaceutical products, medical devices, and healthcare services. Indian companies can participate in public ­private partnerships, establish healthcare facilities, and provide affordable healthcare solutions to cater to the growing needs of the Indian population.

In conclusion, the import and export scenario of the Indian pharmaceutical industry plays a vital role in shaping its growth and global influence. While the industry relies on imports for certain raw materials, efforts are underway to enhance domestic API production and reduce dependence on imports.

On the export front, India has established itself as a leading supplier of cost­effective generic drugs to various markets worldwide. However, regulatory compliance and intellectual property rights challenges need to be addressed. By leveraging opportunities in the generic drug market, contract manufacturing, and emerging markets, the Indian pharma industry can continue to expand its export footprint and contribute to the global healthcare ecosystem.

The author is pharmaceutical consultant

INDIAN CHEMICAL INDUSTRY TO REACH

US$ 304 BN BY 2025

How do you see the Indian speciality chemicals market going ahead?

Speciality chemical manufacturing Industry will be a key player in providing India a boost in export industry worldwide.

The Indian chemicals industry is projected to reach $304 bn by 2025

Indian ranks 14th in export and 8th in import of chemicals (Excluding Pharmaceuticals products) globally

What are the challenges and growth factors for the market?

There has been a continuous volatility in prices for raw materials affecting regular production planning and targeting sales figures. It has also caused Liquidity crunch issues causing slow down in overall market.

Scalability Issue due to less skilled manpower on operational

New age technology, advance machinery and a good technical support are available. Improving Logistic support like

currently in India for Lithium Hydroxide Monohydrate material and with our other Lithium Compounds we are

derivatives, Pharma intermediates, Speciality Chemicals & Lithium Compounds.

What makes you different from other players?

Team of skilled technical and production staff to ensure most optimized system through the whole process We have our presence in the niche chemistry spaces with relatively low competition Pushing innovation agenda – introducing high value products and pioneering technologies, thereby changing the industry landscape.

Please tell us about your expansion plans.How much will you be investing in expansions? Our Upcoming Additional Facility and Infrastructure at SaykhaBharuch Dist – Gujarat: Phase 1 Exclusive 2500 MT Manufacturing capacity for Bromine Derivatives with ultramodern production facilities and

mid ­ level hierarchy of the production team.

According to you, what is the reason, fluorination (specialty chemical) is doing well, especially in the pharma industry?

Speciality chemicals have various internal and external driving factors which will favour the growth in worldwide market.

Post Covid, Indian as well as world wide market has seen India as a major manufacturing hub and also advancing towards major economic power.

High­speed Road corridor’s, Sea ports with better facilities and air cargo networks.

Bromine compounds and Lithium Compounds in Pharma Industry

We specialised in bromination industry as its one of core strength and important segment in our varied product list.

Bromine compounds are used by pharma industry in multiple applications and have a worldwide demand.

In Lithium compounds we are exclusive manufacturers

highly competitive in Pharma industry with our prices and quality.

What are your expectations from the government for the market?

Promote more technical institute to generate skilled manpower to operate advance machinery and equipment’s.

Brief us about your product portfolio.What makes you different from other players? We are into manufacturing of Phase Transfer catalyst, Bromine

Bromine storage ISO tanks. Will be followed by Phase 2 and 3 where we shall also be targeting contract manufacturing for speciality product.

Investment

20 Crore INR in the financial year 23 ­24 followed by Next financial year investment of another 20 Crore INR.

Any plans to launch new products. R& D has always been a key driving factor of Pacific Organics Pvt Limited, as we are increasing our production capacity there will always be development in our product portfolio year on.

RAHUL RAJPUROHIT (DIRECTOR) PACIFIC ORGANICS PVT. LTD.

4-Chloro4-HydroxyBen

Plastics Pv

Carboys, Drums, C Manufacturers of

PRODUCT LIST

API (HUMAN) COMMERCIAL PRODUCTION

CITICOLINE SODIUMIP/USPNOOTROPIC

BUPROPION HYDROCHLORIDEUSPANTIDEPRESSANT

GRANISETRON HYDROCHLORIDEIP/BP/USPLOCAL ANAESTHETIC

MELOXICAMIP/BP/USP/EPANTI-INFLAMMATORY

PIROXICAMIP/BP/USP/EPANTI-INFLAMMATORY

ALBENDAZOLEIP/BP/USPANTHELMINTIC

PRILOCAINEIP/BP/EP/USPLOCAL ANAESTHETIC

PRILOCAINE HYDROCHLORIDEBP/EP/USPLOCAL ANAESTHETIC

ARTICAINE HYDROCHLORIDEIP/BP/USP/EPLOCAL ANAESTHETIC

UNDER DEVELOPMENT

NAME OF PRODUCT CAS NO. END USE

BILASTINE202189-78-4ANTIHISTAMINES

BENFOTIAMINE22457-89-2VITAMIN B1

CELECOXIB169590-42-5ANTIINFLAMATORY (NSAID)

GLICLAZIDE21187-98-4HYPOGLYCAEMIC ANTI-DIABETIC DRUG)

SITAGLIPTIN PHOSPHATE654671-78-0ANTIDIABETICS

METHYLCOBALAMIN13422-55-4VITAMIN B12

RIVAROXABAN22457-89-2ANTICOAGULANT

API (VETERINARY) COMMERCIAL PRODUCTION

FENBENDAZOLEIP/BP/VET/USP/EPANTHELMINTIC CLOSANTEL SODIUMIP/BP/VETANTHELMINTIC CLOSANTEL BASEIN-HOUSEANTHELMINTIC OXFENDAZOLEBP VET/EPBENZIMIDAZOLE

ANTI-HELMINTIC

TRICLABENDAZOLEBP VET/EPBENZIMIDAZOLE

ANTI-HELMINTIC

ALBENDAZOLEIP/BP/USPANTHELMINTIC PYRANTEL PAMOATEUSP/IN-HOUSEANTHELMINTIC

INTERMEDIATE - COMMERCIAL PRODUCTION

NAME

META CHLORO PROPIOPHENONE34841-35-5BUPROPION HCL 2-BROMO-3’CHLOROPROPIOPHENONE34911-51-8BUPROPION HCL

Corporate O ce: 303, Western Edge 1, Western Express Highway Magathane, Borivali (East), Mumbai 400 066 Maharashtra

Tel: 22 40160260 /61/62/63/64

Works: Plot No. 411/1 & 412/2, L.I.C. Sector, Silvassa Road G.I.D.C.

Vapi 396195 Dist, Valsad, Gujrat, India. Tel: 91 260 2453714/ 91 260 2453567

Mob: +91 8689897373 l Email: enquiry@cheminopharma.com

Web: www.cheminopharma.com

Grades

t Names

PANCHSHEEL ORGANICS LIMITED (W.H.O GMP Certified Company)

Ph: 022-43454200/ 214/ 210/ 216/ 213/ 219/ 212/ 218 l Fax No.: 022-22063929; Email: poltd@vsnl.com l Web: www.panchsheelorganics.com

l ACAMPROSATE CALCIUM

l AMIODARONE

l ATOMOXETINE

l BACLOFEN

l BISOPROLOL FUMARATE

l CANDESARTAN

l CARBAMAZEPINE

l CARNOCISTEINE

l CHLORDIAZEPOXIDE

l DENATONIUM BENZOATE / SACCHARIDE

l DIL TIAZEM

API PRODUCT LIST (FROM OUR ASSOCIATE MFGRS)

l HYDROXYZINE HCL

l DISULFIRAM

l DOBUTAMINE

l DOPAMINE HCL

l DOXYCYCLINE MONOHYDRATE

l DUTASTERIDE

l ESLICARBAZEPINE

l FLUTAMIDE

l GATLFLOXACIN

l GRANISETRON HCL

l HYDROQUINONE

l HYDROXYPROGESTERONE CAPROATE

l L ADRENALINE BITARTRATE

l CYPROTERONE ACETATE

l DESOGESTREL

l DROSPIERENONE

l ESTRADIOL / VALERATE / PHENYL

l PROPIONATE / BENZOATE

l IMIPRAMINE HCL / PAMOATE

l IRBESARTAN

l LAMOTRIGINE

l LEFLUNOMIDE

l LITHIUM CARBONATE

l LOMEFLOXACIN HCL

l L- THYROXINE SODIUM

l MELATONIN

l MERCAPTOPURINE

l NAPHAZOLINE / NITRATE

l NEOSTIGMINE METHYL SULFATE

l NITROFURANTOIN MONO / ANHYDROUS

l NITROFURAZONE

l OXCARBAZEPINE

l PERINDOPRIL ERBUMINE

l PHENAZONE

l PIRFENIDONE

l PRAMIPEXOLE DI HCL

l PRAZIQUANTEL

l PROPYLTHIOURACIL

l PYRIDOSTIGMINE BROMIDE

* AVAILABLE AS PER LATEST PHARMACOPEA & CUSTOMER SPECIFICATIONS HORMONES & STEROIDS

l ETHINYL ESTRADIOL

l FINASTERIDE

l HYDROCORTISONE ACETATE

l L-THYROXINE SODIUM

l LEVONORGESTREL

l NANDROLONE PHENYL PROPIONATE/ DECANOATE

l NORANDRENALINE BITARTRATE

l NORGENTAMINE

l NORGESTREL

l NORTHISTERONE / ACETATE

l RUTIN

l SODIUM CROMO GLYCATE

l THALIDOMIDE

l TOLFENAMIC ACID

l TORSEMIDE

l TRIAMTERENE

l VERAPAMIL

l VITAMIN K 1

l XYLOMETAZOLINE HCL

l ZINC BACITRACIN

l PREDNISOLONE ACETATE / METHYL PREDNISOLONE ACETATE

l TESTOSTERONE ENANTHENTE / DECANOATE/ CYPIONATE / UNDECANOATE / METHYL

* THE ABOVE PRODUCT LIST AS PER THE LATEST PHARMACOPEIA NUTRACEUTICALS & HEALTHCARE

l LYSINE MONO ACETATE

l BETASTEROL

l CHONDROITIN SULFATE

l DOCOSAHEXANOIC ACID (DHA ) VEG POWDER

l EICOSAPENTAENOIC ACID (EPA ) POWDER

l GAMMALINOLENIC ACID (GLA ) POWDER

l GINSENG POWDER / EXTRACT .

l ISOTRETINOIN

l L-ARGININE L ASPARTATE

l OMEGA 3 FATTY ACID POWDER

l PHYTOMENADIONE PREMIX

l PHYTOSTEROL AND OTHER ESTER

l TRETINOIN / MICROSPHERES

l VITAMIN E 50% ( PHARMA GRADE )

l VITAMIN K2-7 ( MENAQUINONE )

l ZINC MONOMETHIONINE

MANUF

CTURER & EXPOR A FA

TER

ODUCT LI COPOEIA GRADE FINE CHEMICALS PR

TIFIED T , ISO9001, FSSC 2200, FSSAI, HALAL& K

OSHER CER

TI COMPEND AILABLE IN GRADES : IP / BP / USP/ EP/ FCC/ MUL AVA l

CAS : 800-73-5 AMMONIUMCARBONAATTE l CAS : 7784-31-8 ATTEALUMINIUMSULPHA l CAS 7784-24-9 (POTTAASSIUMALUM) TE ASSIUM SULPHA UMINIUM POT AL l CAS 7784-25-0 UM) (AMMONIUM AL ATE UMINUM AMMONIUM SULF AL

CAS:12054-85-2 ATTEAMMONIUMMOLLYYBADA

CAS :631-61-8 ATTE AMMONIUM ACETA

CAS : 7783-20-2 ATTE AMMONIUM SULFA l

CAS :7783-28-0 TE AMMONIUM PHOSPHA

CAS :04-10-5892 TE BISMUTH SUBCARBONA

CAS 1304-85-4 TE BISMUTH SUBNITRA

CAS :813-93-4 TE BISMUTH CITRA

BENZOIC ACID

CAS :65-85-0

BUTYLAATTEDHYDROXY l

l

CAS :25013-16-5 YAANISOLE

BUTYLAATTHYDROXYTOLUENE

BOREXSODIUMBORAATTE l

BORIC ACID l

CALAMINE l

l

CAS 128-37-0

CAS 1330-43-4

CAS 1303-86-2

CAS 8011-96-9

CAS 574326-0 ATTE CALCIUM ACETA

l

CAS 471-34-1 ATTE CALCIUM CARBONA

CAS 18016-24-5 ATTE

CAS 10035-04-8 TE ORIDE DIHYDRA

CITRA

CAS 813-94-5 ATTE

SULPHA

CAS 7778-18-9 ATTE

CAS 124-43-6 XIDE CARBAMIDE PERO

CITRIC ACID ANHYDROUS

CAS 77-92-9

CAS 13463-43-9

FERROUS SULFA AHYDRA l

ATTEHEPT

FERRICAMMONIUMCITRAATTE l

FERROUSFUMARAATTE l

7782-63-0 ATTE

CAS 1185-57-5

CAS 141-01-5

CAS 110-17-8 FUMARIC ACID l

LITHIUMCARBONAATTE l

CAS 554-13-2

MANGENESE SULPHATEMONOHYDRA l

CAS 10034-96-5 ATTE

MANGANESE CHL l

16674-78-5

ACET l CAS 05-01-7773 ORIDE

7757-87-1 ATTE MAGNESIUM PHOSPHA

KRONOX LAB SCIENCES LIMITED. Corporate Office & Works adra l Dsit: V : Block No. 284 l Village: Dabhasa l P a adodara l Gu Mob: +9313213074 / 9909966408 l Fax: +91 2662 244088 Email: sales@kronoxlabsciences.com, info@kronoxlabsciences.com I

www.kr

MOBILE NUMBER: PRITESH GOHIL: 9324265877 / 9324540033, RUPESH GOHIL: 9324517446 ll Email Id: Info@hapenterprise.com

Office: Shop No. 4, Disha Chs Ltd., L. T. Road, Gorai-ii, Plot No. 50, Opp. Shanti Dham Ashram, Next To Maxus Mall, Borivali (west). Mumbai-400092 . ACTIVE PHARMACEUTICAL INGREDIENTS

v ACECLOFENAC

v v ALLOPURINOL

v v AMITRIPTYLINE

v v AMLODIPINE BESILATE

v v ARIPIPRAZOLE

v v ARTEMETHER

v v ATROVASTATIN CALCIUM

v v BACLOFEN

v v BENFOTIAMINE

v v BENZOCAINE

v v BETAHISTINE DI HCL

v v BROMHEXINE HCL

v v CALCITROL

v v CALCIUM DOBESILATE

v v CARBAMAZEPINE

v v CARVEDILOL

v v CELECOXIB

v v CETIRIZINE DI HCL

v v CHLORPHENIRAMINE MALEATE

v v CHONDROITIN SODIUM

v v CILNIDIPINE

v v CINNARIZINE

v v CITICOLINE SODIUM

v v CLOBETASOL PROPIONATE

v v CLOMIPHENE CITRATE

v v CLOMIPRAMINE HCL

v v CLOPIDOGREL BISULPHATE

v v CLOTRIMAZOLE

v v CLOZAPINE

v v CYCLOBENZAPRINE HCL

v v CYPROHEPTADINE

v v DAPOXETINE HCL

v v D-BIOTIN

v v DEFLAZACORT

v v DESLORATADINE

v v DESVENLAFAXINE SUCCINATE

v v DEXAMETHASONE PLAIN / SODIUM

v v DEXTROMETHORPHAN

HYDROBOMIDE

v v DIACEREIN

v v DICLOFENAC DIETHYLAMINE

v v DICLOFENAC POTASSIUM

v v DICLOFENAC SODIUM

v v DICYCLOMINE HCL

v v DOTHIEPIN HCL

v v DOXEPIN HCL

v v DOXYLAMINE SUCCINATE

v v DULOXETINE HCL

v v DUTASTERIDE

v v EBASTIN

v v EPERISONE HCL

v v ESCITALOPRAM OXALATE

v v ETHAMSYLATE

v v ETODOLAC

v v ETORICOXIB

v v FEBANTEL

v v FEBUXOSTAT

v v FENOFIBRATE /MICRONISED

MUPIROCIN

v v FEXOFENADINE

v v FLUCONAZOLE

v v FLUNARIZINE

v v FLUPENTIXOL HCL

v v FOLIC ACID

v v FUROSEMIDE

v v FUSIDIC ACID

v v GABAPENTIN

v v GLICLAZIDE v v GLIMEPIRIDE v v HYDROXYZINE HCL v v IMIPRAMINE HCL

v v INDOMETACIN v v ISOTRETINOIN v v ITOPRIDE v v IVERMECTIN v v KETOPROFEN v LABETALOL

l Ace c Acid GNFC Intact / Jubilant Intact Dicyandimide

l Ace c Acid Glacial 99%

l Acrylamide

l Alum Lumps/ Powder

l Aluminium Sulphate Powder (Non Ferric Alum )

l Bleaching Powder

l Calcium Chloride

l Caus c Potash make GACL

l Caus c Soda Flakes (Rayon Grade )

l Citric Acid (Monohydrate )

l DCDA

l Di Ammonium Phosphate

l E.D.T.A Powder .

l Ferric Chloride Powder Anhydrous 98.5%

l Ferrous Sulphate Crystal

l Formic Acid

l GH 17

v v LACOSAMIDE

v v LAMOTRIGINE

v v LEFLUNOMIDE v v LEVO SALBUTAMOL SULPHATE

v v LEVOCETIRIZINE HYDROCHLORIDE

v v LEVOSULPRIDE

v v LINAGLIPTIN

v v LINEZOLID

v v LOPERAMIDE

v v LORATADINE

v v LORNOXICAM

v v LOSARTAN POTASSIUM

v v LULICONAZOLE

v v LUMEFANTRINE

v v MEBEVERINE HCL

v v MECLIZINE

v v MEDOXOMIL

v v MEFENAMIC ACID

v v MELATONIN

v v MELITRACEN HCL

v v MELOXICAM

v v MESALAMINE

v v METADOXINE

v v METFORMIN HCL

v v METHYLCOBALAMINE

v v METHYLPREDNISOLONE

v v METOCLOPRAMIDE

v v METOPROLOL SUCCINATE / TARTRATE

v v MINOXIDIL

v v MIRTAZAPINE

v v MONTELUKAST SODIUM

v v MOXIFLOXACIN

v v NIACINAMIDE

v v NIFEDIPINE

v v NIMESULIDE

v v NORTRIPTYLINE HCL

v v OLANZAPINE

l Glycerine (Ip / Cp / Bp / Usp )

l Hyarogen Peroxide – Gaci / Npl / Meghman / IP / Imported

l Hydrated Lime Powder (All Grades )

l Hydrogen Peroxide 50 % intact NPL / GACL / MEGHMANI / IP

l IPA Intact, Deepak

l Liquid Glucose Cargill

l Maize Starch

l Mono Ethylene Glycol (M.E.G )

l Phenol

l Phosphoric Acid Taiwan Intact

l Phosphoric Acid 85% (Taiwan )

l Pine Oil (Phenol Grade / Tex le Grade )

l Poly Aluminium Chloride (Pac)- Grasim

l Propylene Glycol Technical Grade

v OLMESARTAN v ONDANSETRON

v PANTOPRAZOLE SODIUM

v PAROXETINE HCL

v PHENYLEPHRINE HYDROCHLORIDE

v PIOGLITAZONE HCL

v PIROXICAM

v PREGABALIN

v PROGESTERONE

v PYRANTEL PAMOATE

v QUETIAPINE FUMRATE

v v RACECADOTRIL

v v RIBOFLAVIN SODIUM PHOSPHATE

v v ROSUVASTATIN CALCIUM

v v S - AMLODIPINE

v v SERTACONAZOLE NITRATE

v v SILDENAFIL CITRATE

v v SMX / TMP v v SODIUM FUSIDATE v v SULFASALAZINE

v v SULPHADIAZINE

v v TACROLIMUS

v v TADALAFIL

v v TAMSULOSIN HCL

v v TELMISARTAN

v v TENELIGLIPTIN

v v TICAGRELOR

v v TOLPERISONE

v v TOPIRAMATE

v v

l Soda Ash Light (Tata / Nirma / GHCL / Imported )

l Sodium Bi Carbonate Technical / Refined, Tata / Imported

l Sodium Metasilicate (Local / 5h2o / 9h2o)

l Sodium Acetate

l Sodium Bi Chromate (Vishnu )

l Sodium Hypochlorite Hv / Lv Grade

l Sodium Sulphate Anhydrous ( Make Century / Birla / UPL / Imported )

l Sodium Sulphide Flakes (Yellow Chips 50% )

l Soda Ash Light –Tata / Imported / GHCL

l Sulphamic Acid

l Sulphamic Acid Technical / Boiler Grade

l Sulphuric Acid

l Toluene Nitra on Grade

Regularly Available with Cenvat in Bulks (High Seas / Bond Transfer) Ex- Bhiwandi

• Acetic Acid

• Acetone

• Acetonitrile

• Benzene

• Bleaching Powder

• Butyl Acetate

• Butyl Carbitol

• Butyl Cellosolve

• Caustic Potash

• Caustic Soda Flakes (Bag)

• Chloroform

• Citric Acid (Bag)

• Cyclohexane

• Cyclohexanol

• Cyclohexanone

• D88

• DEG

• DEP

• Di-Acetone

• Di-Ethyl Amine

• DIPE

• DMF

• DMSO

• Epichlorohydrin

• Ethyl Acetate

• Ethylene Dichloride

• Formaldehyde 37%

• Formic Acid 85%

• Glycerine

• HCL (Hydro Chloride Acid)

• Hydrogen Peroxide 50%

• Hydroxylamine Sulfate

• Iso Butanol

• Isophorone

• Isopropyl Alcohol

• L(+)Tartaric Acid (Bag)

• Lactic Acid (Bag)

• MDC

• MEG

• MEK

• Melamine

• Methanol

• MIBK

• Mix-Xylene

• MMA (Methyl Methacrylate)

• Mono Chloro Benzene

• Morpholine

• NBA

• n-Heptane

• n-Propanal

• N-Propyl Acetate

• Octanol (2-EH)

• Orthoxylene

• Oxalic Acid

• Paraformaldehyde 96%

• PEG (200 & 400)

• Phenol

• Phosphoric Acid 85%

• Potassium Carbonate

• Propylene Glycol

• SMBS

• Soda Ash (Bag)

• Sodium Nitrate

• Sodium Nitrite

• Sorbitol

• STPP

• Styrene Monomer

• Sulphonic Acid

• THF

• Toluene

• Triethylamine

• VAM

KHUSHBU DYE CHEM PVT. LTD.

Corporate Office:

Gala No. 99, 2nd Floor, New Unique Indl. Estate, Opp. Jawahar Talkies, Dr. R. P. Road, Mulund (W), Mumbai 400 00 Tel: +91-22-67102828 / 67103838 / 66982264 / 66982277 / 25929595

Email: info@khushbudyechem.com / Viral.dand@khushbudyechem.com l Web: www.khushbudyechem.com

Veer Chem Impex is the sister concern company of M/s. Khushbu Dye Chem Pvt. Ltd.

Contact Person (Director): Mr. Ashok Dand Mob: +91-9821110150 / 9223433143

Contact Person: Mr. Viral Dand Mob: +91-9821454191 / 9773222422

Contact Person: Mr. Dhawal Lapasia Mob: +91-7208022278 / 8013334222

Mr. Yash Salot Mob: +91-9223532926

Our Branch: Ankleshwar

v KHUSHBU v KHUSHBU v v KHUSHBU v KHUSHBU v v KHUSHBU v v KHUSHBU v KHUSHBU v v

v KHUSHBU v KHUSHBU v KHUSHBU v KHUSHBU v v KHUSHBU v KHUSHBU v KHUSHBU v KHUSHBU v KHUSHBU v KHUSHBU v KHUSHBU v KHUSHBU

ANTICOAGULANT

ANTI FUNGAL

TREAT HIGH CHOLESTERO; / HEART FAILURE

ANTIDIABETIC

Phosphate

PAIN MEDICATION

Ketoprofen

VITAMINS P-Amino Benzoic Acid

LAXATIVE Docusate Sodium

Silver Spring, A-426, Taloja MIDC, Navi Mumbai, Maharashtra. Email- synchromqc@gmail.com l Contact No. - 9022165688 / 9987702424

SERVICES

Chemical and Pharmaceutical testing

Analytical method development and method validation

Impurity synthesis, custom synthesis and product development

REGULATORY AFFAIRS

DMF (API) and Dossier (Formulation) preparation

DMF and Dossier submission to various regulatory authorities

Assist to prepare draft query responses for DMF/Dossier

WE ALSO OFFER FOLLOWING PRODUCTS

Calcium thioglycolate l l Potassium thioglycolate

Ammonium thioglycolate l Ethanolamine thioglycolate

PHARMA INTERMEDIATES

l 2-(methyl thio) acetamide ( Intermediate of Nepafenac ) CAS No - 22551-24-2

l l 2-Amino-3-benzoyl acetamide (Intermediate of Nepafenac) CAS No. 78281-72-8

l l Isoxepac ( Intermediate of Olopatadine hydrochloride ) CAS No - 55453-87-7

l l Para bromo Toluene CAS No -106-38-7

ORGANIC IODINE DERIVATIVES

l Ethyl Iodide

l Methyl Iodide

l Periodic Acid 50% and 99%

l Potassium Metaperiodate

l Sodium Metaperiodate

l Trimethyl Silyl Iodide

l Trimethyl Sulphoxonium Iodide

INORGANIC IODINE DERIVATIVES

l Calcium Iodate – Monohydrate

l Calcium Iodate – Anhydrous

l Copper Iodide

l Ethylenediamine Dihydroiodide (EDDI)

l Hydroiodic Acid 57%

l Iodine Monochloride

l Potassium Iodate

l Potassium Iodide

l Potassium Iodide – Stabilized

l Sodium Iodate

l Sodium Iodide

ACTIVE PHARMA INGREDIENTS (API)

l Diliodohydroxyquinoline (Iodoquinol)

l Iodochlorohydroxyquinoline (Clioquinol)

l Iodoform

l Oxyquinoline Sulphate

l Potassium Hydroxyquinoline Silphate

l Povidone Iodine

l Povidone Iodine 20%

l Thymol Iodide

l Bromine Compounds

l Calcium Bromide

l Potassium Bromide

l Sodium Bromide

CONTRAST MEDIA

l Barium Sulphate

l Microbar

SELENIUM COMPOUNDS

l Selenium Sulphide

CALCIUM REPLENISHMENT

l Calcium Levulinate

NEW PRODUCTS

l 2 Chloro 5 Iodo Benzoic Acid (CIBA)

l 4 Iodoaniline

l 3,5 Diiodo Salicylic Acid

l 5 Iodo 2 Methyl Benzoic Acid (MIBA)

l Diiodomethane

l Iodobenzene

l L Selenomethionine

l N Bromosuccinimide

l N Iodosuccinimide

l (R) ( ) 3 Carbamoymethyl 5 Methylhexanoic Acid (RCMH)

l Selenious Acid

Mumbai Office Address: 3 – A, Shiv Sagar Estate North Wing, Dr. Annie Besant Road, Worli, Mumbai 400 018, India

Factory Address: 907/2 Jhagadia GIDC Estate, Jhagadia, Gujarat - 393110, India.

Tel: +91-22-6622 7575 | Email: eskay@sk1932.com, mkteskay@sk1932.com | Web: www.eskayiodine.com

INdIAN PlATiNUM PVT. LTd.

Manufacturing & Exporting Superior Quality Prevous Metal Chemicals, Compounds of Rhodium, Gold, Silver, Palladium, Platinum, Iridium, Osmium, Ruthenium, Indium, Bismuth, Molybdenum Etc.

Silver Chemicals

Silver Bars

Silver Nanoparticles

Silver Carbonate

Silver Acetate

Silver Chloride

Silver Chromate

Silver Oxide

Silver Sulphate

Silver Triflate

Silver Lactate

Silver Sufadiazine

Silver Trifluroacetic

Acid

Silver Nitrite

Silver Nitrate AR / LR

Silver Sulfate

Silver Nitrate Crystal

Silver Iodide

Silver Bromide

Silver Iodate

Indium Compounds

l Indium Sulphate

l Indium Chloride

l Indium Phosphate

l Indium Nitrate

l Indium Oxide

Cerium Salts / Cerium

Chloride / Lanthanum Salts

l Ammonium Cerium Sulphate

l Ammonium Cerium Nitrate

l Cerium Acetate

l Cerium Sulphate

l Cerium Hydrate

l Cerium Sulfate Hydrate

l Cerium Oxide

l Lanthanum Nitrate

l Lanthanum Chloride

l Lanthanum Phosphate

Bismuth Salts Compounds

l Bismuth Nitrate

l Bismuth Oxychloride

l Bismuth Carbonate

l Bismuth Citrate

l Sodium Bismuthate AR/LR

l Bismuth Sulphite

l Bismuth Subsalicylate

l Bismuth Oxide

Industrial Chemicals

l Styphnic Acid

l Phenyl Mercuric Acetate

l Peracetic Acid

l Lead Acetate

l Methyl Pyruvate

l Phosphotungstic Acid

l Acid Fuchsin

l Hexachloro Patinic Acid

l Picric Acid

l Resorcinol

l Lead Nitrate

l 5 Sulphosalicylic Acid

l Ethyl Pyruvate

l Pyruvic Acid

l Sodium Molybdate

l Sodium Tungstate

l Ammonium Molybdate

l Phosphomolybdic Acid

l Sodium Pyruvate

l Raney Nickel

Metal Powders

l Silver Metal Powder

l Moly Trioxide

l Gold Metal Powder

l Platinum Metal

l Rhodium Metal Powder

l Copper Metal Powder

Copper Salts

l Copper Sulphate

l Copper Nitrate

l Copper Acetate

l Copper Citrate

Regd. Off.: 401, Aashiya, Narsi Chhaya, J.V.P.D. Scheme, 18, Swastik Society, N.S. Road No. 2, Ville Parle (W), Mumbai - 400056 Tel: 9322395199, 26171279 Mob: 98920 63766 Email: indianplatinum@gmail.com Web: www.palladiumchemicals.com

CELLULOSE ACETATE PHTHALATE (CAP / CELLACEFATE)

IP/BP/USP/EP (U.S. DMF AVAILABLE)

CAS NO. 9004-38-0

HYPROMELLOSE ACETATE SUCCINATE (HPMCAS)

USP (U.S. DMF IN-PROCESS)

CAS NO. 71138-97-1

HYPROMELLOSE PHTHALATE (HPMCP / HPMC PHTHALATE)

IP/BP/EP/USP (U.S. DMF AVAILABLE)

CAS NO. 9050-31-1

CELLULOSE ACETATE

BP/EP/USP (U.S. DMF IN-PROCESS)

CAS NO. 9004-35-7

CELLULOSE ACETATE TRIMELLITATE

CAS NO. 52907-01-4

POLYVINYL ACETATE PHTHALATE (PVAP)

USP (U.S. DMF IN-PROCESS)

CAS NO. 34481-48-6

Film Coating Tablets

Enteric Coating of Tablets

Sustained Release

Delayed Release

Pellet Coating Material

25+ years of Manufacturing V

Animal Health API

Afloxolaner

Amitraz

Buparvaquone

Butaphosphan

Carprofen

Clorsulon

Diminazene Aceturate

Fenbendazole

Human Health API

Fluazuron

Flunixin Meglumine

Fluralaner

Imidocarb Dipropionate

Marbofloxacin

N-Ethyl Glucamine

Nitroxynil

Parvaquone

Praziquantel

Ractopamine Hydrochloride

S-Methoprene

T To um oldimfos Sodium

T Tooltrazuril

Triclabendazzole

Xylazine

Nitazoxanide Atovaquone Praziquantel

ARK CHEMICALS PRIVATE LIMITED

CONTACT DETAILS: Mr.Anmol Wadhwa: Mobile No. 9819592146 Mail Id : anmol@arkchemicals.in

WACKER METROARK CHEMICALS P. LTD/ WACKER CHEMIE AG

Silicones:

1. Silicone Fluids – 10 Ctsk To 10 Lakh Ctsk

2. Geniosil Vinyl Silanes & Genioplast Polymer Addi ves

3. Silicone Greases

4. Silicone For Car Care & Personal Care

Silicone Defoamers/An foams For:

1. Paper And Pulp Industry ( Pulpsil Series)

2. Low Foaming We ng Agent ( Silfoam Series)

3. Etp And Other Low End Applica ons

4. Metal Working Industry

5. Powder And Liquid Defoamer For Detergent Industry

6. Tex le Applica on

7. Powder And Liquid Defoamer For Agro Industry

Silicone Emulsions:

1. Tyre And Dash Board Polish

2. Mould Release

A ) For Rubber Footwear

B ) For Eva Footwear

C ) For Polyurethane Release

D ) Alumininum Dia Cas ng Release

Paints, Coa ng & Construc on:

1. Silicone Resin For Heat Resistant Paints

2. Slip& Mar Addi ve For Solvent Based Paints

3. Hammertone Addi ve For Solvent Based Paints

4. Silicone Addi ve To Make Paints Water Repellent

5. Silicone Binder For Water Based Paints

6. Silicone Based Water Repellents For Natural Stones

7. Powder Based Silicone Water Repellents For Wall Pu y

AQUAPHARM

OTHER PRODUCTS

1. Sles 28% & 70%

VVF

4. Stearyl Alcohols

5. Ldma (For Manufacturing BKC )

Glycerine

Glycerine USP/BP/IP/CP/EP Glycerine Ethoxylates

CLARIANT IGL SPECIALTY CHEMICALS PVT LTD

Ethoxylates

1. Nonyl Phenol Ethoxylates

2. Octyl Phenol Ethoxylates

3. Styrenated Phenol Ethoxylates

4. Tridecyl Alcohol Ethoxylates

5. Cetostearyl Alcohol Ethoxylates

6. Cetyl Alcohol Ethoxylates

7. Castor Oil Ethoxylates

8. Polyethylene Glycols

9. Oleyl Amine Ethoxylates

FUMED SILICA

A. Hydrophilic

1. Wacker HDK® N20

2. Wacker HDK® V15

B. Hydrophobic

1. Wacker HDK® H17

2. Wacker HDK® H18

3. Wacker HDK® H13L

4. Wacker HDK® H15

5. Wacker HDK® H2000

Wood Adhesives

2. Binder For Paper Adhesives / Wood Adhesives

3. Binder For Wood Adhesives / Pvc To Mdf

4. Binder For Membrane Press Adhesives

CHEMICALS PVT.LTD.

1. Phosphonates

2. Polymers

2. Perfume Solubilizer

(INDIA) LTD

1. Lauryl Alcohols

2. Cetyl Alcohols

3. Ceto Stearyl Alcohol (30:70/50:50/70:30)

Adi Metchem Private Limited

PRODUCTS

l Bis(Benzonitrile Dichloropalladium(II)

l Dichlorobis(Acetonitrile)Palladium(II)

l Bis(Acetylacetonato)Palladium(II)

l Tris(Dibenzylidecetone)Dipalladium (O)Chloroform

l Bis(Triphenyl Phosphine)

Dichloropalladium(II)

l Palladium Acetate,Trimer Or Palladous Acetate,Trimer

l Diactatebis(Triphenyl Phosphine)

Palladium(II)

l Dichloro-Bis(Triphenal Phosphine)

Ruthenium(II)

IRIDIUM

l Iridium Black

l Iridium Chloride Hydrate

l Iridium (IV) Oxide

l Carbonylchloridobis (Triphenylphosphane)Iridium(I)

l Cycloocta-1,5-Diene)(Pyridine) (Tricyclohexylphosphane)Iridium(1+) Hexafluoridophosphate(1 )

l Chlorobis(Cyclooctene)Iridium(I) Dimer

l Methoxy(Cyclooctadiene)Iridium(I)

Dimer

l 1,5-Cyclooctadiene-Iridium(I) Chloride

Dimer

PALLADIUM

l Palladium Black

l Palladium(II) Oxide

l Palladium Chloride

l Palladium (II) Nitrate Solution

l Tetraamminepalladium Chloride

l Palladium Acetate,Trimer Or Palladous Acetate

GOLD

l Gold Power

l Gold(I) Chloride

l Ammonium Tetrachloroaurate(III)

l Hydrogen Tetrachloroaurate (III)

l Gold (I) Iodide

PLATINUM

l Platinum Black

l Platinum (IV) Oxide Adam’s Catalyst

l Chloroplatinic Acid Hydrogen

Hexachloroplatinate (IV) Hydrate

l Ammonium Tetrachloroplatinate (II)

l Dinitrodiammine Platinum (II)Platinum ‘P’ Salt

l Platinum (IV) Chloride

NICKEL

l Nickel(II) Chloride

l Nickel(II) Oxide , Nickel Monoxide , Oxonickel

l Nickel Hydroxycarbonate

l Nickel(II) Nitrate , Nickelous Nitrate

l Nickel(2+) Diacetate

l Nickel(II) Hydroxide

l Nickel Arsenide(II)

l Nickel Antimonide

l Nickel Arsenide

l Raney Nickel

l Nickel(II) Oxide

l Nickel Sulphate/Solution

SILVER

l Silver Metal Power

l Silver(I)Chloride

l Silver(I) Nitrate

l Silver(I) Oxide

l Silver(I) Iodide

l Silver(I)Fluoride

l Silver Bromide

l Silver Acetate

l Silver Carbonate

l Silver Lactate

COBALT

l Cobalt(III) Hydroxide

l Cobalt(III) Nitrate

l Cobalt(III) Oxide

l Chloropentamminecobalt Chloride

RHODIUM

l Rhodium Black

l Rhodium(III) Chloride

l Rhodium Octanoate Dimer

l Rhodium (II) Acetate, Dimer

l Ammonium Hexachlororhodate(III)

l Hydrido Tetrakis 1triphenylphosphine) Rhodium(I)

RUTHENIUM

l Ruthenium Black

l Ruthenium (III) Chloride

l Ammonium Chlororuthenate

l Ruthenium(IV) Oxide Hydrated

l Ruthenium(III)Acetate

l Ruthenium Nitrosyl Nitrate Solution

l Potassium Pentachlororythenate

l Ruthenium (IV) Oxide Anhydrous

l Ruthenium Red Powder

12-Samrat Ind. Area, Nr. Satyanarayan Way Bridge, Gondal Road, Rajkot (Gujarat) 360 004. Contact: Jitendra Chauhan : 9328533777 | Email: adimetchem@gmail.com | Web: www.adimetchem.com

l l Emulsifier 4.5(Alphox 100)

l Emulsifier 9.5(Alphox 200)

l Emulsifier 30(Alphox 500)

l Benzoic Acid 99% Tech Grade

l l Butyl Cellosolve

l l Butyl Carbitol

l Castor Oil 40 (Castrox 200)

l l Cetomacrogol 1000(Cetodet 500)

l l Ethyl Carbitol (Igtol 12016 E)

l Ethyl Cellosolve(Igsol 12026 E)

l Ethyl Cellosolve Acetate (Igace 6701 E)

l l Methyl Cellosolve

l Maleic Anhydride

LIST

l Poly Ethylene Glycol 200 (Peg 200)

l Poly Ethylene Glycol 400 (Peg 400)

l Poly Ethylene Glycol 600 (Peg 600)

l Poly Ethylene Glycol 1500 (Peg 1500)

l Poly Ethylene Glycol 4000 (Peg 4000)

l Poly Ethylene Glycol 6000 (Peg 6000)

l Polysorbate 80 (Sorbox 80 / Twin 80)

Ethoxylate

l l Propylene Glycol

l l Toluene (Bulk)

l Methyl Ethyl Ketone (Bulk)

l Butyl Acetate (Bulk)

PRODUCT KAMLESH ENTERPRISE D003, Vijay Park, Iraniwadi Road No.3, Kandivali West, Mumbai-400067 Rajesh Goradia- Mob: 9820019738/9223433306 Kamlesh Garodia - Mob: 9820019788 / 9224701344 www.kamleshenterprise.in

v All Amino Acid

v v Budesonide

v v Cabergoline

v v Carbidopa

v v Caroverine

v v Carvedilol

v v Colchicine

v Dibucain BP/USP/JP

v v Edaravone

v Empagliflozin

v v Ezetimibe

v v Fosfomycin Sodium

v v Fosfomycin Trometamol

v v Glimpiride IP/USP

v Glipizide IP

v Iron Protein Succinylate

v Indapamide IP/USP

v Ketoprofen IP/USP/EP

v Levodopa

v Linagliptine IP/BP/EP/USP

v Midodrine HCL

v Orlistat IH

v v Oxybutynin HCL BP/EP

v v Pepsin (1:3000)

v v Pimecrolimus

v v Pro-Pre Biotic Blend (As per customer request composition)

v v Risperidon USP

v v Rifaximin BP

v v Rutoside Trihydrate BP

v v Serratiopeptidase Plain / Granuals

v v Tacrolimus

v v Tetrabenazine

v v Trypsin BP

ALL TYPES OF HERBAL EXTRACTS & NUTRACEUTICAL RAW MATERIAL

v Acrycoat (Eudragit Equivalent)

v v Acrypol 934/940/971G/980 (Carbopool Equivalent) & Others

v v Acrysol K-140/K-150/EL-135

v Crosscarmellose Sodium IP / USP

v v Kyron T-134/T-314/T-114 & Others

v v MCCP IP/BP/USP PH 101,102,112,200

v v Magnesium Stearate IP/BP/USP

v v Sodium Starch Glycolate IP/BP/USP

R. D. Shah: 9820130897 & D. D. Shah: 9820084312

Contact Details : 9870795121 / 9825242122

Office No.: 7021778189 / 8591740139

Email: sales@panchamrutchemicals.com / info@panchamrutchemicals.com

PANCHAMRUT CHEMICALS PRODUCTS

HYDROQUINONE

TRI BUTYL PHOSPHATE

L ASPARTIC ACID

SODIUM FORMATE

ORTHO CHLORO BENZOIC ACID

SUCRALOSE ASPARTAME

GLYCERINE

BENZOPHENONE

l BILASTINE

l CINNARAZINE BP

API PRODUCT API PELLETS

l CINITAPRIDE HYDROGEN TARTRATE

l CLOPIDOGREL IP/ USP

l CITICOLIN

l DAPAGLIFLOZIN

l DIACERIN

l DOMPERIDONE IP

l DEX RABEPRAZOLE IP

l DEVLANSOPRAZOLE

l ESOMEPRAZOLE MAGNESIUM

l FAMOTIDINE

l FEBUXOSTAT IP

l FENOFIBRATE MICRONIZE

l LLAPRAZOLE IP

l AMMONIUM

l BENTONITE

l CALCIUM CARBONATE

l IMEGLIMIN

l ITRACANOZOLE BP

l LANSOPRAZOLE IP/ USP

l LEVOCETRIZINE HYDROCHLORIDE IP

l MONTELUKAST IP

l OMEPRAZOLE IP / USP / BP

l POSACONAZOLE

l PREGABLIN

l PRUCALOPRIDE SUCCINATE

l RABEPRAZOLE SODIUM IP

l SILDENAFIL IP

l SILODASIN

l SPARFLOXACIN

l TRICLABENDAZOLE

l TADALAFILL USP

l XANTHAN GUM

l FELDSPAR

l LACTIC ACID

CHEMICALS

l PARA TOLUENE SULPHONIC ACID

l DEX RABEPRAZOLE PELLETS

l DEX LANSOPRAZOLE PELLETS

l ESOMEPRAZOLE MAGNESLUM TRIHYDRATE PELLETS

l ITRACONAZOLE PELLETS 20% , 22%, 40% , 44%

l LANSOPRAZOLE IP/ USP PELLETS

l OMEPRAZOLE POWDER IP / USP PELLETS

l PANTOPRAZOLE SODIUM SESQ IP / USP / BP PELLETS

l RABEPRAZOLE SODIUM IP PELLETS

l PANTOPRAZOLE (EC) & DOMPERIDONE (EC ) PELLETS

l OMEPRAZOLE (EC) & DOMPERIDONE (SR ) PELLETS

l RABEPRAZOLE SODIUM (EC) DOMPERIDONE (SR ) PELLETS

l ESOMEPRAZOLE MAGNESIUM (EC ) & DOMPERIDONE (SR ) PELLETS

l RESORCINOL

l TALC POWDER

l THIO PHENOL

SMALL PACKING AVAILABLE

SHEETAL CHEM

CONTACT PERSON: RAJIV PUGALIA - MOB: 9004034930 / 9322255377

Key Products:

HEPARIN SODIUM

ENOXAPARIN SODIUM Registration Complete

OUR REGISTERED PRODUCTS LIST

ERYTHROMYCIN THIOCYANATE

AZITHROMYCIN IP / USP

GENTAMYCIN SULPHATE IP

SUCRALFATE USP

METAMIZOLE SODIUM EP SPIRAMYCIN EP CLOTRIMAZOLE IP/BP/USP

STEROID, HORMONES & INTERMEDIATES

l l 16ALPHA METHYLEPOXIDE 8DM l 17A HYDROXYPROGESTERONE

l l 11B 16B 11 HYDROXY 2 METHYL 5H PREGNA 1 4 DIENO 17 16D OXAZOLE 3 20 DIONE D5 l 16BETA-METHYL EPOXIDE (DB11

l 6A METHYL 11B 17A DIHYDROXY 1 4 DIENE PREGNA 3 20 DIONE INTERMEDIATE

l l DEXAMETHASONE BP-USP l l BETAMETHASONE BASE l l 19 HYDROXY 4 ANDROSTENEDIONE

l l BISNORALCOHOL l l 9 11 B EPOXIDE TRIAMCINOLONE 5TR

l l 3 20 DIOXOPREGNA 1 4 9 11 16 TETRAEN 21 YLACETATE 3TR

STRONG API'S

Amoxicillin Trihydrate Compacted

Amoxicillin Trihydrate Powder

Ampicillin Compacted

Azithromycin Trihydrate

Cephalexin

Clortrimazole

Cyanocobalamin [Vitamin B12]

Doxycycline

Enoxaparin Sodium

Erythromycin Thiocyanate

Gentamycin Sulphate

Heparin Sodium

Metamizole Sodium

Orlistat

Prednisolone

Spiramycin

Sucralfate

Vitamin B2 Feed Garde

Vitamin B2 Pharmam Grade

Vitamin B6

*WE CAN OFFER MANY OTHER API'S , KINDLY SEND YOUR REQUIRED API'S TO OFFER*

FOR ANY ASSISTANCE AND ENQUIRES PLS CONTACT:

205, Janki Centre, 29, Shah Industrial Estate, Off. Veera Desai Road, Andheri (W), Mumbai-400 053 Tel No.:-6694 3012 / 3013 Email: unitrade@unitradeagencies.com Website: www.unitradeagencies.com

Email:

G-2 Om Mayureshwar Co-Op. Housing Society Limited, L. T. Road, Dharamdas Marg, Babhai Naka, Opp. Dwara Hotel, Borivali (West), Mumbai - 400 092. Tel. No.: 8655448030 | Email: novachemie1@gmail.com

l Amoxicillin Sodium Sterile

l l Aceclofenac

l l Albendazole

l l Alpha Beta Arteether

l l Ambroxol Hcl

l l Amlodipine Besilate

l l Ampicillin Plain/Comp/Sterile

l l Artemether

l l Artesunate ( Oral & Injectable )

l l Azithromycin Dihydrate

l l Beclomethasone Dipropionate

l l Betamethasone Di Propionate

l l Betamethasone Sodium Phosphate

l l Betamethasone Valerate

ll Brinzolamide

ll Bupropion Hcl

ll Caffeine Anhydrous

ll Carisoprodol

ll Cefixime Trihydrate Compoacted

l l Cefalexin Compacted

l l Cefadroxil

l l Cefpodoxime Proxetil

l l Ceftriaxone Sodium Sterile

l l Cefoperazone Sodium Sterile

l l Celecoxib

l l Cetirizine Dihydrochloride

l l Chlorzoxazone

l l Chymotrypsin

l l Ciprofloxacin Salts

l l Citicoline Sodium

l l Clarithromycin

l l Clobetasol Propionate

l l Clopidogrel Bisulphate

l Cloxacillin Plain/Comp/Sterile

l Colloidal Silicon Dioxide

l Dapoxetine Hcl

l Deflazacort

l Dexamethasone Sodium Phosphate

l Dextromethorphan Hbr

l Diclofenac Salts

l Dicloxacillin Sodium Sterile

l Dicyclomine Hcl

l Diethyl Carbamazine Citrate

l Di Dihydro Artemesinin

l Diloxanide Furoate

l Dimenhydrinate

l Diphenhydramine Hcl/Base

l Doxophylline

l Enrofloxacin

l Erythromycin Estolate

l Erythromycin Ethyl Succinate

l Erythromycin Stearate

l Esomeprazole Mg. Trihydrate

l Etoricoxib

l Febuxostat

l Fenbendazole

l Fenofibrate

l Ferrous Ascorbate/Dc Grade

l Finasteride

l Flucinolone Salts

l Fluconazole

l Fluticasone Propionate

l Folic Acid

l Furosemide

l Glimepiride

l Glucosamine Hcl

l l Glucosamine Sulphate Potassium Chloride.

l l Glucosamine Sulphate Sodiumchloride.

l l Hydrocortisone Salts

l l Irbesartan

l l Ketoconazole

l l Levetiracetam

ll Levocetirizine Hcl

ll Levofloxacin Hemihydrate

ll Levosulpiride

ll Lornoxicam

ll Luliconazol

ll Lumefantrine

ll Mefenamic Acid

ll Meropenem Sterile

ll Mesalamine

ll Metformin Hcl

ll Methyl Prednisolone Acetate

ll Methylcobalamin

ll Metoclopramide Hcl

ll Metoprolol Succinate

ll Metoprolol Tartrate

ll Metronidazole Salts

ll Miconazole Nitrate

l l Mometasone Furoate

l l Montelukast Sodium

l l Moxifloxacin

l l Niacin

l l Niacinamide

l l Nimesulide

l l Nitazoxanide

l l Norfloxacin

l l Ofloxacin

l l Olmesartan Medoxomil

l l Ondansetron Hydrochloride

NEW

l Ornidazole

l Pancreatin

l Paracetamol

l Phenazone

l Phenytoin Base/Sodium

l Picosulfate Sodium

l Pioglitazone Hcl

l Pipercillin + Tazobactum Sodium Sterile (8:1)

l Praziquantel

l

l Pregabalin

l l Propyl Gallate

l l Quinine Salts

l l Risperidone

l Rosuvastatin Calcium

l Roxythromycin

l Secnidazole

l Serratiopeptidase Plain /Coated

l Silver Sulfadiazine

l Sulbactum Sodium Sterile

l Tamsulosin Hcl

l Tapentadol

l Telmisartan

l Teneligliptin Hbr

l Tetracycline Hcl

l Tolnaftate

l Tolfenamic Acid ( Oral & Injectable )

l Tricholine Citrate

l Trypsin

l Vildagliptin

l Vitamin B1 Hcl / Mono

l Vitamin B12 (Cyanocobalamin)

l l Vitamin B2 (Riboflavin)

l l Vitamin B2

5 Phosphate

l l Vitamin B6 (Pyridoxol 5

Phosphate)

CR PHAR R MA A

Proprietor: Chintan Domadia

Mobile:- +91 9324211958, +91 9022445757

Email:- sales.crpharma@gmail.com | Website:- www.crpharma.co.in

511, 5th floor, Zest Business Space, M.G.Road, Ghatkopar (East), Mumbai-400077

HARIKA DRUGS REPRESENTATIVE

PROCHLORPERAZINE MALEATE IP/BP/USP (PREMIUM SELLER)

DOXYLAMINE SUCCINATE USP (PREMIUM SELLER)

GLICLAZIDE IP/BP

PROMETHAZINE HCL IP/BP/USP (PREMIUM SELLER)

PROMETHAZINE THEOCLATE IP/BP (PREMIUM SELLER)

OTHER PRODUCTS:-

ETORICOXIB IP

OXYCLOZANIDE BP VET LULICONAZOLE IP

LINEZOLID IP VILDAGLIPTIN IP

METHYLCOBALAMIN IP

ALBENDAZOLE IP & USP (PLAIN)

CLOPIDOGREL BISULPHATE IP

LEVOCETIRIZINE HCL IP

DOMPERIDONE IP

AMBROXOL HCL IP

RIFAXIMIN EP

MONTELUKAST SODIUM IP

MEFENAMIC ACID IP/BP

BRIVARACETAM IHS

*All Prices are Subject to final confirma on and availability of the stock at the me of order.

Corp. Office: Ground Floor, Usha Building, S. V. Road, Near Nanavati Hospital, Vile Parle (West), Mumbai-400056, Maharashtra.

Tel: +91(022) 26104647 / 25188195

Mobile: +91(0) 9768456789 / 9768312345

Email: info@siddhambikaimpex.com

Authorised Distributor of Worlds Largest Producer of Lactulose

Concentrate 67% USP From Fresenius Kabi Austria

You Can also contact us for: 1)Opthalmic API 2)Anti Cancer API 3)Excepients

Fresenius Kabi Austria is one of the leading lactulose suppliers, with more than 40 years of experience in its production and distribution. We supply lactulose in liquid and crystalline form manufactured at two production sites in Linz, Austria, and in Vicchio, Italy.

For more information on our Lactulose product portfolio and services, please contact our Indian Distributor.

Regd. Office: Shri Muni Suvrat Complex, F-209, 2nd Floor, Phase-1, Rehnal Village, Bhiwandi – 421 302, Thane, Maharashtra.

B.J. SCIENTIFIC CO.

27/29, Popatwadi, Kalbadevi, P.B. No. 2177, Mumbai - 400 002 Tel / Fax : 0091-22-22013581, 22032275, 22017040 Email: bjscientific@yahoo.com / Email: bjscientific@ gmail.com Web : www.bjscientific.com

EUTECH HANNA ORION HACH

PALL SARTORIUS MILLIPORE AXIVA

TARSONS POLYLAB ABDOS KASABLANKA

EUTECH REAGECON HAMILTON

WHATMAN AXIVA

AUTHORISED DEALER

Laboratory Glasswares, Tubings, Rods, Microlitre Pipettes, Bottle Top Dispensers

JAYANT TECHNOLAB SHANTI PILOT

Membrane Filter Papers & Syringe Filters

TEMPO KUMAR PATHAK METALAB SHANTI

Plasticware

AXIVA VOLEX SONAR REMI ELTEK EMTEK

Filter Papers, Plasticwares, Microlitre Pipettes, Tips

Standard Buffer Solutions

Filter Papers Test Sieves & Sieve Shakers

QUARTZ SILICA

TOSHNIWAL SYSTRONICS ELICO

LOVIBOND AQUALYTIC

SUPERFIT

Rotary Evaporators, TLC Kits etc.

DHONA TAPSONS

pH, ION, TDS, Conductivity Meters Mechanical Analytical Balances

Lab Stirrers, Centrifuges, Magnetic Stirrers

METTLER SARTORIUS SHIMADZU

Electronic Balance, Spectrophotometer

TEFLON PTFE

Bushes, Beakers, Magnetic Needles

Tubings, Rods, Crucibles, Plates, Beakers etc.

HAMILTON AGILENT SGE

Microliter Syringes

Oven Incubator Furnace Digital Viscometers

BROOKFIELD FUNGILAB

Thermometers, Calibration Certificate for ISO

MITUTOYO JAPAN

Vernier Calipers, Gauges etc.

pH Meter, Conductivity Meter

MERCK BRAND EPPENDORF

Digital Burettes, Micro Pipettes.

Comparators, Cells Turbidity / Photometers

LUTRON FLUKE MECO

Anemometer, Ammemeter, Sound Level Meter, Lux Meter, Digital Multimeter, Tong Testers etc.

EQUITRON

Autoclave. Colony Counter etc.

PLATINUM

Crucibles,Basins, Wires & Basket

A TRUSTED NAME IN LABORATORY GLASSWARE & SCIENTIFIC INSTRUMENTS

Admin O : Unit No 12, 1St Floor, Neminath Indl Estate No. 6, Navghar, Vasai East, Dist Palghar- 401210

TEL : 91-250-2390032 / 2390989

Email: sales@oxfordlabchem.com, info@oxfordlabchem.com Web: www.oxfordlabchem.com / www. oxfordlabfinechem.com

MANUFACTURERS OF WIDE RANGE OF LABORATORY CHEMICALS

l ACRIDINE ORANGE

l AGAR AGAR ( FOR MICROBIOLOGY )

l AGAROSE

l ALCIAN BLUE 8 GX

l ANTHRONE LR/ AR

l AZUR A & B

l BASIC FUCHSIN

l BILIRUBIN

l BIOLOGICAL BUFFERS

l CARMINE

l CHOLESTEROL

l CRYSTAL VIOLET (GENTIAN VIOLET )

l ERIOCHROME BLACK T

l ERIOCHROME CYANINE R

l ETHIDIUM BROMIDE AR

l FIELD STAIN A

l FIELD STAIN B

l GOLD CHLORIDE (24% AND 49% )

l HEMATOXYLIN STAIN CERTIFIED

l IMMERSION OIL

l IODINE MONOBROMIDE

l LEISHNAN STAIN

l MERCURIC CHLORIDE LR/AR

l MERCURIC IODIDE RED LR/AR

l MERCURIC SULPHATE LR/AR

l MERCURY AMMONIATED LR/AR

l META PHOSPHORIC ACID STICKS

l METAL SALTS LR/AR GRADES

l METHYL ORANGE

l MUREXIDE

l N-1 NAPHTHYL ETHYLENE DIAMINE DIHYDROCHLORIDE LR/AR

l N, N –DIMETHYL –PPHENYLENEDIAMINE OXALATE AR

l NEOCUPROINE

l N-PHENYL ANTHRANILIC ACID

l PALLADIUM CHLORIDE (59-60% PD )

l PHENYL MERCURIC ACETATE

l PHENYL MERCURIC NITRATE

l PLATINUM CHLORIDE (40% PT )

l POTASSIUM BROMIDE IR SPECTROSCOPY

l POTASSIUM CHLOROPLATINATE

l POTASSIUM IODATE LR/AR

l POTASSIUM IODIDE LR / AR

l POTASSIUM TELLURITE

l PYRONIN B l PYRONIN G (Y)

l RESAZURIN SODIUM SALT

l SAPONIN

l SILVER DIETHYL DITHIOCARBAMATE

l SILVER METAL SALTS

l SILVER NITRATE LR/ AR

l SILVER SULPHATE LR/AR

l SODIUM ARSENATE LR/AR

l SODIUM ARSENITE LR/AR

l STAINS & INDICATORS

l THIOMERSAL

l THYMIDINE

l WRIGHT STAIN

l XYLENE CYANOL FF

l XYLENOL ORANGE

JEEVAN CHEMICALS AND PHARMACEUTICALS

Plot no: - C-431, T.T.C. Industrial area, Turbhe, Navi Mumbai-400705.

Email: info@jeevanchempharma.org

Website: www.jeevanchempharma.org

Phone no: - 9326362295, 9833140986.

BACTERIOLOGICAL RAW MATERIALS

1. Protein Hydrolysate.

2. Yeast Extract.

3. Betaine Anhydrous.

4. Dimethyl Glycine.

5. Glycine.

6. Cerebro protein Hydrolysate.

7. Ovotranferrin

1. Liver Tonic.

2. Probiotics.

3. Prebiotics.

4. Enzymes.

5. Amino Acids.

6. Dried Yeasts.

Committed

Office no :- 45, 3rd Floor, Pheerbhoy Build Mob.: ( ) 093

Eil bhhd@il

Email: bshahandsons@gmail.com

for Quality Services Since 1957 ing, Dawabazar, 89, Princess Street, Mumbai - 400002. 3222 11535 / 079771 80631 com Website: www.shahandassociates.co.in

l Aleovera gel / Juice

l Asst axanthin 10% powder

l Bronopol B. P

l Bromelain 2400 GDU

l Beta Carotene

l Cranbarry

l Carbopol 940/934

l Chlorohexadin Gluconate 20% soln

l Ajowan Oil

l Anethi Oil

l Almond Oil

l Anisee Oil

l Arachis Oil

l Basil Oil

l Cardamom Oil

l Clove Oil

l Chawl Mogra Oil

l Cinammon Oil.

l Capsicumtinctue

l Caraway Oil

l Citramide

l CMC sodium HVP I.P

l Castor oil

l D mannose

l Farric Maltol

l Fungal Diastase I. P

STOCK READY ILABLE

AVAILABLE READY STOCK

l L Lyycopene 6% and 10 %

l Pepsin I. p

l Papain Pure / I. p /2X /5 x

l X Para Chloro Meta Xyynol

l X Di chloro meta Xyynol

l Trypsin B. P

l Trypsin Chemo trypsin 1:6

l Methy Salicylate I. p

l Propyl Paraben I. P

l Propyl Paraben Sodium I. p

l Rutoside

l Serratiopeptadise

l Salicylic Acid I. P

l Thymol

l Iron III Polymaltose

l Niacinamide I. p yl I. p

l Methyl paraben I. p

l T Teer pentine oil

l Methyl paraben sodium I. p oil

l T Teerpeniol

ALL ESSENTIAL OIL IN SMALL AND BIG PACKS

PAACKS BIG AND SMALL IN OIL ESSENTIAL ALL P

l Citronella Oil

l Cajuput Oil

l Castrol Oil

l Coriender Oil

l Cumin Seed Oil

l Chemphor Oil

l Corriender Oil

l Cedarwood Oil

l Creosote Oil

l Dill Seed Oil

l Davana Oil

l Evening Prime

l Euginol

l Eucalyptus Oil

l Fennel Seed Oil

l Grape Seed Oil

l Ginger Oil

l Geranium Oil

l Jojoba Oil

l Juniper Berry Oil

l Kokam Oil

l Linseed Oil (Flaxseed Oil)

l Lemon Oil

l Lime Oil

l Lemon Grass Oil

l Lavender Oil

l Linseed Oil

l Mentha Oil

l Malka Agni Oil

l Menthol Crystal

l Nutmeg Oil

l Neem Oil

l Olieo Resin Cap. Tincutre

l Olive Oil

l Orange Oil

l Peppermint Oil

l Palm Rosa Oil

l Pine Oil

l Palm Oil

l Rose Oil

l Spearmint Oil

l Seasum Oil

l T Teea Tree Oil

l T Teerpeneol

l Turpentine Oil

l Thymol Crystal

l V Veetivert Oil

l Wheat Germ Oil

l Winter Green Oil

1. Peptone.

2. Tryptone.

3. Soya Peptone.

4. Yeast Extract.

5. Liver Extract.

6. Bile Salt.

7. Brain Heart Infusion etc.

CHEMSTAR GLOBAL PRODUCTS LLP

CORE PRODUCTS:

l Hydroquinone (HQ)

l Tert Butylhydroquinone (TBHQ)

l Propionic Acid

l Butylated Hydroxyanisole (BHA)

l Butylated Hydroxytoluene (BHT)

l Tert Butylcatechol (TBC)

l Iodine

ACIDS:

l Ace c Acid

l Acrylic Acid

l Adipic Acid

l Benzoic Acid

l N Butyric Acid

l Citric Acid Anhydrous (CAA)

l Citric Acid Monohydrate (CAM)

l 2 Ethylhexanoic Acid (2 EHA) / Octoic Acid

l Formic Acid 85%

l Formic Acid 99%

l Isobutyric Acid

l Lac c Acid 80%

l Lac c Acid 88%

l Oxalic Acid

l Phosphoric Acid 85% Food Grade

l Phosphoric Acid 85% Technical Grade

l Sulphamic Acid

l Sorbic Acid

PRODUCT LIST:

l Chloranil

SOLVENTS:

l Acetone

l n Butanol

l Tert Butanol (TBA)

l Chloroform

l Cyclohexane

l Cyclohexanone

l Dimethyl Formamide (DMF)

l Dimethyl Sulfoxide (DMSO)

l Ethyl Acetate

l 2 Ethylhexanol (2 EH) / Octanol

l Isopropyl Alcohol (IPA)

l Methylene Chloride (MDC)

l Propylene Glycol (PG) Technical Grade

l Tetrahydrofuran (THF)

l Toluene

l mixed Xylene

l Ortho Xylene

SPECIALTY CHEMICALS:

l Acetophenone

l Ac vated Carbon

l Amprolium

l Anisole

l Ascorbyl Palmitate (AP)

l Benzotriazole

l Butylated Octylated Diphenylamine (BODPA)

l Tert Butylchloride (TBC)

l Calcium Propionate (CP) Feed Grade

l Calcium Propionate (CP) Food Grade

l Catechol

l Chloro Acetyl Chloride (CAC)

l Dicyandiamide (DCDA)

l Diortho Tolylguanidine (DOTG)

l Di tert Butylhydroquinone (Di TBHQ)

l Etamsylate

l Ethyl Vanillin

l Glycerine

l Glycerol Monostearate (GMS) Non Self Emulsifying (NSE) Grade

l Glycerol Monostearate (GMS) Self Emulsifying (SE) Grade

l Glycerol Monooleate (GMO)

l Isopropyl Myristate (IPM)

l Isopropyl Palmitate (IPP)

l Maleic Anhydride

l Methylene Diphenyl Diisocyanate (MDI)

l Mono Methyl Ether of Hydroquinone (MEHQ)

l Paraformaldehyde 91%

l Paraformaldehyde 96%

l Polyols

l Polypropylene Glycol (PPG)

l Polysorbate 80 (Tween 80)

l Sodium Formate

l Sodium Propionate Food Grade

l Sodium Selenite

l Stearic Acid

l Toluene Diisocyanate (TDI)

l Tolyltriazole

l Vanillin

l Xanthan Gum

METALLIC SALTS:

l Cobalt Sulphate

l Copper Sulphate

l Ferrous Sulphate

l Manganese Sulphate

l Potassium Iodate

l Potassium Iodide

l Zinc Oxide

l Zinc Sulphate

AROMA CHEMICALS:

l Benzyl Isoeugenol

l Caryophyllene

l Caryophyllene Acetate

l Clove Oil (Bud)

l Clove Oil (Leaf)

l Dihydro Eugenol

l Dimethyl Hydroquinone (DMHQ)

l Eucalyptol

l Eucalyptus Oil

l Eugenol

l Eugenyl Acetate

l Green Patchouli Absolute

l Isoeugenol

l Isoeugenyl Acetate

l Methyl Eugenol

l Methyl Isoeugenol

l Patchoulol

l Tabac Dodecane

And many more products....

AURANGABAD

METHYLCOBALAMIN

HYDROXYCOBALAMIN

METHYLPREDNISOLONE IP

WE OFFER FOLLOWING PRODUCTS BEING MANUFACTURED BY KINDLY CONTACT FOR YOUR REQUIREMENT:

A-602, 6TH FLOOR, HERITAGE PLAZA, TELLI GALLI CROSS ROAD, NR. CITI POINT ANDHERI (EAST), MUMBAI – 400069. Tel. No.: + 91 22 4002 3345 /4002 4456 l E-mail : apex.pravinchandra@gmail.com

SIDDHIVINAYAK PHARMA

l ETHYL OLEATE

l BENZYL ALCOHOL / BENZOATE / ZINC PYRITHIONE

l CHLORPHENIRAMINE MALEATE / DEX CPM

l COLLIDAL SILLICON DIOXIDE (EQ AEROSIL)

l PERMITHRIN / PHENOLPHTHALEIN LP

l MEDIUM CHAIN TRIGLYCERIDE (MCT OIL)

l ALL TYPE OF FLAVOUR / COLOUR / WAXES / OILS

l LACTIC ACID / S.S.G / M.C.C.P

l CETIRIZINE DI HCL IP / FUROSEMIDE IP

l TRICLABENDAZOLE / BRONOPOL IP

l ADAPALENE / NEPAFENAC (STERILE & MICRONISED)

l INDOMETHACIN BP / CABERGOLINE

l INDAPAMIDE IP / IVERMECTIN IP VET

l METOPROLOL SUCCINATE / MOMENTASONE FUROATE IP

l NICORANDIL / VOGLIBOSE / PHENAZONE IP

l ARACHIS OIL / LINSEED OIL / CALCIUM LACTATE

l AVOBENZONE / BENZOPHENONE (OXYBENZONE)

l B.H.A / B.H.T / PROPY GALLET / D.C.P. / T.C.P.

l COLOUR ERYTHROSIN / BRILLANT BLUE / PONCEAU 4R

l PANCREATIN I P

l COLOUR QUINOLINE YELLOW / SUNSET YELLOW / TARTRAZINE

l CHOLINE CHLORIDE (FEED) / PHARMA

l DIVAPROEX SODIUM / SODIUM VALPORATE

l D.H.A (VEG) / GINSENG POWDER / EXTRACT

l EMULSIFYING WAX / PEG / TWEEN-60-80

l H.P.M.C / ETHYL CELLULOSE / H.P.M.CP

l IRON OXIDE RED / YELLOW / BLACK

l LIVER / YEAST EXTRACT POWDER / HONEY

l MAGNESIUM STEARATE / CROSS CARMOLOSE SODI

l MAIZE STARCH / SORBITOL / LIQUID GLUCOSE

l MANITOL / XANTHAN GUM / P.V.P.K.-30

l N-ACETYL-CYSTIN / L-ARGININE (L-SERIES)

l OCTINOXATE (OCTYL P-METHOYCINNAMATE)(O.M.C)

l P.G. / GLYCERIN / I.P.A / M.D.C / B.H.A / B.H.T / GUAR GUM

l PROTIN LIQ. / POWDER55-60% / 75-80%

l SIMITHICON / CETOSTRYLALCHOL / STRYLALCOHOL

l SODIUM / POTASSIUMHYDROXIDE PALLETS

l SODIUM SACCHARINE / B.H.A / B.H.T / GUAR GUM

l VITB1 / B2 / B6 / B12 / D3 / D3 STABILISED

l METHYL FOLATE CALCIUM (MAXFOL)

l TRETINOIN USP

l CAMPHOR USP / BP

l METHYLCOBALAMINE IP / JP

A-102, Gharkul Bldg., Missquitta Cross Lane, Azad Road, Vileparle (E), Mumbai - 400057. Tel No. - 022-26123411/ 65276034 Mobile No. - 9322593515 / 9323128870

Email: siddhivinayakpharma@yahoo.co.in / siddhivinayakpharma@hotmail.com

Cobalt

Cobalt Chloride l

tate Cobalt Ace l

te Cobalt Sulpha l

xide Cobalt O l

PRODUCTLIST

ODUCT LIST ck

tate el Ace

te el Sulpha ck

ate el Nitr ck

te el Carbona ck

omium

omium Chloride hr

tate omium Ace hr

omium Fluoride hr

ate omium Nitr hr

103, Savera, offff. Shimpoli Road, Mobile: 9 Email:

Chromiu l

Tungsten

ormate m F

Sodium T l

Tungstate

Phospho l c Tungs l

c Acid ungs o T Acid

Stannous l Tin

Stannous l

Potassiu l

te s Sulpha s Chloride

annate m St

Sodium S l

Stannate

Borivali-west, Mumbai – 400092, Ma 9833 251 567, 9167 551 567

aharashtra, India

60%Cereal Base

l Choline Chloride 60%Corn Base

l Choline Chloride 50%Silica Base

l Choline Chloride 50%Corn Base

l Choline Chloride 75%Liquid

l Choline Chloride 70%Liquid

l Choline Chloride 60%Liquid

l Choline Chloride 97 98%Pure

l Di Calcium Phosphate (Dcp)

l (T Tri Calcium Phosphate Tccp)

l Monocalium Phosphate (Mcp)

l T Tooxin Binder (Datox)

l Phytase 5000 u/Granular/Powder

l Cocktail Enzymes l Mono Sodium Phosphate

l Vitamin Premix

: gogri.harsh@gmail.com

R Rice Bran

il Bran il l Rice Gluten

Groundnut Meal

eal Meal

eal der l Cereal Maize Powder

Wheat Bran

MINERALS

l Hydrated Lime

l Precipitataed Silica

l Bentonite Powder

l Quick Lime

l Dolomite Powder

l Dextrose Monohydrate

l Salt (Sodium Chloride)

l Table Salt l Industrial Salt

l Iodised Salt

l Copper Sulphate

l Zinc Sulphate l Zinc Oxide

l Ferrous Sulphate (Crysal/Powder)

l Rice Flour

l Corn (Yello

l Soybean M

l Soya Protei

l Soya Protei

O

l Acidifier l Formic Acid l Bronopol

l Humic Acid l Mono Sodium Glutante

l Magnesium Sulphate l Manganese Sulphate

l Sodium Bi Carbonate l Sodium Humate

l Sodium Perborate l Sodium Percarbonate

l Calcium Propionate l Calcium Carbonate

l Calcium Sulphate l Calcium Chloride

l Di Amonium Phosphate

l Potassium Nitrate l Potassium Chloride

n Powder l Corn Flour ow Maize)

eal

n Powder

ENZ

l Phytase 5000 Granules l Xylanase

l Alkaline Protease l Beta Glucanase

l Cellulase l Lipase l Neutral Protease

l Pec nase l Cocktail Enzyme

AMIN

l Dl Methio

l L Lysine (H

MANUF

l Choline Chloride75/90/60 Liquid For Oil Driling

l Cobalt Sulphate

DR

l Dry Jawla Fish

l Bhel Kuta Mix Dry Fish

l Sun Dry Fish

n Isolate e l Wheat Grains

O nine F.G.99% cl)

l L Theronin

l L Tryptoph

l Chlortetra

l T Tyylosin Pho

l Broken Ric VIT

l Enzymes With Probio cs

FISH

l Steam Sterilized Fish Meal

l Sun Dry Fish Meal

l Aquaculture Fish Meal

l 60+ Protein Fish Meal Powder

SHRIMP

l Vitamin A

l Vitamin E

l Vitamin D

l Vitamin A

l Vitamin A

l Tiamulin F FISH

l Vitamin A

e F.G.98.5% an 98.5% cycline 15% osphate 10% unerate 10%

INS 1,00,000i.U 50% 600/50,000 I.U d3 1000/200 d2 98.5%Liquid

l Shrimp Head Powder

l Steam Shrimp Meal Powder

l Shrimp Meal Powder

l Steam Jawla Fish Powder

l

www.indiamart.com/sdaproducts

YEVE CHEMICALS INDUSTRIES

SPECIALIZED CHEMICALS AND RAW MATERIAL TRADERS

MANJEERA TRINITY CORPORATE, Plot No. S2, Survey No. 1050, Unit No. 810 & 811, Kukatpally, JNTU Road, Ranga Reddy District, Hyderabad, Telangana, 500072.

Contact Person: Mrs.Akanksha Golwala (Managing Partner), Mr.Pra k Golwala (Proprietor)

PHONE: 9924125003, 9075530925 l EMAIL: yevechemicals@gmail.com, pra k.golwala@ymail.com

l 1, 4 –Dioxane

l 1, 2 Dichloro Ethane (EDC)

l 1, 2-Dimethoxy Ethane (Monoglyme)

l 1, 3-dichloro acetone

l 2, 2-dimethoxy propane

l 2-Chloro Thiophene

l 3-Chloro Propionyl Chloride

l 4-Chloro Benzophenon

l 2-Methyl THF

l Acetyl Chloride

l Acetonitrile

l Alpha Picoline

l 2- Bromo Butane

l Benzene Sulfonyl Chloride (BSC)

l Benzophenone

l Benzyl Chloride

l Benzoyl Chloride

l Boron Trifluoride Diethyl Etherate (BF3)

l Chloroacetyl chloride (CAC)

CORE PRODUCTS:

l Chlorosulfonic acid (CSA)

l Diglyme

l Di Iso Propyl Amine (DIPA)

l Di iso propyl ether (DIPE)

l Di Iso Propyl Ethyl Amine (DIPEA)

l Diethyl Ether (DEE)

l Dimethyl Carbonate (DMC)

l Dimethyl Formamide (DMF)

l Dimethyl Malonate

l Dimethyl Sulfoxide (DMSO)

l Ethyl Bromide

l Ethyl Chloro Formate

l Ethyl Format

l Fluorobenzene

l Heptane

l Hydrazine Hydrate HH 80%

l Imidazole

l Iso Propyl Acetate

l L+Tartaric Acid

l Malonic Acid

l Methyl Acrylic Acid

l Methane Sulfonic Acid

l Methane Sulfonyl Chloride

l MIBK (Methyl Iso Butyl Ketone)

l Mono Chloro Benzene (MCB)

l MTBE (Tert Butyl methyl Ether)

l Meta Amino Phenol

l N, N – BIS (2-Chloro Ethyl Amine) HCL

l N-Heptane

l N-Hexane

l N-Propanol (NPA)

l N, N Dimethyl Acetamide (DMAC)

l N, N Dimethyl Aniline

l N-Butanol (NBA)

l N Methyl 2 Pyrrolidine (NMP)

l N Methyl Morpholine

l N-Pentane

l Ortho Nitro Chloro Benzene (ONCB)

AND ALL INDUSTRIAL SOLVENTS.

l Para Nitro Chloro Benzene (PNCB)

l Paraformaldehyde (96% & 91%)

l Propionoldehyde

l Propionyl Chloride

l Piperdine

l Piperzine Anhydrous

l Pyridine

l Sodium Boro Hydride Powder

l Sodium Metal

l Sulphuryl Chloride

l Tetra Isopropyl Titanate (TIPT)

l Titanium Iso Propoxide

l Titanium Tetra Chloride

l Tetra N Butyl Titanates

l Tert Butanol (TBA)

l Tetra Hydro furan (THF)

l Triethylamine (TEA)

l Triethanolamine (TEA)

l Thionyl Chloride

98200 34250

l1,4 - Butanediol

l l Acetic Acid

l l Acetophenone

l l Acrylic Acid

ll Acrylonitrile

ll Adipic Acid

ll Benzoic Acid

l l Bisphenol A

l l Butyl Acrylate

l l Butyl Carbitol

l l Butyl Carbitol Acetate

l l Butyl Cellosolve

ll Butyl Cellosolve Acetate

ll DEG

l l Diethanolamine

PRODUCT LIST

l l Dimethyl Formamide

l Dimethyl Sulfoxide

ll Epichlorohydrin

ll Ethyl Acetate

ll Ethyl Carbitol

ll Ethyl Cellosolve

ll Ethyl Cellosolve Acetate

ll Hexamine

l Isobutanol

l l Maleic Anhydride

l MDI

l MEG

l Methacrylic Acid

l Methoxy Propanol

l l Methoxy Propyl Acetate

l l Methyl Carbitol

l l Methyl Cellosolve

l l Methyl Methacrylate

l l Mix Xylene

ll Monoethanolamine

ll PEG 200/400/600/6000

l l PPG 400/1000/2000

l l Propylene Glycol

l l PTMEG 1000/2000

l l TEG

l l THF

l l Toluene

l l Triethanolamine

l l Vinyl Acetate

Import

oducts Our Pr Melamine l Acetone l

l Acetonitrile

l Bisphenol-A

l Chloroform

l Benzyl Alcohol

l Benzyl Chloride

l Benzaldehyde

l Calcium Chloride-Powder

l Caustic Potash Flakes

l Caustic Soda Flakes

l Chloroform

l Hydrogen Peroxide-50%

l Ammonium Bicarbonate P

l Dimethyl Formamide

l Sodium Nitrate

l Sodium Nitrite

l Trimethylamine

Powder

l Citric Acid

l Cyclohexane

l Cyclohexanone

l Diethylamine

l Dimethyl Forma

l Dimethyl Sulfoxi

l Diethylene Triam

mide (DMF) de (DMSO) mine

Methan Sulfonyl

l Methyl Aceto Acetate

l Methyl Ethyl Ketone

l MethanSulfoonyl Chloride Acetate Ketone

l Methyl Isobutyl

l Methylene Dichloride

l N.Propanol

tyl Ketone chloride

htylene

l Per Chloro Ehtylene

l Phthalic Anhydro

l Propylene Glycol

l Purazine Anhydrous

l MethyleneDichloride

Methylene Dichloride

l Phosphoric Acid 85% Min

l Potassium Carbonate

l Epichlorohydin

l Ethyl Chloro For

l Formamide

l Soda Ash

l Sodium Bicarbonate

Granular/Powder ISO Propyl

l Cyclohexane

l Cyclohexanone

l Formic Acid

l Glycering

l Gum Rosin

l Hydrogen Perox

l Hydroxylamine S

l Sodium Nitrite

l Sodium Bicardonate

l Sodium Metal

l Sodium Nitrate

l Sodium Tripoly

l Sodium Gluconate

l T Teetra Hydrofu

l Titanium Dioxide

l L(+) T Taartaric Acid

Contact Details:

rmate xide 50% Sulphate d

l riethylene T T Te e Alcohol ISOPropyl l

r y View T 1101, Ba Toower,,Sector 11, Opp. Dominoz, CBD B

Ph: 022 6464 0085 / 9223434334 / 9223433883

l Em

ydro Maleic Anhydride T ycol Teech hydrous e rdonate al te Phosphate T oly Teertiary Dutanol onate uran xide Anatase/Rutile etramine

Belapurr, , Navi Mumbai 410 209 mail: rasayan_India@yahoo.In

Nisha Chemicals

D-501, Neelkanth Business Park, Behind Bus Depot, Vidyavihar (W), Mumbai : 400086. Tele Nos: (+91)(022) - 61271617 / 18 Fax: (+91)(022) - 35100110

Email: Info@nishachemicals.com Web: http://www.nishachemicals.com

Contact: +919892821414 / +91 9223383831 / +919967186874

l 2 Ethyl Hexanoic Acid (Octoic)

l 2 Ethyl Hexyl Acrylate (2EHA)

l 4 Di Methyl AminoPyridine (4DMAP)

l Acetonitrile

l Acrylamide

l Acrylic Acid

l Acrylonitrile

l Ascorbic Acid

l Bronopol

l Buffered Lactic Acid

l Butyl Acetate Intact

l Butyl Carbitol

l Butylated Hydroxy Toluene (BHT)

l Butylated Hydroxy Anisole (BHA)

l Bisphenol A

l Calcium D Panthothenate

l Calcium Lactate

l Cyclohexane

l Cyclohexanone

l Cyclohexanol

l Dicyclopentadiene (DCPD)

l Di Iso Propyl Ether (DIPE)

l Di Methyl Carbonate

l Di Methyl Formamide

l Di Methyl Sulphoxide

l Di Propylene Glycol (DPG)

l Ethyl Acrylate

l Ethyl Carbitol (IG)

l Ethylene Glycol Mono Methyl Ether (Methyl Glycol)

l Formamide

l Formic Acid 99 % & 85 %

l Glyoxal 40%

l Glycine

l Hexa Methyl DiSilazane (HMDS)

l Hexamine

l Hydrazine Hydrate 100%

l Hydroxylamine Sulfate (HAS)

l Itaconic Acid

l L ( + ) Tartaric Acid

l Lactic Acid 80%, 88% & 90%

l Lactic Acid Liquid

l Lactic Acid Powder

l Lactose Mono / Anhydrous

l Lauric Acid

l L Alanine

l L-Arginine

l L Lysine

l L Glutamic Acid

l L-Valine

l Magnesium Lactate

l Methyl Aceto Acetate

l Methyl Metha Acrylate (MMA)

l MethAcrylic Acid (MAA)

l Methane Sulphonic Acid (MSA)

l Methane Sulphonyl Chloride (MSC)

l Methyl Iso Butyl Ketone (MIBK)

l Methyl Tert Butyl Ether (MTBE)

l N Butyl MethAcrylate (NBMA)

l N-Methyl Pyrrolidone (NMP)

l N Hexane

l Paraformaldehyde 91% & 96%

l Para Toulene Sulphonic Acid (PTSA)

l Pentaarythritol

l Potassium Bi Carbonate

l Potassium Bi Sulphate

l Potassium Carbonate Powder

l Potassium Sorbate

l Propylene Glycol

l Propylene Glycol Technical

l Skim Milk Powder

l Sodium BoroHydride Powder

l Sodium Formate

l Sodium Lactate

l Sorbic Acid

l Tetrahydrofuran (THF)

l Xanthan Gum

Food Colours, Lake Colours and Pearl Pigments

Attn.: Pharmaceutical, Capsules, Tablets, Cosmetics & Edible Product Manufacturers and Exporters

ALLURA RED LAKE AMARANTH LAKE BRILLIANT BLUE FCF LAKE

CARMOISINE LAKE CHOCOLATE BROWN HT LAKE ERYTHROSINE LAKE

FAST GREEN FCF LAKE FAST RED E LAKE INDIGO CARMINE LAKE

PONCEAU 4R LAKE QUINOLINE YELLOW LAKE

TARTRAZINE LAKE SUNSET YELLOW FCF LAKE

BLENDED LAKES APPLE / PEA GREEN / BLACK / BROWN LAKE

IRON OXIDE (RED / YELLOW / BLACK / BROWN )

Also available D & C Colours and D & C Lakes Like Green 5, 6 / Violet 1,2 / Yellow 7,8 / Red 4,6,7,17,19,21,22,27,28,30.33,36.

Available Pearl Pigments in various shades

DISTRIBUTORSHIP / DEALERSHIP / AGENCY INQUIRIES SOLICITED

SADHANA ENTERPRISES

Dealers And Importers In Pharmaceuticals Raw Material, Chemicals & Solvents

Add: J-47/602, Poonam Sagar Complex, Near Allahabad Bank, Miraroad (E), Thane - 401 107, Maharashtra (India)

Tel.: 022-28100190 / 28100191 | Email: sadhanaenterprises77@gmail.com

SANDEEP MEHTA: +91 9322334989 / +91 9322403205

l Acetonitrile (ACN)

l Acid Slurry (Labsa)

l Castor Oil

Akshar C

Product List l , A ound Floor F-8, Gr r, Avvtari Indu Mobile: 9833878293 / 998774

hemicals India Pvt Ltd.

Website: www.aksharinterna

l T Teetrahydrofuran(THF)

l TRO (Turkey Red Oil)

l Caus c Soda Prills & Flakes

l Soda Ash (Sodium Carbonate)

l Sodium Lauryl Ether Sulfate (SLES)

l Sodium Laureth Sulfate (SLS)

l Acid Thickner

l Soap Noodles

l T Taansparent Soap Base

l Alpha Olefin Sulfonates (AOS)

l Pine Oil

l Cocamidopropyl Betaine (CAPB)

l Alphox 200

l Fro

l Sodi

l Poly

l Coc

ar stries, Hatkesh Udhyog Nag r, , Mira-Bhayander Road, Miraroad (East), Thane-401107 4529 l Email: aksharchem.mum@gmail.com / info@aksharinterna onal.in onal.in

Product List

mic Acid um Sulphate ohol (PV vinyl Alc VAA)

o Diethanolamie (CDEA)

l Sodi

l Tris

l Ace

um Tripolyphosphate (STPP)

odium Phosphate (TSP)

c Acid

l Sodi

l Pot

um Bicarbonate

asium Bicarbonate

l Sodi

l Xan

l DEG

l Nitr

l O-D

l P-Di

l Mo

um Benzoate than Gum (Diethylene Glycol)

o Benzene

i Chloro Benzene

Chloro Benzene

no Chloro Benzene

l Naphthalene Powder / Balls

l Benzene

l Benzyl Alcohol

l Dimethyl Formamide (DMF)

l T Tooulene

l Phosphoric Acid

l ohol (IP Isopropyl Alc PAA)

l Ethyl Acetate

l Acetone

l O-xylene

l Tri Chloro Benzene

l Silica Gel

l Formaldehyde

l Para Nitro Chloro Benzene (Pncb)

l Ortho Nitro Chloro Benzene (Oncb)

l Para Nitro Aniline (Pna)

l Gum Rosin (Grade-WW / N / K)

INTERMEEDIIAT T E E S

Name End use e

4-(2-Amino Ethyl) Benzene Sulfonamide Glipizide/Glibenclamide

Glimepiride SulphonamideGlimepiride

4-Hydroxy Pyridine-3-Sulfonic AcidTorsemide

4-(3-Methyl Phenyl)Amino-3-Pyridine Sulfonic AcidTorsemide

LasamideFurosemide

4-Amino-2-Chloro-6,7-Dimethoxy QuinazolinePrazosin/Doxazosin/Alfuzosin/Terazosin

4-Hydroxy-3-Methoxy-5-Nitro-Methyl BenzophenonePharma Intermediate

2, 5 Dichloro ThiophenePharma Intermediate

2-Dibutylamino-1-(2, 7-dichloro -9H-Fluoren -4yl0 EthanolLumefantrine Intermediate

Alfa CalcidolVitamin D3 Analog

BaclofenAnti Spasmodic

CalcitriolVitamin D3 Analog

Dapoxetine HClCardio Tonic

Dopamine HClNeurotransmittor

EthamsylateHaemostatic

FenofibrateTreat High Cholestrol Levels

FurosemideDiuretic

GlipizideAnti Dibetic

Hydroxyzine HClAntihistamines

Phone:

Corporate

IopromideIodinated Radiographic Contrast Agent

NimodipineCalcium Channel Blockers

ProbenecidUricosuric

RivaroxabanTreat Deep Vein Thrombosis

Rosuvastatin CalciumAnti-Hyperlipoproteinemic

Sodium Pico SulphateLaxative

TolperisoneMusce Relaxant

TorsemideDiuretic

Trimethobenzamide HClAntiemetic

(An ISO 9001-2015 Certified Company)

CIN. L24100MH1992PLC066691

SIDDHARTH Interna onal

AVAILABLE

Caproic Acid (C 6)

Caprylic Acid (C 8)

Capric Acid (C 10)

Lauric Acid (C 12)

Myris c Acid (C 14)

Palmi c Acid (C 16)

Stearic Acid (C 18)

Oleic Acid (C 18.1)

Dis lled Coconut Fa y Acid

Hydrogenated Palm Stearin

Hydrogenated Technical Oil

Hydrogenated Soya Oil

For Quality, Regular Supply & Compe ve Prices

Contact: Sunil Goenka

Green House, 2nd Floor, Green Street, Fort, Mumbai 400 023. Phone: 022 22662136 / 22663119 l Mobile: 9820026621

Email: sales@siddhint.com l Web: www.siddhint.com

SKY CHEM

NEHA PHARMA PVT. LTD.

(Since 1988)

v TRIPROLIDINE HCL

v SELEGILINE HCL

v METHYLCOBALAMINE

v MEFENAMIC ACID

v SODIUM LACTATE USP 60% SOLUTION

v LACTIC ACID

v COD LIVER OIL BP

v FISH LIPID OIL BP

v PSEUDOEPHEDRINE HCL

v EPHEDRINE HCL

v ALPRAZOLAM

v DIAZEPAM

v BUPRENORPHINE HCL

v TRAMADOL HCL

v PHENOBARBITAL BASE / SODIUM

v MEPROBAMATE

f{xà{ gÜtw|Çz VÉÅÑtÇç

2nd floor, Diamond Building, Lohar Chawl, Pathak Wadi, Marine Lines, Mumbai, 400002 Ph.: 022-40048174 l Email: chromasheth@gmail.com / shethchroma@gmail.com.

Kalpesh Sheth : +91-9820715414, Rajesh Sheth : + 91-9821435228, Samyak Sheth : +91-9820715956

CHROMA CHEMICAL CORPORATION / SHETH TRADING COMPANY.

A One Stop Solu on For Your Chemical & Pharmaceu cal Needs.

Established In 1983, Chroma Is An Industry Leader And A Pioneer, With A Premium Clientele. We Are Importers Of Chemicals, Pharmaceu cals, Rare & Research Chemicals, Speciality Chemicals, High Purity Biochemicals And More.

We Have Catered To Leading Stakeholders Of Industries Across Di erent Horizons Like Defence, Aerospace, Polymer, Vaccine Development, Culture Media, Research & Development Among Others.

Both Companies Are ISO Cer fied.

PRODUCTS

l 2 HYDROXY PROPYL BETA CYCLODEXTRINE

l 2,2-BIPYRIDE 99% AR

l 2-3-DIMERCAPTO-1-PROPANOL

l 2-AMINO-5-CHLOROBENZOPHENONE

l 2-THIOBARBITURIC ACID AR/ACS

l 4-AMINO ACETOPHENONE 99%

l 5,5-DITHIOBIS-2-NITROBENZOIC ACID AR

l 6-BENZYL ADENINE (6-BA)

l ABSCISIC ACID

l ACTIDIONE / CYCLOHEXIMIDE

l ADENINE

l ADENINE SULPHATE

l ADENOSINE

l BETA NICOTINAMIDE ADENINE DINUCLEOTIDE

l BILIRUBIN 98% MINIUMUM

l BISMUTH ALL SALTS

l BUFFERS FULL RANGE

l CARMINE 60% DYE CONTENT

l CHOLESTEROL USP GRADE

l COLCHICINE IP/BP/USP

l D-CELLOBIOSE ACS/AR

l DL - SERINE

l DTT

l ERICHROME BLACK T

l EUDRAGIT (RS-RL 100)

l GIBBERELIC ACID (GA 90%)

l GLYCOGEN AR/ACS

l L-ARABINOSE

l MEGLUMINE

l O-NITROBENZALDEHYDE / 2-NITROBENZALDEHYDE

l ORTHO NITROBENZOIC ACID / 2-NITROBENZOIC ACID

l OSMIUM TETROXIDE 99.95%

l PYROGALLOL

l RUBIDIUM CHLORIDE 99.99%

l SULPHANILAMIDE

l TETRAMETHYL AMMONIUM HYDROXIDE

PENTAHYDRATE

l TPTZ

l TRANS-1,2-DIAMINOCYCLOHEXANE TETRA ACETIC ACID MONOHYDRATE (C.D.T.A. AR)

l URIDINE

l ZINC SULPHIDE (VENATOR)

Soda Ash

Tris Buffer

MIVON CHEMICALS

Acetophenone

Adipic Acid

Benzyl Alcohol

Benzaldehyde

Benzoic Acid

Butyl Acetate

Butyl Carbitol

Butyl Cellosolve

Bkc-50%

Caustic Potash

Caustic Potash Flakes

Caustic Soda Flakes

Chloroform

Cetyl Alcohol

Di Iso Propyl Ether

Di Methyl Acetamide

Di Methyl Aniline

Di Methyl Formamide

Di Methyl Sulphoxide

Ethyl Acetate

Ethylene Diamine (eda)

Ethyl Cellosolve

Formic Acid-85%-99%

Methyl Iso Butyl Ketone

Methylne Di Chloride

Methyl Tert Butyl Ether

Mix Xylene

Mono Ethylene Glycol

Mono Ethanolamine

N-butanol

Potassium Sorbate

Phthalic Anhydride

Propionic Acid

Propylene Glycol Tech/ Usp

Pyridine

Palmatic Acid

Sodium Borohydride

Sodium Benzoate

Sodium Citrate

Stearic Acid

Sls Powder

Tri Ethyl Amine

Tertiary Butanol

Tetra Hydro Furan

Thiglycolic Acid-80% (bruno Book Jarman)

Toluene

GODREJ

Ginodet Bkc 50

Godrej Stes 24-230/n 235 Kg

Godrej Sles L24-230 in 50 Kg

Ginol 16 (cetyl Alcohol)

Ginol1618 Ta (cetostearyl) Alcohol

Ref. groundnut Oil

Ginopal 24p-sls Powder

Stearic Acid Distric

Steanc Acid Hystric

Ginonic Csa20 In 25 Kgs (cm-1000)

Ginopol L24-sls Liquid In 235 Kgs

Ginol-18 Stearly Alcohol

Ginal 1618 50:50 (cetostearyl Acohol)

Aos L-46

Aos P-46 (pest)

Aos X146-235 Kgs N/m

Emul. Eco

Ginasul 46p 25 Kg (aos Powder)

Gincol Cp (cetyl Palmitate)

Ginol Ew6820

Ginonic Csa20 In 25 Kgs

Ginopol 24p-sls Powder

Acid-85% (tech /food Grade)

Tri Ethylene Glycol

Tri Ethanolamine

Poly Iso Butane 10/30/200

1.4.dioxane

Acetic Acid Glacial

Acetone

Acetonitrile

Formamide

Glycerine

Hydroquinone

Hydrogen Hydrate 80%-100%

Hydrogen Peroxide-50%

Iso Butanol

Iso Octane

Iso Propyl Alchohol

Iso Propyl Myristate

Malic Anhydride

APAR

White Petroleum Jelly

Heavy Liquid Paraffin

Light Liquid Paraffin

DAELIM KOREA

Polybutene 1300

Polybutene-2400

Polybutene-950

Glycerin Cp

Lubolic 20-monocarboxylic (oleaic Acid)

Stearic Acid-Lubstric 995

MELZER

Microcheck Mz Bnp

Microcheck Mz Mc 99

Santreat Mz 3050 (bkc 50%)

Santreat Mz 3080 (bkc 80%)

LAXMI/ALCHEMIE

Di Ethyl Phthalate

INDUSTRIAL SOLVENTS

Di Ethyl Ether

Dealers

We Stock & Supply : Chemicals and Bio- Chemicals for Research and Industry Manufactured by Merck (Germany ), BDH (UK), Sigma (USA) , Aldrich (USA), Difco & Oxoid Culture Media , Lancaster (UK), ICN (USA).

Chemicals : Glaxo , E-merck, BDH, SRL -SD's , Ranbaxy, Loba - Chemie Spectrochem, Hi - Media.

Sartorius (German) / Pall (UK) / Millipore

Membrane Filter Papers, Prefilteres and Filtration Assemblies, Filter Pads, all sizes with or without hole as per required sized,

Filter Cartridges.

Whatman Filter Papers, Thimbles, Chromatography Sheets and Glass Microfibre Filters for Enviornment and Pollution Control Testing. Laboratory Sealing & Parafilm.

TLC/ HPTLC / Gas Chromatography

Equipments and Spares, GC/ HPLC Grade Chemicals, Phases, Supports, Columns etc. Top/Hamilton (USA), SGE, Micro Syrings Reference Standards.

Pharmaceutical Raw Materials, Solvents ( Bulk & Small Packing).

Precoated TLC, Plates Merck

(Germany) for TLC/HPTLC. Certified Reference Material (Standards). Ethanol for UV & HPLC /AR 99.95% China

/Hayman (UK) & Merck (Germany)

Borosil / Riviera Glasswares, Glass Assemblies upto 200 Ltr. Hydrometers, Hygrometers

Silicawares, Proceleinwares, Tefton items, Tarson Plasticwares, Thermometers.

(with certificate for ISO 9000)

Scientrific Instruments of Imported and Reputed Indian make, Quartiz Cells, Refractometers.

KIRAN TRADERS

e : 7 Th Floor , Unit No 716, Highway Commercial Center Premises Co-Op Soc Ltd, I.B. Patel Road Goregaon (E), Mumbai - 400 063

T Teel: 91-22-46051578, 9819811703 l Email: info@nakshapharma.com Web: www. Nakshapharma.com

ANTIASTHAMAATTIC

AMINE HCL DIPHENHYDR

AMBROXOL HCL IP

BROMHEXINE HCL IP

LEVOSALBUTTAAMOL SULPHA

UKAST SODIUM MONTEL

TE IP AT

ANTI -BIOTIC

METFORMIN HCL IP

AMOXICILLIN TRIHYDRA

POWDER IP/ BP

ATTECOMPACTE

POWDER -IP/BP ACTED / OXACILLIN SODIUM COMP CL

ANTI CHOLELITHIC

ANTIDIARRHOEALS

ANTI EMETIC

S

ANTI-FIBRINOL

LYYTICS

ANTI-FUNGALS

DICL

POWDER -IP/ BP ACTED / OXACILLIN SODIUM COMP

CEFIXIME IP COMP

ACTED

CEFPODOXIME PROXETIL IP / USP

CEFUROXIME AXETIL IP / USP

CHOLIC ACID IP URSODEOXY

ORNIDAZOLE IP

DOMPERIDONE IP

ANEXAMIC ACID IP TR

UCONAZOLE IP FL

We provide best solutions in: APIs | Pellets | Excipients | Flavours | Fragrances

Active Pharmaceutical Ingredients (APIs)

P P RODUCT LIST T

u AMOXAPINE

u LOXAPINE SUCCINATE

u AMISULPRIDE

u DABIGATRAN ETEXILATE

u SILODOSIN

u MONTELUKAST SODIUM

u FINASTERIDE

u LEVOSULPRIDE

u TENELIGLIPTIN

u TORSEMIDE

u PRAZIQUANTEL

u PRUCALOPRIDE SUCCINATE

u IRON SURCLOSE

u CILIDIPINE

u RABEPRAZOLE SODIUM

u RIFAXIMIN

u KETOPROFEN

u FEBANTEL

u OMEPRAZOLE POWDER

u BREXPIPRAZOLE

u CABERGOLINE

u FEBUXOSTAT

Contact : Agam Shah : +91 9920899117

Office Address: 502,Shree Radhe Empire, Chandavarkar Road, Borivali (West), Mumbai:- 400092. Tel +91 022-35593585 | Email: juanapharma@gmail.com | Web: www.juanapharma.com

304, Western Edge I, Above Metro Store, W E Highway,Borivali (E), Mumbai 400066 EMAIL: emco@emcochemicals.com, WEB: www.emcochemicals.com

TEL: 91-22-42433333 I FAX: 91-22-42433366 I Factory : G.I.D.C., sachin-Surat, Pin code - 384230

PRODUCT LIST

2-METHYL-5-NITROANILINE

ACRYLIC ACID

ALPHA NAPHTHOL

ALUMINIUM CHLORIDE (ADITYA BIRLA)

ANILINE

ANTHRAQUINONE

BETA NAPTHOL

D-TARTARIC ACID/L(+) TARTARIC ACID/DL-TARTARIC ACID

DI CYANDIAMIDE (DCDA )

DI METHYL FORMAMIDE (DMF)

DIETHANOLAMINE (DEA)

DIETHYLENETRIAMINE (DETA)

EDTA PURE ACID/2NA/4NA

EPICHLORO HYDRINE

SODIUM BOROHYDRIDE

ETHYL CYANO ACETATE

ETHYLENE DIAMINE (EDA)

GUM ROSIN(W/W)

MALEIC ANHYDRIDE

META AMINO PHENOL (MAP)

SODIUM METAL

METHYL ACETO ACETATE (MAA)

ORTHO CHLORO BENZOIC ACID

ADIPIC ACID

METHYL CYANO ACETATE(MCA)

MONO ETHYL AMINE 70%

MONOETHANOLAMINE

NONYL PHENOL ETHOXYLATE (NAP) 9.5%

PARA ANISIDINE

PHOSPHORIC ACID - FOOD GRADE

P-HYDROXY BENZOIC ACID

PROPYLENE GLYCOL- TECH/USP

SALICYLIC ACID (SUBLIM / TECH)

DIMETHYL ACETAMIDE

SODIUM HEXAMETA PHOSPHATE 68% (SHMP)

SODIUM NITRITE

SODIUM SULPHIDE 60% YELLOW FLAKES

PARA TOLUIC ACID

SULPHANILIC ACID

TETRA SODIUM PYRO PHOSPHATE

THIOUREA

TRIETHANOLAMINE

v Aspartame FCC/USP

v Acesulfame K

v Alpha Lipoic Acid

v Azithromycin IP / USP

v Aceclofenac IP

v Artemether INT Ph. / USP

v Amoxycillin IP

v Ambroxol HCl IP

v Benfothiamine

v BW

v Biotin

v Clindamycin Phos

v Cloxacillin Sodiu

v Clarithromycin IP

v Colours - Food

Import & Tradng Pharmaceutical R & Chemicals

LIST ODUCT

phate /HCl

m IP

v Colours - Pharma

v Di Propylene Glyc

v Domperidone IP

v Diclofenac Sodiu

v Diclofenac Potass

v Dhh Waax

v BHA A /BHT

v Cross Povidone

v Caustic Soda Flakes

v Caustic Potash Flakes

v Citric Acid Mono

v Citric Acid Anhydrous

v Clotrimazole IP/BP/USP

v Calcium D Pantothenate

v Ciprofloxacin IP / USP

v Cefixime IP / USP

v Cefpodoxime Proxetil IP

v Cefuroxime Axetil IP

ol (DPG)

m IP/ BP ium IP/ BP

Dextromethorphane

Hydrobromide (DMR)

v DiCalcium Phosphate (DCP)

v DMF

v Erythromycin Stearate IP

v Fluconazole IP / USP

v Folic Acid IP

v Glycerine CP / IP / USP

v HPMC-E-5

v HPMC-E-15

v HPMC-K-100M

v Hyoscine Butyl Bromide IP / BP

v Alcohol (IP Iso Propyl A A)

v Ibupprofen IP / BP

v Levofloxacin Hemihydrate IP

v Lumefantrine IH / USP

v Levoctrizine HCl IP

v Linseed Oil

v Levoctrizine HCl IP

v Light Liquid Parafin (LLP)

v Methylene Chloride (MDC)

v Mannitol Ip / BP / USP / Ph.eur

v Methylcobalamine IP

aw Material

v Suc

v Suc

v Sor

v Sod

ralose USP

ralfate JP / USP bitol 70 % IP

a Ash

v Teelm

v Vita

v Vita

v Vita

v Vita

isartan IH / IP

A min Palmitate1.7Miu

min A Acetate Powder

min AD3

min C Plain IP

v NiiidIP/BP

Niacinamide IP / BP

v Neotame

v Ornidazole IP

v Ofloxacin IP

v Paracetamol IP / BP

v PVPK-30

v PG- Teech

v PG- USP

v Polysorbate 80

v Pantaprazole Sodium IP

v Piracitam IP

v Quinine Sulphate USP

v Quinine HCl BP

v Quinine Di-HCl BP

v Vi

amin C Coated IP

amin B1 Mono (Thiamine

nonitrate)

amin B1 HCl Thiamine drochloride)

amin B2 (Riboflavin)

boflavin 5 Phosphate Sodium IP amin B6 (Pyfidoxine HC l) amin B12 (Cyanocobalamine )

amin D3

amin E Liquid (DL-Alpha copherol)

amin E Powder 50 %

nthan Gum (200 Mesh)

C-32 Aditya Villa, Near Prabhuta Hall, B/h SBI Bank, Ramakaka e emple R

Vaadodara - 391740, Gujarat (India). M: +91-9426985832 | Email: contactus@

oad, Channi, malayenterprise.in

AMINO ACID

l BCAA 2:1:1

l BETA ALANINE

l CREATINE MONO 200 MESH

l D-ASPARTIC ACID

l GLYCINE

l INOSITOL

l L- GLUTATHIONE REDUCED

l L- THERONINE

l L-ARGININE BASE

l L-ARGININE HCL

l L-CARNITINE BASE

l L-CARNITINE L-TARTARATE

l L-CITRULLINE DL MALATE

l L-CITRULLINE PLAIN

l L-GLUTAMINE

l L-HISTIDINE HCL

l L-LYSINE HCL

l L-PROLINE

l L-TRYPTOPHAN

l L-TYROSINE

l MELATONIN

l N-ACETYL L-CYSTEINE

l SODIUM HYALURONATE

l TAURINE

SINCE 1985

SWEETENERS

l ACESULFAME K

l ASPARTAME

l ERYTHRITOL

l FRUCTOSE

l NEOTAME

l SODIUM SACCHARINE

l SORBITOL POWDER

l SUCRALOSE

l XYLITOL

FEED PRODUCTS

l BIOTIN 2%

l DL METHIONINE

l L-LYSINE HCL

l VITAMIN AD3

l VITAMIN E 50 % POWDER

Address: 77/78 Ashok Chambers, 5th Floor, 56, Devji Ratansey Marg, Masjid - East, Mumbai - 400 009

Tel.: 022-66108086/87/88 | What’s App No. 09223433408

EMail.: nikeoncorp@gmail.com | URL.: www.nikeon.com

VITAMINS

l ALPHA LIPOIC ACID

l CO-ENZYME Q 10

l D BIOTIN

l FOLIC ACID

l VITAMIN A DRY POWDER

l VITAMIN A PALMITATE 1.7

l VITAMIN B1 MONO/ HCL

l VITAMIN B12 (CYANOCOBALAMIN)

l VITAMIN B2 (RIBOFLAVIN)

l VITAMIN B3 (NIACINAMIDE)

l VITAMIN B5 (CALCIUM D PANTOTHENATE)

l VITAMIN B6 (PYRIDOXINE HCL) IP

l VITAMIN C (ASCORBIC ACID)

l VITAMIN D3

l VITAMIN E ACETATE- BASF

EXTRACTS

l GRAPE SEED EXTRACT 95%

l SILYMARIN UV 80%

EXCIPIENTS

l BETA CYCLODEXTRIN

l CAFFEINE ANHYDROUS

l CITRIC ACID MONO /ANHYDROUS

l COLLOIDAL SILICON DIOXIDE (AEROSIL)

l DIMETHYL FORMAMIDE (DMF)

l DIPROPYLENE GLYCOL (DPG)

l EDTA DI SODIUM SALT

l EDTA TETRA SODIUM SALT

l GLYCERIN

l ISOPROPYL ALCOHOL

l LACTIC ACID 88%

l LACTIC ACID POWDER

l LACTOSE 200 MESH

l MAGNESIUM STEARATE

l MANNITOL IP/BP/USP

l METHYLENE DICHLORIDE (MDC)

l PARACETAMOL IP/ BP/USP

l POTASSIUM SORBATE

l PROPYLENE GLYCOL - SK PIC GLOBAL KOREA

l PVP K-30

l PVP K-90

l SODIUM CITRATE

l SODIUM CMC

l SORBIC ACID

l TITANIUM DIOXIDE (TIO2)

l XANTHAN GUM

l XANTHAN GUM TRANSPARENT

AUTHORISED DISTRIBUTOR WACKER CHEMIE, GERMANY & CJ BIO, KOREA

Manufacturing unit: 68 69 G.I.D.C. Industrial Estate, Nandesari 391340, Vadodara, Gujarat ce: 5531, Bas Harphool Singh, Sadar Thana Road, Delhi 110006 Email: info@qualikems.com / salesindia@qualikems.com

l Website: h ps://qualikems.com/

DEPRODUCT NAME

BARIUM CHROMATELR/AR

BARIUM NITRATE LR

BISMUTH CARBONATELR

TE PENT

BISMUTH NITRA TAAHYDRATELR/AR

CHL BISMUTH OXY O ORIDE LR

BISMUTH SUBGALLATELR

BISMUTH SUBNITRATELR/AR

BISMUTH SULPHATELR

BORAX DECAHYDRATEAR

BORIC ACID

BUFFER CAPSULE 4 , 7,& 9.2LR

CADMIUM CARBONATELR

CADMIUM CHLORIDE MONOHYDRATELR

CADMIUM IODIDE LR

CADMIUM NITRATE TETRAHYDRATELR/AR

CADMIUM SULPHATE 8/3 HYDRATELR/AR

CALCIUMACETTA

NICKEL CARBONATELR

NICKEL PHOSPHATE LR TEHEPT NICKEL SULPHA TAAHYDRATE

NICKEL SULPHATE HEXAHYDRATELR/AR

POTTAASSIUM BROMIDELR/AR/ACS

POTTAASSIUM CHROMATELR/AR

POTTAASSIUM DICHROMATELR/AR

POTTAASSIUM DIHYDROGEN O-PHOSPHATE LR/AR

ANHYY.

POTTAASSIUM FLUORIDELR/AR

POTTAASSIUM HYDROGEN SULPHATELR/AR/ACS

POTTAASSIUM HYDROXIDE PELLETSLR/AR/ACS

POTTAASSIUM NITRATEAR

SODIUM BISULPHATELR/AR

SODIUM BROMIDE LR/AR/ACS

SODIUM COBALLTTINITRITE LR

CARBONATE ANHYDROUS

SODIUMCARBONATEANHYDROUSLR/AR/ACS

CARBONATE MONOHYDRATELR/AR/ACS

HYDROXIDE PELLETSLR/AR/ACS

SODIUM NITRITE LR/AR

SODIUM SULPHATE LR

SODIUM THIOSULPHATE ANHYDROUSLR/AR UBLE (POT STTAARCH SOL TAATO)LR

STRONTIUM BROMIDELR

STRONTIUM CARBONATELR

STRONTIUM CHLORIDELR

A STRONTIUM NITRATTELR

STRONTIUM SULPHATELR

TETRAPOTTAASSIUM PYROPHOSPHATELR/AR

TETRA SODIUM PYROPHOSPHATELR/AR

TINMETTAALGRANULARAR

UREA LR/AR

ZINC FLUORIDE LR

ZINCSULPHATEHEPT AT TAAHYDRATELR/AR

ZINC SULPHITE LR UDIT AND VQ SUPPORT

Mr. Kamlesh Doshi

: DEALERS IN : PHARMACEUTICALS RAW MATERIALS, VITAMINS, FINE CHEMICALS, SOLVENTS, ESSENTIAL OIL & FOOD COLOURS

PARSHWA PHARMA CHEM IS A CONVENIENCE STORE / SOLUTION FOR ALL API / CHEMICAL / BULK DRUG / SOLVENT’S REQUIREMENTS

WE CAN PROVIDE ANY TIME ANY QUALITY ( SMALL / BIG ) OTHER THEN ABOVE AS PER YOUR VALUABLE REQUIREMENTS.

l ACCECLOFENAC

l l ALBENDAZOLE

l l ALLOPURINOL

l AMBROXOL HCL

l ATOMOXETANE HCL

l l BROMHEXINE HCL

l l CLOTRIMAZOLE

l l CIPROFLOXACIN HCL

l l CHLOROQUINE PHOSPHATE

l l CHLORZOXAZONE

l l CROSS CARMILOSE SODIUM

l l CLOBETASOLE

l l DICLOFENAC POTASSIUM

l l DICLOFENAC SODIUM

l l DICYCLOMINE HCL

ll DROTAVERINE HCL

l l DMR

l l DEFLAZACORT

l l DOMPERIDON

l l ERYTHROYCIN STERATE

l l ENROFLOXACIN

l l FERROUS ASCORBATE

9325352677

9222241417

PRODUCT LIST

l IVERMECTINE

l KETOCONAZOLE

l LACTOSE

l LEVOCETRIZINE HCL

l LISINOPRIL

l L-LYSIN

l LORATIDINE

l MCCP

l METHYL COBALAMINE

l METHYL FOLATE CALCIUM

l METFORMIN HCL

l METRONIDAZOLE

l MAIZ STARCH POWDER

l l NIACINAMIDE

l l NIMUSULIIDE

l l ORNIDAZOLE

l l OFLOXACIN

l l PARACETAMOL

l l PENTOPRAZOLE SODIUM

l l POVIDON IODIN

l l PROGESTERONE

l l PREGABALIN

l l FERROUS ASCORBATE DC GRADE

l FOLIC ACID

l FLUCONAZOLE

l GLYCERINE

l GLIMIPRIDE

l GRISOFULVIN

l IPA

l l SUCRALFATE

l l THIAMINE HCL

l l TERBUTALINE SULPHATE

l l TRIFLUPERAZINE HCL

l l TRANEXAMIC ACID

l l VITAMIN A ACETATE

Chlorzoxazone USP- Samarth l l Serra opep dase- Enzyme

Registered Add: A/06, Shivshakti Apt., Sangeetawadi, Shiv-Mandir Road, Dombivli (E), Thane-421201, Maharashtra Office Add: Office No. 220, Commerce Plaza, Near Godrej Showroom, Manpada Road, Dombivli (E) - 421201., Thane-421201, Maharashtra Office: 7900001075 / 9323613209 | Email: doshikamlesh84@gmail.com

PRODUCT LIST - API`S

ANTI FUNGAL Ketoconazole

Terbinafine

Micafungin

Fluconazole

Caspofungin

Luliconazole

ANTIHYPERLIPIDEMIC

Atorvastatin Calcium IP

Rosuvastatin Calcium IP

Simvastatin USP

DIURETICS

Torsemide USP

Eplerenone IP

ANTI ANGINAL

Ranolazine INH

ANTI DIABETIC Pioglitazone HCl IP

Voglibose IP

ANTI EPILEPTIC

Levetiracetam USP

Gabapentin

ANTI-DEPRESSENT Sertraline HCL

ANTI RHEUMATIC /

ANTI INFLAMMATORY (PAIN)

Ketorolac Tromethamine USP

Etoricoxib

Lornoxicam

Tapentadol INH

Etodolac

IMMOUNOSUPPRESSANTS

Tacrolimus

Tacrolimus Premix

Cyclosporine

Mycophenolate Mofetil

Mycophenolate Sodium

Sirolimus

Pimecrolimus

ONCOLOGY

Anastozole

Bicalutamide

Bortezomib

Cisplatin

Erlotinib

Gencitabine Hcl

Imatinib

Letrozole

Tamoxifen

Zoledronic Acid

API FOR VETERINARY

Niclosamide

Rafoxanide

Closantal Base

Levamisole

Oxyclozanide

Sulfadiazine

PHYTOCHEMICALS

Thiocolchicoside

Vinpocetine

Colchicine

Paclitaxel

Quinine Sulphate

TOPICAL ANTIBIOTIC Mupirocin

ANTIHYPERTENSIVE / CARDIOVASCULAR

Amlodipine Besylate

Cilnidipine IH

Lisinopril IP/USP

Losartan Potassium IP / USP

Nebivolol Hcl IP

Olmesartan Medoxomil IP/BP

Ramipril IP / BP

Telmisartan IP/USP

Irbesartan

Prazosin

Verapamil

ANTI BACTERIAL / ANTI VIRAL

Cefixime USP/IP

Cefpodoxime Proxetil USP/IP

Famciclovir Faropenem

Gemifloxacin

Nadifloxacin

Prulifloxacin

Moxifloxacin

ANTIPSYCHOTIC Olanzapine Haloperidol Pimozide

Quetiapine Fumarate IP Aripiprazole INH

STERILE PENECILLIN

Ampicillin Sodium Sterile

Amoxycillin Sodium Sterile

Cloxacillin Sodium Sterile

Dicloxacillin Sodium Sterile

Flucloxacillin Sodium Sterile

Oxacillin Sodium Sterile

Piperacillin+Tazobactum

Sodium Sterile (8:1)

Sulbactum Sodium Sterile

Tazobactum Sodium Sterile

Ceftraixone Sodium Sterile

ANTI HISTAMINE Cetrizine

Levocetrizine

ANTIOBESITY Orlistat

PENEM`S Faropenem Meropenem

Imepenem + Cilastatin Sterile

ANTI ULCERATIVE

Pantoprazole Sodium Sesquihydrate IP

ANTI HISTAMINE

Fefofenadine

ANTIBIOTIC RIFAXAMINE

READY STOCK

t ALPHA AMYLASE (1:2000) IP

t BROMELAIN 2400 GDU

t BROMELAIN 1200 GDU

t D CHIRO INOSLTOL HCL/DASE

tt FOLIC ACID IP/BP/USP

t FUNGAL ALPHA AMYLASE DIASTASE 1:2000 IP

t FUNGAL DIASTASE 1:2000 IP

t FUNGAL DIASTASE 1:5000 IP

t t HYALURONIC ACID

t t LACTIC ACID BACILLUS 150 BILLION CFU/GM

t t LACTIC ACID BACILLUS 300 BILLION CFU/GM

t t LACTIC ACID BACILLUS 6 BILLION

t t LACTIC ACID BACILLUS 6000 BILLION

t t LACTULOSE CONCENTRATE USP

t t LIGNOCAINE BASE USP

t t PANCERATIN (IP)

t t PEPSIN (1:3000. IP)

t t PAPAN IP

t t PROBIOTIC BLEND 1 TO 200 BILLION CFU

t t RUTOSIDE TRIHYDRATE

t t SERRATIOPEPTIDAS E/C

t t SERRATIOPEPTIDASE PLAIN POWDER

tt TRYPSIN

tt TRYPSIN CHYMOTRYPSIN MIX (6:1)

tt L- GLUTATHION REDUCED

JAKSON PHARMA

AYON PHARMA CHEM

CHEMXLNC PHARMA PRIVATE LIMITED

PRODUCT LIST :

• Tri Choline Citrate 50%/65%/70% Aq. Solution

• Choline Bitartrate USP/FCC4

• Choline Chloride Solution and 98% Powder

• Choline Salicylate

• Choline Bicarbonate

• Sulfadimidine Sodium

• Adapalene

• Bisoprolol Fumarate

Mr Bhargav Shah/ Mr Nirav Shah

Phone Numbers : 9867677754/ 8779902522

e: bhargav@ayonpharmachem.com/ info@ayonpharmachem.com

a: D/211, Samruddhi CHS LTD, M.G.Road, Kandivali-West,Mumbai-400067

w: www.ayonpharmachem.com

Trading house of API , chemicals and excipients...

l Abacavir

l Alfuzosin HCl

l Amiodarone hcl IP/BP

l Bronopol IP/BP

l Brinzolamide

l Calcium Levulinate IP

l Chlorzoxazone USP

l CPM IP/BP

l Cloprostenol Sodium IP

l Clopidogrei BI Sulphate IP

l Daclarasvir

l Darunavir

l Emtricitabine

l Ethyl Cellulose all Grade

l Finasteride

l HPMC Phthalate

l Ketotifen Fumarate BP

l Leteozole

l Lurasidone

l Misoprostol

l Montelucast Sodium IP

l Naproxen plain USP

l Phenramine Maleate IP

l Pregabalin

l Propanol

l Protein Hydrolisate 60 & 80%

l Thiocoichicoside

l Sofosbuvir

l Velpatasavir

l Vitamin K 3 feed & pharma

l IPA Deepak Intact

l MDC GACL/GFL

GANDHI CHEMICA

ALS

301, Purva Plaza CHS L LTTD., Shimpoli road, Opp. Adani Electricity, Borivali Bordline: 91-022-61276444(6 lines) - 7208855010/11

Website : www.gandhichemicals.com l Email : mktg@gandhichem

Partner : Mr. Alpesh Doshi - 9

All solvent availa

All other solvents and ch

9223433838 | Mr. Alpesh Gandhi - 922 able in bulk and drum pack hemicals as per the need o

l Acetone

l Acrylic Acid

l Aerosil 200

l Butyl Acetate

l Ethyl acetate

l Glycerine

UTHOR

I

AUTHORIZED DISTRIBUTOR OF

A OF OR TRIBUT DIS ZED

l Methanol

l Methylene Chlor

l N Butanol

l N Propanol

l Di Methyl Formamide (DMF)

l Propylene Gloco

l Sorbitol

l T Tooluene

(W), Mumbai-92 icals.com 3433034 king of customer ride (MDC) l (PG)

l yl Alcohol (IP Iso prop PAA)

l Xylene

KIP

CHEMICALS PVT. LTD. C

Marg, Ghatkopar (West), Mumbai - 400 086. Tel: + 91-22-4973 0577 / 4973 0677

Email: kipchemicals@gmail.com / sachin.shah@kip.co.in Website: www.kip.co.in

Manufacturer and Distributor of below products

PHARMA INDUSTRY

v Gum Rosin (Indonesia /Indian)

v Paraffin Wax (Fully/ Semi Refined)

v Waxes – (Slack / Residue)

v Chlorinated Paraffin Wax (CPW)

v DCDA

v Acrylamide

v SLES / SLS

v AOS (powder / liquid)

l Acetone Cyanohydrin

l Thiophene

l Bulyraldehyde

l Glyoxylic Acid -50%

l Glutaraldehyde-50%

l Isobulyraldehyde

l Gamma Butyrolactone

l 5 - Bromo Indole / 5 - Cyano Indole

l Allantoin

l DMDM Hydantoin

l 2 Pyrrolidone

l 1,5 Pentanediol Liquid

l 5-5 Dimethyl Hydantoin & Derivatives

l 2- Bromo/ 2- Chloro / 2 – Nitro / 2- Acetyl Thiophene

l Meta Bromo Anisole / Meta Chloro Anisole

l 5 - Acetyl Salicylamide

COSMETIC INDUSTRY

l Thioglycolic Acid 80 / 99% & Derivative

l Acrylate Copolymer – Liquid / Powder (Thickener)

l Benzophenone 3 & 4

l Behentrimonium Chloride 85% pellet form

l Silicon Quaternium-22 Conditioning Agent

l Pearlcare DS-400- Cold process pearlizing Agent

l Carbomers Series – Rheology Modifier

l PEG 150 Distearate

l APG- Alkyl Polyglucoside

HOME / PERSONAL CARE INDUSTRY

l Acid Thickener l PCMX – Para Chloro Meta Xylenol

l Ethoxylate Series – Powder/ Liquid

l Benzalkonium chloride – BKC 50% & 80%

v Di Octyl Phthalate (DOP)

v Di Butyl Phthalate (DBP)

v Liquid Paraffin (Heavy / Light)

v Petroleum Jelly

v Rubber Process Oil (RPO)

v Liquid Glucose

v Melamine

v Hexamine

v Glycerine

v Methanol

v Stearic Acid (PVC /Rubber Grade)

v Nonyl Phenol (Alphox)

v Xylene (Ortho/ Mix)

v Maleic Anhydride

v Phthalic Anhydride

v Pentaerythritol

v Formaldehyde

v Caustic Soda / Caustic Potash

v Soda Ash

v Pyridine

v MDC

v Urea (Technical)

l Anti-Ozone Softener l Ester Quat Fabric Softener

TEXTILE INDUSTRY INDUSTRIAL CHEMICALS

l 1,6-Hexanediol l BCDMH- Bromo Chloro Dimethyl Hydantoin Powder

l Vulkanox BKF- Rubber Antioxidant

l Rheovis – HEUR

Methyl Cyclohexane

Thickener for Paint Industry

v Tri Ethanol Amine (TEA)

v Tricloroethelene (TCE)

v Ammonium Chloride

v Citric Acid (Mono)

v Boric Acid / Borax

v Oxalic Acid (94% / 99%)

v Benzoic Acid

v Poly Vinyl Alcohol (PVA)

v Phosphorous Oxychloride

v Propylene Glycol (PG)

v Phosphoric Acid

v DiMethyl Formamide (DMF)

v Salicylic Acid

v Phosphorus Oxchloride

v Di Ethylene Glycol (DEG)

v Mono Ethylene Glycol (MEG)

v Iso Propyl Alcohol (IPA)

v TETA

v DETA

v Toluene

v Acetone

v Sodium Petroleum Sulphonate

-1/ 23, M.I.D.C. T Plot No. C Ta a Area, Boisarr, , Dist. P Mobile: 9323804995

Email: vitabiotic6

Web: www.vitamin ow.

Make: NHU and BASF

rapur Industrial. Palghar-401506. 5/ 7317246324 60@gmail.com n-probiotic.com we manufacture in our company y powders which These are some dr

• tified company Our company is also GMP cer

• food grade, pharma grade, cosmetic grade etc. provide all IU material and feed grade, We

Unipharma

(Dealers In Ac ve Pharmaceu cal Raw Material)

• py 28, Lohar Chawl, Ground Floor, Mahim (West), Mumbai 400016 Contact: 022 24451832 /24457618/9820051832

E Mail: Unipharma81@Gmail.Com

Products

l Ambroxol Hcl Ip

l Aceclofenac

l Alpha Lipoic Acid

l Ascorbic Acid

l Azithromycin

l Cefixime Trihydrate

Compacted

l Ciprofloxacinhcl

l Diclofenac Potassium

l Diclofenac Sodium

l Doxycycline Hydrochloride

l Enrofloxacin

l Fusidic Acid

l Griseofulvin

l Isoxsuprine Hcl

l Levo Salbutomal Sulphate

l Lumifentrine

l Metronidazole

l Norfloxacin

l Ofloxacin

l Paracetamol

l Pvpk 30

l Salbutamol Sulphate

l Sodium Fusidate

l Teneligliptin Hydrobromide Hydrate

l Terbutaline Sulphate

l Ivermectine Ip/ Bp/ Vet

l Ribavirin

We Can Provide Any Item Other Than Above As Per Your Valuable Requirement

We Manufacture: Specialist in Zinc Chloride Solution.

l Zinc Chloride Solution with all Metallic Impurities Less Than 5 PPM.

l Customized Zinc Chloride Solution as per customers need and specification.

l Radiator Flux (Zinc Chloride based)

l Zinc Chloride Based Fluxes.

Contact M/S. SIGMA CHEMICAL INDUSTRIES.

341, Uday Ground Floor, Ghantali Devi Road, Naupada, Thane (W).-400602, Mumbai, Maharashtra-India.

Contact no.: +91-22-25423456, +91 8097001101

Visit Us @: www.sigmachem.in

Email: info@sigmachem.in

P. G. Shah & Co.

Bulk Drugs, Intermediates, Excipients & Formula ons

Email: info@pgshah.com

Tel: +91 22 28990032; +91 22 28980312

Web: www.pgshah.com

APIs :

l l Azathioprine

l l Ci coline

l l Dil azem HCl

l l Esomeprazole Magnesium Trihydrate

l l Fexofenadine HCl

l l Fluconazole

l l Itraconazole

l l Levocetrizine Di HCl

l l Tadalafil

l l Iron Sucrose

l l Levosalbutamol Sulphate

l l Levothyroxine Sodium

l l Efinaconazole

l l Mycophenolate Mofe l/Sodium

ll Tigecycline

Vetrinary APIs :

l Albendazole

l l Butaphosphan

l l Clorsulon

l l Diminazene Di Aceturate

Excipients :

l l Cellulose Acetate Phthalate(CAP)

l l Hypromellose Phathalte(HPMCP)

l l Calcium Carbonate

ll Dapagliflozin

l l Pantoprazole Sodium

l l Rabeprazole Sodium

l l Riboflavin Phosphate Sodium

l l Enoxaparin

l l Vardenafil

l l Sildodosin

l l Bilas ne

l l Tirofiban

l l Terbutaline Sulphate

l l Tramadol HCl

l l Valsartan

l l Salbutamol Sulphate

l l Sumatriptan Succinate

l l Heparin Sodium

l l Fenbendazole

l l Triclabendazole

ll Flunixin Meglumine

l l Oxfendazole

l l Talcum

l l Dibasic Calcium Phosphate

Contact Person: Ravindra J. Hire, Mob. No. 9821962248 / 9029797870 / 7021582290 / 9029797880

Regd. office: 02/B, Madhuvanti Co. Op. Hsg. Society Ltd., Plot No. 81/82, Sector No.9, New Panvel, Navi Mumbai, Maharashtra, India, PIN Code – 410206

R & D Lab: B-194, Kohinoor Industrial complex, Opp. Hindalco Company, MIDC Taloja, Tal. Panvel, Raigad. 410208

deepapharma69@yahoo.com, hire@deepapharma,com, deepapharma69@gmail.com

www.deepapharma.com

Mobile

Email

v Aceclofe e nac c

v v A Adapaalleenne e

v AAllpha a Lippooic c AAccid d

v AAllbeennddaazo olle e

v v A Amoor o olffiine e

v AAr te e sunnaatte e

v AAr r tteemmeeeetthheer r

v AAssppaar r ttaamme e

v Beettaammeetthhaassoonne e Sa alltts s

v v B Biim m at to o p prr os st t

v v B Biio o t ti i n USSP

v Brriimmoonniiddiinne e Ta arr t trraat tee

vv Caar r b b a am m e ezzaap p ine

v v Cl l o ottr r ima azzool l e IP

v Deeffllaazzaaccoor r tt

v Diiccllooffeennaac c Diieetthhaallaammiinne e

v Diiccllooffeennaac c S Sooddiiuum m I IPP/B BPP

vv DDi i ccl l oof feen n aac c PPo o t taas s s siiu umm

vv DDo orr zool l aam m dde e

vv DDu u t taas s teer riid dee

vv Ebbeer r c coonnaazzoolle e

v v Ettiizzoollaam m

v v Feennttiiccoonnaazzoolle e Niittr r a atte e

v v Gl l i i m m ip p r r i i d de e

v v Hyd drr o o c c o orr t ti i s s o onne e Sa alltts s

v v IIb buup prr o o f f enn

v v LLa a t a anno oppr r o o s t

v v LLuul liic c o onna a zo olle e

v v Miissooppr r o ossttool l

v v Moonntteelluukaasstt

v v M Muupiir r o occiin n

v v N Neepaaffeennaac c

v v Ol l o op p a attaaddi i n n e

v v P P e er r m m e etth h r r i i n n

v v P P r r e ega a b b alli i ne

v v Qu u itti i a ap p i i n n e F F u u m m e er r a atte e

v v Roossuuva a s t a a t tiin n C C a allc ciiu u m m

vv T Tr r a a va appr r o o s s t t

vv UUD D C C A

Email :

Import | Export | Inden ng | Distribu on | Marke ng

CORE PRODUCTS

l HYDROQUINONE (HQ)

l PROPIONIC ACID

l IODINE PRILLS

l BKC 50% AND 80%

l TERT BUTANOL (TBA)

l TERT BUTYLHYDROQUINONE (TBHQ)

l ALL TYPES OF AMMINO ACIDS

l ACETIC ACID

l BENZOIC ACID

l N- BUTYRIC ACID

l CITRIC ACID

l ISOBUTYRIC ACID

l LACTIC ACID

l OXALIC ACID

l PHOSPHORIC ACID

SOLVENTS

l CYCLOHEXANONE

l PROPYLENE GLYCOL (PG)

l NORMAL BUTANOL (NBA)

l METHYL ISOBUTYL KETONE (MIBK)

FOOD ANTIOXIDANTS

l BUTYLATED HYDROXYANISOLE (BHA)

l BUTYLATED HYDROXYTOLUENE (BHT)

SPECIALTY CHEMICALS

l CALCIUM PROPIONATE (CP)

l TOLYLTRIAZOLE (TTA)

l XANTHAN GUM

METALLIC SALTS

l COBALT OXIDE

l COBALT SULPHATE

l COPPER SULPHATE

l FERROUS SULPHATE

l MANGANESE SULPHATE

l POTASSIUM IODATE

l POTASSIUM IODIDE

l SODIUM SELENITE

l ZINC OXIDE

101 Madhuram Apartment, Sainagar, Near 60 Feet Road, Vasai Road West, Palghar 401202.

S.A.I. PRODUCTS

W 54, PHASE II, M.I.D.C.AREA, DOMBIVLI (EAST) – 421 204. Mob: +91 9821142051 l Email: saiproducts@yahoo.co.in

PRODUCTS APPLICATIONS

CHEMICAL INTERMEDIATES

i)Sodium Azide For Bulk Drug Intermediates, For Explosives & Agicultural Products

ii) Ethyl/Methyl Palmitate As Chemical Intermediate

iii)Ethyl/Methyl Oleate

AGRICULTURAL PRODUCTS

i) MFA (Triacontanol) Powder Plant Growth Promoter & Fomulation-2%, 1%, 0.1%, 0.05%

ii) Dipping Oil Fruit Drying Oil

iii) Biosuper Plant Growth Regulator

iv) SuperFresh For Fruits & Vegetables

v) Vegetable/Fruit Special

vi) Herbogaurd Soil Fumigator

BIO PRODUCTS

i)Sophorolipid-Biosurfactant Used in Paint Industries, Biological, Agricultural,Bio-Processing, Cosmetic, Soap,Detergent, Mining, Petroleum, Environmental, Food Industries.

POULTARY FEED ADDITIVE

i)EnhanSo Powder Additive for Poultary Feed

ii)EnhanSo Liquid

Crystal Pharma

Importers & Mfgrs. Agents

ALBENDAZOLE CP / IP

AMPROLIUM BP VET

BUTAPHOSPHAN

CARPROFEN

CLOPIDOL B VET

CLOSANTEL BASE

COLLISTIN SULPHATE

DIAVERIDINE HCL

DL-TETRAMISOLE

ETHOPABATE BP VET

ETHOXYQUINE 66.6%

ENROFLOXACIN BASE

FENBENDAZOLE BP / VET

c, Think Us Think Logis

Pallet Racking System

We Store on racks with high tech ma

achines

FLUNIXIN MEGLUMIN

FURAZOLIDONE BP

IVERMECTIN EP 2000

LEVAMISOLE HCL BP

NEOMYCINE SULPHATE

OXYCLOSANIDE BPV

OXYTETRACYCLINE BP

PRAZIQUENTEL USP

RAFOXANIDE BPV

STREPTOMYCIN SULPHATE

SULPHAQUINOXALINE SODIUM

TOLTRAZURIL

VITAMIN ALL MUMBAI, MAHARASHTRA

Tel: 022-25927631 / 67107631 l Fax: 022-25925874

l Mob: 09820141331 / 09322218073

Email: crystalpharma9@gmail.com / hls_crystal10@yahoo.com

l Website: www.crystalpharma.co.in

l COMPLETE FORM

MALITIES WITH NOC

l ALL SAFETY MEA

l WORK ENVIRON

l A NE AT T & CLEAN E

T ASURE HAS BEAN TAAK NMENT IS EMPLOY FR NVIRONMENT

x, Building No. T Globe Comle T, , Godown No. 4,5,6,7,8, Near R Opp CNG Pump, Dapoda Rd, Bhiwandi Thane 4213

Contact: Jitendra Mane: 9221553456, 9869427039| O . .No. Email: info@omkarlogis c.in|Web: webmail.loginomkar

C KEN REINDLLY Y uchita Hotel, 302. : 8369268692 rlogis c.in

LABORATORY CHEMICALS

Dealers & Re-packers of Laboratory Chemicals. We Provide Laboratory chemicals in BULK & Small Packing. We Organize your EXPORT Order for Laboratory Chemicals.

Amino Acids

Culture Media

Iron Pairing Reagents

Metal Salts

Chemicals for feed Ind.

Biochemicals

Dye & Stains

Metal Powders/Turnings

Solvents & Acids

POWDER PACK CHEM

R.no.8, 1st Floor, Patel Villa, Pethe Wadi,Jambli Galli, Off. S.V.Road,Borivali (w), Mumbai-400092

Tel: 91-22-28989262

Mob. no: 9223433936 / 9320433236.

Email: powderpack1@gmail.com

AVAILABLE PRODUCTS

PARACETAMOL IP / BP/ EP / USP

FOLIC ACID IP / BP / EP / USP

DOMPERIDONE MALEATE IP / BP

ENELAPRIL MALEATE IP / BP

GLIPIZIDE IP / BP

SRI PHARMACARE

Chemicals for Cosmetic Ind. 205, Srish Plaza, Saki Vihar Road, Powai, Mumbai 400072

A ARNISH LAABOR R A NAME OF PRODUCT CAS NO CAPACITY STANDARD/ MT/ANNUM MINIMUM PACK ACID FUCSHIN SODIUM SALT 3244-88-0 2 5 Kgs ACRIDINE ORANGE BASE 494-38-2 3 1 Kgs ACRIFLAVIN HYDROCHLORIDE 8063-24-9 10 25 Kgs ALIZARINE COMPLEXONE 3952-78-1 1 1 Kgs AMMONIUM CERIC NITRATE AR 16774-21-3 50 25 Kgs AURIN (p-ROSALIC ACID) 603-45-2 5 5 Kgs AZUR – A 531-53-3 5 25 Kgs BLUE TETRAZOLIUM (BT) 1871-22-3 5 5 Kgs CALCON 2583-85-4 2 1 Kgs CHROMOTROPIC ACID DI-SODIUM 5808-22-0 5 25 Kgs SALT D-HYD. o-CRESOLPHTHLALEIN 596-27-0 2 10 Kgs 2:6 DICHLOROPHENOL INDOPHENOL 620-45-1 10 5 KGS SODIUM SALT MALACHITE GREEN OXALATE 2437-29-8 100 25 kgs METHYLENE BLUE ZINC FREE 7220-79-3 100 25 Kgs METHYL RED FREE ACID 493-52-7 25-30 25 kgs MUREXIDE 3051-09-0 25 25 kgs NINHYDRIN 485-47-2 50 25 kgs THIOFLAVIN – T 2390-54-7 10 5 Kgs THYMOLPHTHALEIN 125-20-2 20 25 kgs

Ph: +22 40151518 / 19 l Fax: +22 40151520

Email: pharma@sripharmacare.com

Website: www.sripharmacare.com

Propylene

l Thioglycolic Acid 80%,99%

l 3 Mercaptopropionic Acid 99%

l Potassium Thioglycolate

l Monoethanolamine Thioglycolate

l Diammonium Dithiodiglycolate

l Pentaerythritol 3 Mercaptopropionate

l POLYTHIOLS

l Monothioglycerol 90,98,NF

l Thiodipropionic Acid

l 2 Sulfoethyl Methacrylate

l An oxidant for Polymers

l Ditridecyl Thiodipropionate

l Distearyl Thiodipropionate

l Dilauryl Thiodipropionate

Services:

Purity of solvents by GLC and KF

Metal tes ng by ICP OES up to ppb level

Anions and Ca ons by Ion Chromatography up to 0.1 ppm

Molecular weight determina on by GPC

Purity by HPLC FAME Analysis

Contact Us @ DR. KETAN MERCHANT

Email ID: saslab21@gmail.com , info@saslabindia.com

Mobile: 8850413449 / 9821291797 / 9821075247

Tel: 91-22-25000386 / 25000186 / 42150502

Website: www.saslabindia.com

Address: 305, 3rd Floor, Jhalawar Building, Patanwala compound, opposite Shreyas Talkies, LBS Marg, Ghatkopar-West-400086

PRODUCTS

TRICHOLINE CITRATE

50% & 65% & 70% Solution – IHT

CHOLINE DIHYDROGEN CITRATE

50% Solution – IHT

CHOLINE BICARBONATE

50% Solution – IHT

CHOLINE BITARTRATE COATED with 1% Silicon Dioxide – IHT

CHOLINE SALICYLATE

50% Solution – IHT

CHOLINE CHLORIDE Pure IHT

CHOLINE CHLORIDE

70% Solution – IHT

CHOLINE CHLORIDE

60% Feed Grade – IHT

M/S. ALBA ORGANICS

v Aerosil (Madhusilica)

v Acetic Acid Glacial

v Acetone

v Alum (Ferric /Non Ferric /Powder)

v Ammonium Bi Carbonate (RCF)

v Ammonium Chloride (IP) (China)

v CarbonTTeetra Chloride

v Caustic potash Flakes

v Di Ammonium Phosphate (DAP)

v Dex Mono / Anhy (Universal)

v Ferric Chloride Anhydrous

v Glycerine(Indonasia)

v Alcohol. (T Iso Propyl Taaiwan / Deepak)

v Methyl Ethyl Ketone (M.E.K)

v Methanol

v Malto Dexstrine (Ambuja)

v Phosphrous Acid (China)

Available in small packing and in Bulk

Chlorosulphonic Acid

Oleum Acid 25% and 65%

Nitric Acid 72% and 98%

Diethyl Sulphate

Benzene Sulphonic Acid

Thionyl Chloride

SUNRAJ CHEMICAL CO.

K. B. Achhra Chambers, 2nd Floor, Behind Hari Kirtan Darbar, Section 17, Ulhasnagar – 421003. Tel.: 0251 – 2707408, 2731484

Mob.: 9422686622 / 9096576500

Email: sunraajchem@yahoo.co.in

ly Aluminium Chloride

ttasium Chloride

tassium Sorbate (China)

fined Salt(GHCL)

dium Benzoate da Ash (Dense / Light)

dium Hypochloride (6% & 12%)

dium Sulphate Anhydrous dium Starch Glycolate dium Bi Carbonate rbitol

ulphamic Acid

v S v S

A/56, Sector-3, Shanti 202, Bldg

Address: F 63,First floor, The Zone Mall, Chandavarkar Road, Borivali West, Mumbai 400092. Factory: Dewa, Barabanki, U ar Pradesh.

odium Metabi Sulphide odium Sulphate Flakes (YYeellow) hioure (Imported)

rea T Teechincal Grade White dexstrine

Maharashtra. , Mira Road (East). Nagar

Mobile:9820430709 / Dist-Thane, Pin-401 107

Email:keshariya_cor@yahoo.co.

www.keshariyacorp

www.keshariyacorpo

9222447459

ration.co.in oration.com in, infokc9@gmail.com

Dev Pharmaceuticals

Shap No. 8, Gr. Floor, Shree Naman Plaza, Behide Namah Hospital, S. V. Road, Kandivli-

HRITIK CHEMICALS PVT. LTD.

STEROIDS:HORMONES:

l Fluocinolone Acetonide

l

USP

l Beclomethasone Dipropionate IP/ BP/USP

l Betamethasone Valerate IP/ BP/ USP

l Budesonide

l Clobetasol Propionate BP/ USP

l Clobetasone Butyrate BP

l Mometasone Furoate IP/ BP/ USP

l Halobetasol Propionate

ENZYME LIST:

l Bromelain (IP/BP/USP & JP)

l Serratiopeptidase powder

l Serratiopeptidase enteric coated granules

l Trypsin (BP/ USP)

l Trypsin Chymotrypsin

l Chymotrypsin

l Pepsin (USP, EP & Injectable Grade)

l Lipase

PROBIOTIC LIST:

l Bacillus Coagulans(250 Billion)

l Lactobacillus Acidophilus (200 Billion)

l Lactobacillus Rhamnosus (200 Billion)

l Bacillus Subtilis (200 Billion)

l Bacillus Clausii (300 Billion)

l Saccharomyces Boulardii (20 Billion)

l Streptococcus Thermophilus (400Billion)

l Bacillus Licheniformis (200 Billion)

l Dutasteride

l Fluticasone Propionate

l Finasteride

l Budesonide

l Triamcinolone Acetonide/ Base

l Desonide

l Betamethasone Sodium Phosphate

l Co-enzyme Q10

l Pancreatin (USP, BP & EP)

l Cellulase

l Hemicellulase

l Beta Glucanase

l Xylanase

l Pectinase

l Transglutaminase

l Bifidobacterium Breve (300 Billion)

l Bifidobacterium Infantis (50 Billion)

l Bifidobacterium Longum (100 Billion)

l Bifidobacterium Bifidum (100 Billion)

l Bifidobacterium Lactis/ Animalis (500 Billion)

l Lactobacillus Brevis (200 Billion)

l Lactobacillus Bulgaricus (50 Billion)

l Cyproterone Acetate

l Drosperinone

l Desogestrel

l Tibolone

l Levonorgestrel

l Estradiol/ Estradiol Hemihydrate

l Norgestrel

l Ethinyl Estradiol

EXCIPIENTS:

l Starch All Grades

l High Maltose Corn Syrup

l Glucose Anhydrous BP

l Liquid Glucose (SO2 Free)

l Lactose IP/ BP/ USP

NUTRACEUTICALS LIST:

l Sodium Hyaluronate (Food Grade, Injectable & Cosmetic)

l Lutein (Oil, Powder& Beadlets) (Ester & Ester Free)

l Unique Blend of TBR (Powder, DC Granules) (Trypsin + Bromelain+ Rutoside)

l L- Glutathione Reduced (Food & Injectable)

l Beta Glucan- (Yeast, Oat & Schizophyllum commune)

HERBAL & OIL EXTRACTS:

l Almond Oil l Aroma Oils

l Black Seed Oil

l Citronella Oil l Essential Oils

l Eve. Primrose Oil

l Flaxseed Oil l Nutmeg Oil

l Herbal Actives l Herbal Extracts

l Estradiol Velerate

l Nomegestrel

l Lynestrenol

l Ulipristal Acetate

l Gestodene

l Conjugated Estrogen

l Dienogest

l Dextrose Monohydrate

l Dextrose Anhydrous IP

l Liquid Glucose (Confectionery)

l Dextrose Syrup

l S- adenosyl-L-methionine (SAMe)

l Adenosine Triphosphate (ATP)

l L- methyl Folate

l Bile Salt

l Alpha GPC

l Pyrroloquinoline Quinone Disodium Salt)

l Phosphatidyl Choline

l Phosphatidyl Serine

l Superoxide Dismutase (SOD)

l Chondroitin Sulphate Sodium

l N- Acetyl Glucosamine

l Jasmine Concrete

l Kalongi Oil l Clove Oil

l Lemon Grass Oils (70+)

l Linseed Oil

l Neem Extract (Of Seed, Leaf & Bark)

WE ALSO SUPPLY ALL CHEMICAL & SOLVENT IN DRUMS AND TANKER

Suppliers of API’s | Excipients | Vitamins | Additives

Group HQ: B­503, Eureka Tower, Mindspace, Off. Link Road, Malad (West), Mumbai­ 400064, India. Contact: +91 22 48822900 & +91 22 50622900 | Email: info@pharmakpi.com | Web: www.pharmakpi.com

Contact Person: Mr. Viral Jitendra Patel, Vice President Mob: +91-9867828894

ACECLOFENAC IP

FLUCONAZOLE IP

TELMISARTAN IP

FOLIC ACID IP

UDCA IP

MELATONIN IP / USP

ISOTRETINOIN IP / USP

ISOTRETINOIN IP MICRONISED

VOGLIBOSE IP

FUSIDIC ACID IP

VITAMIN A ACETATE IP

ACYCLOVIR

ATORVASTATIN CALCIUM

DICLOFENAC SODIUM

IBUPROFEN USP IP BP CP JP

LIGNOCAINE HYDROCHLORIDE

MECOBALAMIN USP IP BP CP JP

PARACETAMOL IP BP USP

POLYMIX B

PREGABALIN

CEFOTAXIME SODIUM IP BP USP

CEFTRIAXONE SODIUM IP BP USP

API’s

CEFUROXIME AXETIL IP BP USP

CHLORAMPHENICOL IP BP USP

CLINDAMYCIN HCL

CLINDAMYCIN PHOSPHATE

CYANOCOBALAMIN IP BP USP

DICLOFENAC SODIUM

DOXYCYCLINE HCL IP BP USP

ALLOPURINOL

ALBENDAZOLE IP / USP

BENFOTHIAMINE IHS

ETAMSYLATE BP

FEXOFENADINE HCL IP

LORNOXICAM IH

ONDENSETRON HCL IP

QUETIAPINE FUMARATE

CLOPIDOGREL BI SULPHATE IP

DROTAVERINE HCL IP

MEBVERINE IP

METAXALONE IP

SERTRALINE IP

METFORMIN HCL IP

MONTELUKAST SODIUM IP

EXCIPIENTS ADDITIVES

CITRIC ACID MONO

HPMC E5

HPMC E15

HPMC K100M

HPMC K4M

PVPK 30 (USP 26 / USP 39)

PVPKP 90

MICROCRYSTALLINE CELLULOSE

MCCP

MCCP IP

SODIUM STARCH GLYCONATE IP

MAGNESIUM STEARATE IP

CROSS CARMELOSE SODIUM USP

CALCIUM CITRATE

BRONOPOL BP

v ACESULFAME v ASPARTAM

v SACCHARIN SODIUM v SUCRALOSE

SELF IMPORT ( APIs)

AZITHROMYCIN IP

OXYTETRACYCLINE BASE USP IP BP

OXYTETRACYCLINE HCL USP IP BP

SULBACTAM SODIUM IP BP USP

PIRACETAM IP BP USP

DOXYCYCLINE HCL IP BP USP

CLINDAMYCIN HCL

CLINDAMYCIN PHOSPHATE

CYANOCOBALAMIN IP BP USP

CHLORAMPHENICOL IP BP USP

BETA CYCLODEXTRIN

n-Butyl Magnesium Bromide

n-Butyl Magnesium Chloride

n-Propyl Magnesium Bromide

t-Butyl Magnesium Chloride

RUSKIN CHEMIPHARM (Your Sourcing Partner)

PRODUCTS AVAILABLE INDENTING /READY STOCK

AMPHOTERICIN

ARBEKACIN SULPHATE

ATRACURIUMBESYLATE

AZITHROMYCIN

BACITRACIN ZINC

BENZATHINEBEZYLPENICILLIN STERILE

BENZYLPENICILLIN SODIUM STERILE

5 CALCIUM SALTS

CAPREOMYCIN SULPHATE

CASPOFUNGIN ACETATE

CILASTATIN

CISATRACURIUMBESYLATE

CROSSPOVIDONE XL - 10

DEXMEDITOMIDINE HYDROCHLORIDE

DOXYCYCLINE HYCLATE

ETOPOSIDE

HPMC E5 / E15

KANAMYCIN SULPHATE STERILE

LEVAMISOLE HYDROCHLORIDE

LINCOMYCIN HYDROCHLORIDE

MEFENAMIC ACID

MESNA

MITOMYCIN

NEOMYCIN SULPHATE

NYSTATIN

OXALIPLATIN

PIRACETAM

POLYMYXIN B SULPHATE STERILE

PROCAINE BENZYLPENICILLIN STERILE

RIFAMPICIN

ROCURONIUM BROMIDE

SEVOFLURANE

SPIRAMYCIN

STRETPOMYCIN SULPHATE STERILE /ORAL

SUCRALOSE

TACROLIMUS

TEICOPLANIN STERILE

TETRACYCLINE

VANCOMYCIN

CONTACT:

Mr. Krishnakumar: +919322226307.

Mr. Yash: +919819826611

Tel: +91‐22‐22059494/22068330.

Email ID: sourcing@ruskinchemipharm.in, sales@ruskinchemipharm.in

Website: www.ruskinchemipharm.in